UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_____________________________

FORM 10-K

~~_____________________________~~(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

	For the Fiscal Year Ended April 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT

	For the transition period from ________ to ________

~~For the fiscal year ended April 30, 2014~~BioQuest Corp.

OR(Exact Name of Registrant as Specified in Its Charter)

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Nevada

000-56260

99-0378854

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

~~Commission~~4570 Campus ~~File~~Drive, ~~Number: 333-186461~~Suite 23

~~_____________________________~~Newport Beach, CA 92660

~~SELECT-TV SOLUTIONS, INC~~714.978.4425

~~f/k/a~~(Address of ~~Sedition~~Principal ~~Films~~Executive ~~Inc.~~Offices, Zip Code & Telephone Number)

~~(Exact~~Securities registered ~~name~~pursuant ofto ~~registrant as~~Section ~~specified~~12(b) inof ~~its~~the ~~charter)~~Act: None.

~~_____________________________~~Securities registered pursuant to section 12(g) of the Act:

Nevada			99-0378854
(State or other jurisdiction of incorporation or organization)			(IRS Employee Identification No.)
1395 Brickell Avenue, Suite 800 Miami, FL			33131
(Address of principal executive offices)			(Zip Code)

Common Stock, Par Value $0.001 per share

~~Registrant’s~~Indicate ~~telephone~~by ~~number,~~check ~~including~~mark ~~area~~if ~~code:~~the ~~(418)~~registrant ~~264~~is a well-~~7134~~known seasoned issuer, as defined in Rule 405 of the Securities Act.

~~_____________________________~~Yes ☐ No ☒

~~Securities~~Indicate by ~~registered~~check ~~under~~mark if the registrant is not required to file reports pursuant to Section 1213 or Section 15(bd) of the ~~Exchange~~ Act:

~~None~~Yes ☐ No ☒

~~Securities~~Indicate by ~~registered~~check ~~under~~mark whether the registrant (1) has filed all reports required to be filed by Section 1213 or 15(gd) of the ~~Exchange~~Securities Exchange Act: of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

~~Common~~Yes ☐ ~~Stock,~~No ~~$.001 Par Value~~☒

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (~~Title~~§232.405 of ~~class~~this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

~~_____________________________~~Yes ☐ No ☒

Indicate by check mark if ~~the~~disclosure ~~registrant is~~of adelinquent ~~well~~filers pursuant to Item 405 of Regulation S-~~known~~K ~~seasoned~~is ~~issuer~~not contained herein, asand ~~defined~~will innot ~~Rule~~be ~~405~~contained, to the best of ~~the~~registrant’s ~~Securities~~knowledge, ~~Act.~~in odefinitive proxy or information statements incorporated by reference in Part III of this ~~Yes x~~Form No10-K or any amendment to this Form 10-K. ☐

Indicate by check mark ifwhether the registrant is ~~not~~a ~~required~~large toaccelerated ~~file~~filer, ~~reports~~an ~~pursuant~~accelerated tofiler, ~~Section~~a 13non-accelerated filer, a smaller reporting company, or ~~Section~~emerging ~~15(d)~~growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. ~~o Yes x~~(Check Noone):

~~Indicate~~Large byAccelerated ~~check~~Filer ~~mark~~☐ ~~whether~~Accelerated ~~the~~Filer ~~registrant (1)~~☐ ~~has~~Non-Accelerated ~~filed~~Filer ~~all~~☐ ~~reports~~Smaller ~~required~~Reporting toCompany be☒ ~~filed by Section 13 or 15~~(d)Do ofnot ~~the~~check ~~Exchange~~if ~~Act~~a ~~during~~smaller ~~the~~reporting ~~preceding 12 months (or for such shorter period that the issuer was required to file such reports~~company), ~~and~~Emerging ~~(2)~~Growth ~~has~~Company ~~been subject to such filing requirements for the past 90 days. x Yes o No~~☐

~~Indicate~~If an emerging growth company indicate by check mark ~~whether~~if the registrant has ~~submitted~~elected ~~electronically~~not ~~and~~to ~~posted~~use onthe ~~its~~extended ~~corporate~~transition ~~Website,~~period iffor complying with any, ~~every Interactive~~new ~~Data~~or ~~File~~revised ~~required~~financial toaccounting bestandards ~~submitted and~~provided ~~posted~~ pursuant to ~~Rule~~Section ~~405 of Regulation S-T~~ 13(~~§232.405~~a) of ~~this chapter) during~~ the ~~preceding~~Exchange 12Act ~~months (or for such shorter period that the registrant was required to submit and post such files). x Yes o No~~☐

~~Indicate by check mark if disclosure of delinquent~~Securities ~~filers~~registered pursuant to ~~Item~~Section ~~405 of Regulation S-K~~ 12(§b) ~~229.405~~ of ~~this chapter) is not contained herein, and will not be contained, to~~ the ~~best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x~~Act:

~~Indicate~~Title byof ~~check~~each ~~mark~~class ~~whether~~Trading ~~the~~Symbol(s) ~~registrant~~Name isof aeach ~~large~~exchange ~~accelerated filer,~~on anwhich ~~accelerated~~registered ~~filer, a non-accelerated filer or a smaller reporting company filer~~None. ~~See~~ ~~definition~~N/A ~~of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act~~None.

~~Large~~Indicate by ~~accelerated~~check ~~filer~~mark owhether ~~Accelerated~~the ~~filer~~registrant ois ~~Non-accelerated~~a ~~filer~~shell ocompany (Doas ~~not~~defined ~~check~~in ifRule a12b-2 ~~smaller~~of ~~reporting~~the ~~company)~~Exchange ~~Smaller reporting company x~~Act).

~~Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). x~~ Yes o☐ No ☒

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was ~~last~~ sold, or the average bid and asked ~~price~~prices of such common equity, as of the last business day of the registrant'’s most recently completed ~~second~~ fiscal quarter. $$947,730 on April 30, 2021

OnIndicate the ~~October~~number 31of shares outstanding of each of the registrant’s classes of common stock, ~~2013~~as of the latest practicable date. The number of shares outstanding of the registrant’s only class of common stock, ~~there~~as of August 9, 2021, was no8,795,733 ~~market~~shares ~~for~~of ~~our~~its ~~securities~~$.001 par value common stock.

~~As of August 11, 2014 the registrant had 62,134,000~~Documents ~~shares~~incorporated ofby ~~its~~reference: ~~Common Stock, $0.001 par value, outstanding.~~None

~~SELECT-TV SOLUTIONS,~~BioQuest ~~INC~~Corp.

ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED APRIL 30, 2014

TABLE OF CONTENTS

		Page
			Page No.
PART I		3
Part I
Item 1.	~~Business.~~	3Business	4
Item 1A.	~~Risk Factors.~~	5Risk Factors	9
Item 1B.	~~Unresolved Staff Comments.~~	7Unresolved Staff Comments	16
Item 2.	~~Properties.~~	8Properties	16
Item 3.	~~Legal Proceedings.~~	8Legal Proceedings	17
Item 4.	~~Mine Safety Disclosures.~~	8Mine Safety Disclosures	17
PART II		9
Part II
Item 5.	~~Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.~~	9Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	17
Item 6.	~~Selected Financial Data.~~	10Selected Financial Data	19
Item 7.	~~Management’s Discussion and Analysis of Financial Condition and Results of Operations.~~	10Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 7A.	~~Quantitative and Qualitative Disclosures About Market Risk.~~	12Quantitative and Qualitative Disclosures about Market Risk	22
Item 8.	~~Financial Statements and Supplementary Data.~~	13Financial Statements and Supplementary Data	23
Item 9.	~~Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.~~	14Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	35
Item 9A.	~~Controls and Procedures.~~	14Controls and Procedures	35
Item 9B.	~~Other Information.~~	15Other Information	35
PART III		16
Part III
Item 10.	~~Directors, Executive Officers and Corporate Governance.~~	16Directors and Executive Officers	36
Item 11.	~~Executive Compensation.~~	17Executive Compensation	39
Item 12.	~~Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.~~	18Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	41
Item 13.	~~Certain Relationships and Related Transactions, and Director Independence.~~	19Certain Relationships and Related Transactions	42
Item 14.	~~Principal Accounting Fees and Services.~~	19Principal Accounting Fees and Services	42
PART IV		20
Part IV
Item 15.	~~Exhibits, Financial Statement Schedules.~~	20Exhibits	43
SIGNATURES		21
Signatures			44

~~PART 1~~Part I

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING ~~STATEMENTS~~INFORMATION

~~Certain statements made in this~~ This Annual Report on Form 10-K ~~are~~contains "forward-looking statements" (within the meaning of ~~the~~Section ~~Private~~27A ~~Securities Litigation Reform Act~~ of ~~1995)~~ ~~regarding~~ the ~~plans~~Securities ~~and~~Act ~~objectives~~ of ~~management~~1933, ~~for~~as ~~future~~amended (the ~~operations.~~“Securities ~~Such~~Act”) ~~statements involve known~~ and ~~unknown~~Section ~~risks, uncertainties~~21E ~~and~~of ~~other~~the ~~factors~~Securities ~~that~~Exchange ~~may~~Act ~~cause~~of ~~actual results~~1934, ~~performance~~as oramended ~~achievements of~~ (the ~~Registrant~~“Exchange ~~to be materially different~~Act”). ~~from~~These ~~any future results, performance or achievements expressed or implied by such~~ forward-looking statements. ~~The~~are ~~forward-looking statements~~not ~~included~~historical ~~herein~~facts but rather are based on current expectations, ~~that~~estimates ~~involve numerous risks~~ and ~~uncertainties~~projections. ~~The Registrant's plans~~We ~~and~~may ~~objectives~~use ~~are~~words ~~based,~~such inas ~~part~~“anticipate,” ~~on assumptions involving the continued expansion of business. Assumptions relating to the foregoing involve judgments with respect to~~“expect,” ~~among other things~~“intend,” ~~future economic~~“plan,” ~~competitive and market conditions and future business decisions~~“believe,” ~~all~~“foresee,” of“estimate” ~~which are difficult or impossible to predict accurately~~ and ~~many~~variations of ~~which~~these ~~are~~words ~~beyond~~and ~~the~~similar ~~control~~expressions ofto ~~the~~identify ~~Registrant. Although the Registrant believes its assumptions underlying the~~ forward-looking statements. These statements are ~~reasonable,~~not ~~any~~guarantees of ~~the~~future ~~assumptions~~performance ~~could prove to be inaccurate~~ and, ~~therefore,~~are ~~there~~subject ~~can be no assurance the forward-looking statements included in this Report will prove~~ to becertain ~~accurate.~~risks, ~~In light of the significant~~ uncertainties, ~~inherent~~and inother ~~the forward-looking statements included herein~~factors, ~~the~~some ~~inclusion~~ of which ~~such~~are ~~information~~beyond ~~should~~our ~~not~~control, beare ~~regarded~~difficult asto apredict ~~representation~~and bycould ~~the~~cause ~~Registrant~~actual orresults ~~any~~to ~~other~~differ ~~person~~materially ~~that~~from ~~the~~those ~~objectives~~expressed ~~and~~or ~~plans~~forecasted. ofThese ~~the~~risks ~~Registrant~~and ~~will~~uncertainties beinclude ~~achieved.~~the following:

● The ~~forward-looking~~availability ~~statements~~and ~~included~~adequacy ~~in this~~of ~~Form~~our ~~10-K~~cash ~~and~~flow ~~referred~~ to ~~elsewhere~~meet ~~are~~our ~~related~~requirements; to● ~~future~~Economic, ~~events~~competitive, ordemographic, ~~our~~business ~~strategies~~and orother ~~future~~conditions ~~financial~~in ~~performance.~~our Inlocal ~~some cases,~~and ~~you~~regional ~~can~~markets; ~~identify~~● ~~forward-looking~~Changes ~~statements~~or bydevelopments ~~terminology~~in ~~such~~laws, asregulations ~~"may,"~~or ~~"should,"~~taxes ~~"believe," "anticipate,"~~in ~~"future,"~~our ~~"potential,"~~industry; ~~"estimate,"~~● ~~"encourage,"~~Actions ~~"opportunity," "growth,"~~taken ~~"leader,"~~or ~~"expect,"~~omitted ~~"intend,"~~to ~~"plan,"~~be ~~"expand,"~~taken ~~"focus," "through,"~~by ~~"strategy,"~~third ~~"provide,"~~parties ~~"offer,"~~including ~~"allow,"~~our ~~commitment,"~~suppliers ~~"implement," "result,"~~and ~~"increase~~competitors," ~~"establish,"~~as ~~"perform,"~~well ~~"make,"~~as ~~"continue~~legislative," ~~"can~~regulatory,~~" "ongoing,"~~ ~~"include"~~judicial orand ~~the~~other ~~negative~~governmental ofauthorities; ~~such~~● ~~terms~~Competition orin ~~comparable~~our ~~terminology.~~industry; ~~All~~● ~~forward-looking~~The ~~statements included~~loss inof ~~this~~or ~~Form~~failure ~~10-K~~to ~~are~~obtain ~~based~~any onlicense ~~information~~or ~~available~~permit tonecessary usor asdesirable ofin the ~~filing~~operation ~~date~~ of ~~this~~our ~~report,~~business; ~~and~~● ~~the~~Changes ~~Company~~in ~~assumes no~~our ~~obligation~~business tostrategy, ~~update~~capital ~~any~~improvements ~~such~~or ~~forward-looking~~development ~~statements.~~plans; ~~Our~~● ~~actual~~The ~~results~~availability ~~could~~of ~~differ~~additional ~~materially~~capital ~~from~~to ~~the~~support ~~forward-looking statements.~~capital ~~Important~~improvements ~~factors~~and ~~that~~development; ~~could~~and ~~cause~~● ~~actual~~Other ~~results~~risks toidentified ~~differ~~in ~~materially~~this ~~from~~report ~~expectations~~and ~~reflected~~ in our ~~forward-looking statements~~other ~~include~~filings ~~those~~with ~~described~~the inSecurities ~~Item~~and ~~1A,~~Exchange ~~"Risk~~Commission ~~Factors~~or the SEC."

~~Item~~This report 1should be read completely and with the understanding that actual future results may be materially different from what we expect. The ~~Business~~forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

~~General~~Use of Term

~~Select-TV~~Except as ~~Solutions,~~otherwise ~~Inc.~~indicated (by the "context, references in this report to “Company"”, “~~SELT~~BioQuest”, “BQST,” “we”, “us” orand “our”) ~~was~~are ~~incorporated~~references into ~~Nevada~~BioQuest onCorp. ~~May~~All ~~17,~~references ~~2011~~to ~~under the~~“USD” ~~name~~or ofUnited ~~Renaissance~~States ~~Films~~Dollars ~~Inc.~~refer ~~(“RFI”) and intended~~ to ~~produce~~the ~~documentary~~legal ~~films.~~currency Onof ~~September 26, 2011,~~ the ~~Company changed~~United ~~its~~States ~~name~~of ~~to Sedition Films Inc~~America.

On April 7, 2014, the Company experienced a change in control. Conseil Plumage Blanc Ltd. (“CPB”) acquired a majority of the issued and outstanding common stock of the Company in accordance with a stock purchase agreement by and between CPB and Jesse Lawrence, the Company’s former director and majority shareholder. On the closing date, April 7, 2014, pursuant to the terms of the Stock Purchase Agreement, CPB purchased from Jesse Lawrence 4,000,000 shares of the Company’s outstanding common stock for $375,000. As a result of the change in control, CPB owned a total of 4,000,000 shares of the Company’s common stock representing 74%.3

~~In conjunction with the change in control,~~Item Mr1. Jesse Lawrence resigned as the Company's director, and any other positions held by him on April 9, 2014. The resignation was not the result of any disagreement with the Company or any matter relating to the Company's operations, policies or practices. On the same date, Mr. Philippe Germain and Mr. Antonio Treminio were appointed as directors.Business

~~On May 1, 2014, the Company filed an amendment~~Description ~~to its Articles~~ of ~~Incorporation in~~ the State of Nevada to change its name to Select-TV Solutions, Inc. The Company intends to pursue significant opportunities available within the Hospitality sector providing end to end IPTV (Internet Protocol Television) solutions. The Company has a strong technology platform, and believes a great opportunity to become a leader in the North American hospitality market over the next few years.Business

OnThe following ~~May~~description 1,of ~~2014,~~our ~~the~~business ~~Company's~~contains ~~Board~~forward-looking ofstatements ~~Directors declared~~relating ~~a ten-~~to~~-one~~ ~~forward~~future ~~stock~~events ~~split~~or ofour ~~all~~future ~~outstanding~~financial ~~shares~~or ofoperating performance ~~common~~that ~~stock.~~involve ~~The~~risks ~~effect~~and ofuncertainties, ~~the~~as ~~stock~~set ~~split~~forth ~~increased~~above ~~the number~~under of“Special ~~shares~~Note ofRegarding ~~common~~Forward-Looking ~~stock~~Statements.” Our ~~outstanding~~actual results could differ materially from ~~5,413,400~~those toanticipated ~~54,134,000.~~in ~~The~~these ~~total~~forward-looking ~~number~~statements as a result of ~~authorized~~certain ~~common~~factors described ~~shares~~in ~~and~~this Annual Report, including those set forth above in the ~~par~~ ~~value~~Special ~~thereof~~Cautionary ~~was~~Note ~~not~~Regarding ~~changed~~Forward-Looking byStatements or under the ~~split~~heading “Risk Factors” or elsewhere.

~~On July 7, 2014, the company’s shareholders~~Business ~~appointed Mr. Geoffrey P. Mott as the Company’s Chief Executive Officer.~~Overview

OnBioQuest, Corporation ~~July~~– ~~31,~~plans ~~2014~~to market, ~~the~~package ~~Company~~ and ~~Select~~distribute health Hemp-~~TV Solutions~~CBD ~~(USA),~~based ~~Inc~~products. ~~entered~~Our ~~into~~mission ais ~~binding~~to ~~merger~~Create ~~agreement~~High ~~whereby all of the right~~End, ~~title,~~ Products and ~~interest~~aggregate in all ofrelevant ~~the~~CBD ~~assets, properties,~~content ~~and~~in ~~associated~~the ~~rights~~Nutraceutical ~~that~~markets. ~~are~~In ~~used~~addition, orBioQuest ~~held~~will ~~for~~also ~~use of Select-TV Solutions (USA), Inc.~~ be ~~automatically~~positioned ~~transferred~~ to ~~The~~generate ~~Company~~revenue by ~~free~~acquiring ~~and~~established ~~clear~~companies ofwho ~~any~~have ~~and~~a ~~all~~current ~~liens.~~presence ~~The~~in ~~assets~~the ofnutraceutical ~~Select-TV~~and ~~Solutions~~CBD ~~(USA),~~industry ~~Inc.~~if ~~consist~~the ~~primarily~~opportunity ofpresents ~~its sublicense~~itself ~~giving~~and itbring ~~the~~its ~~right~~products to ~~carry on~~ the ~~Select-TV~~market ~~Business,~~generating ~~Intellectual~~immediate ~~Property~~revenues, ~~Trademarks,~~created ~~trade Names~~ and ~~Copyrights~~marketed ~~and~~by ~~Trade Secrets~~BioQuest.

3We believe that we can build our Company into a recognizable brand in the Nutraceutical and Pharmaceutical industry. We recognized early on the importance of creating a strong, identifiable, and lasting brand that would separate our Company from the competition and resonate with customers. Our logo, our name, the style of our ads, and all collateral material will reflect our “brand image.” Since the legalization of medical and recreational CBD, numerous states have created new and exciting markets with great investment potential.

~~Our~~We will ~~Products~~sell primarily into the business-to-business market and ~~Services~~internet-based business to consumer, which includes legally operating medical and adult-use dispensaries, store fronts, and brand owners in states with CBD programs.

~~Select-TV~~In addition ~~Solutions~~to ~~provides~~our aexisting ~~complete~~product ~~end~~line of high-~~to-~~end IP TVwomen ~~platform~~products, ~~for~~our ~~the~~proposed ~~delivery~~products, ofwhich ~~content~~are currently still in development, will contain both non-CBD and ~~services~~CBD toingredients ~~Hospitality~~that ~~clients~~are derived from hemp. ~~The~~A ~~platform~~specialized ~~delivers~~extraction aprocess ~~wide~~is ~~range~~used ofto ~~entertainment options,~~yield ~~guest~~highly ~~services~~concentrated CBD oil that ~~are~~also ~~tailored~~contains toother ~~each~~potentially ~~individual~~nutritious ~~property~~materials ~~and~~such ~~other~~as ~~services~~omega-3 ~~that~~fatty ~~improve~~acids, ~~the~~terpenes ~~quality~~(a class of ~~the~~organic ~~guest~~compounds ~~experience~~which atwhen modified are used in a ~~hotel~~variety ~~property~~of medicines and alternative medicines such as aromatherapy), ~~clinic~~vitamins, ~~retirement~~chlorophyll, ~~home~~and oramino acids. ~~other~~Our ~~location~~existing ~~where~~and ~~guests~~proposed ~~spend~~products ~~considerable~~have ~~amounts~~no ofTHC ~~time~~and are parasite-free.

~~The~~BioQuest’s mission ~~Company~~is ~~has~~to ~~developed~~lead ~~state~~the ofindustry ~~the~~in ~~art entertainment~~bringing ~~options~~unique ~~for~~Men’s, ~~guests~~Women’s, ~~including~~Lifestyle ~~BYOC~~and ~~(bring~~Pet ~~your~~products ~~own content)~~ that ~~allows~~are ~~users~~(CBD) tobased ~~see their own favorite downloaded~~products ~~items~~to on the ~~large screen TV in the hotel~~marketplace. ~~The~~We ~~Company~~strive ~~also~~to ~~helps~~educate the ~~Hotel~~world ~~deal with the impact of web videos~~ on the ~~quality~~benefits of ~~the~~ ~~internet~~hemp ~~access~~extract, ~~network~~and byit ~~making~~is ~~available~~our agoal ~~range of excellent web content for guests~~ to ~~access~~offer onthe ~~its system, as well as~~industry’s ~~providing~~highest ~~access~~quality ~~to social networks and other web content on the “big screen”~~products.

~~The~~We have ~~Company~~been isreviewing ~~also~~all ~~able~~of toour ~~deliver~~marketing toand ~~the Hotel~~other aefforts ~~simple~~to ~~platform~~ensure ~~for~~that ~~launching~~it ~~new~~is ~~services~~clear that ~~will~~no ~~both~~claims ~~generate~~of ~~revenue~~any ~~for~~medical ~~the~~or ~~property~~health ~~and~~benefit be ~~increase~~made ~~guest~~by ~~satisfaction~~us or anyone representing us with regard to any of our proposed products. These ~~services~~proposed ~~may~~products ~~include~~are ~~anything~~not ~~from~~pre-approved by the ~~ability~~FDA toor ~~order~~any ~~take-out~~other ~~meals~~regulatory toagency. ~~taxicabs,~~We ~~spa~~do ~~appointments~~not ~~and~~make ~~other~~any ~~services~~claims ~~available~~not covered by actual research. However, users rely on statements made ~~close~~on tosocial ~~the~~media ~~property~~by ~~without~~many ~~leaving~~users ~~the~~of ~~room~~similar orproducts. ~~having~~We tohave ~~work~~no ~~through~~association awith ~~variety~~any of ~~sites~~the toindividuals ~~find~~posting ~~what~~about ~~they~~these ~~need~~types of products on social media.

~~All these options give the hotel the opportunity~~The tounique ~~engage~~strains onof acannabinoid-rich ~~much~~hemp ~~broader~~are ~~basis~~specially ~~with~~bred from the ~~guest~~most ~~and~~medicinally ~~become~~high ~~the~~cannabidiol ~~hub~~strains of ~~the~~medical ~~guest visit~~cannabis. ~~This~~These plants ~~benefit~~with isthe ~~significantly~~highest ~~leveraged by~~CBD ~~the~~and ~~Company’s~~lowest ~~mobile~~THC ~~application~~concentrations ~~that~~were ~~gives~~stabilized ~~guests~~and ~~full~~cross ~~control~~bred. ofThis ~~all~~resulted ~~services~~in ~~and~~consistent ~~entertainment~~plant ~~from~~levels ~~their smartphones,~~of ~~untethering~~less ~~the~~than ~~guest~~0.3% ~~from~~THC on a ~~single~~dry ~~location~~weight basis.

~~Market~~Our company is in the development stage and ~~Competition~~has generated no revenues.

~~According to estimates, the US hospitality sector presents a $2 to 3 Billion opportunity for in-room entertainment and guest services systems.~~ 4

~~Based on recent industry statistics, Occupancy~~The rates, RevPar and ADR are all on the increase on a year-over-year basis and hoteliers continue to focus on expenses in order to enhance guest loyalty and retention, streamline operations, increase per guest revenues and occupancy rates, differentiate property accommodations, maintain brand identity, and optimize services to reduce costs.Company

~~Key~~Our Products ~~drivers~~ and ~~trends~~Future ~~occurring in the hospitality vertical as it relates to technology are:~~Products

1.Planned Products ~~recognition~~we ofwill ~~the need for more interactive systems that encourage greater guest engagement~~sell:

2.Vital-Q products ~~desire~~are toour ~~integrate~~branded ~~the~~range ~~guests’~~of ~~devices~~CBD ~~and~~products ~~content~~featuring; ~~into~~Men’s ~~the~~products; ~~in-room~~Women’s ~~experience~~Products; ~~(BYOD,~~Pet ~~BYOC)~~products and Lifestyle products.

~~3. desire to engage with guests before, during and after their stay, leveraging mobile technology~~Products Line:

4.Vital-QTM - ~~elimination~~Age ofRefining ~~the~~Serum- ~~“one~~Sculping ~~size~~Formula ~~fits~~Plus ~~all” approach to content and services; each hotel is different, each guest has unique needs~~CBD

5.Vital-QTM - ~~reduction~~Royal inQ ~~cost~~- toCBD ~~supply~~infused ~~and~~Majestic ~~support~~Body ~~hotel systems by basing them on industry standards and open platforms~~Cream

6.Vital-QTM - ~~use~~Responsive ofFormula ~~business~~- ~~intelligence~~Collagen toRetinol ~~more~~Anti-Aging ~~effectively~~Cream ~~deliver~~plus ~~attractive content and desired services~~CBD

~~In order to appeal to business and vacationing~~Vital-QTM ~~travelers,~~- ~~hotels~~Age ~~must~~Defying ~~provide~~Skin ~~improved~~Cream- ~~access~~Apple toStem ~~content~~Cell ~~and~~Plus services to stay competitive. For limited service hotels this means for the first time increasing service availability, such as access to external services and dining options. For full service hotels this means increasing service convenience by making internal and externally sourced services available easier to order and enjoy.CBD

~~There are multiple competitors in this market,~~Vital-QTM ~~including long~~-~~standing~~ ~~vendors~~Gorgeous asEyes ~~well~~- asUnder aEye ~~number~~CBD ofInfused ~~newer, less established companies. The Company believes its system is both competitively priced and offers more benefits to the Hotel owner than other systems on the market.~~Cream

~~Employees~~Vital-QTM - Radiant Youth Serum - CBD infused and Vitamin C

~~As of April 30, 2014, the Company had no employees.~~Vital-QTM ~~The~~- ~~Company~~Flawless ~~did~~Neck ~~however~~- ~~retain~~CBD ~~consultants~~Formula ~~to assist~~ with ~~the~~Hemp ~~creation of the go-to-market strategy, creation of the business plan and other related start-up work.~~Extracts

~~Available~~Vital-QTM - ~~Information~~Delicate Facial Wash - Deep Cleansing with CBD

~~All reports of the Company filed with the SEC~~Vital-QTM ~~are~~- ~~available~~Rich ~~free~~Facial ofToner ~~charge~~- ~~through~~Hydrating ~~the~~CBD ~~SEC’s~~infused Web site at www.sec.gov. In addition, the public may read and copy materials filed by the Company at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. The public may also obtain additional information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330.

4We will utilize a rigorous testing and verification system that will consist of on-site analysis and redundant third-party batch testing, ensuring accurate levels of phyto-cannabinoids and confirms the legal levels (or non-detectable levels) of THC through our proprietary processes. The end result is the highest quality hemp-derived phyto-cannabinoid-rich (PCR) oil extracts that contain zero solvents, zero heavy metals, and zero pesticides.

~~Item 1A. Risk Factors~~Marketing

The ~~following important factors among others,~~ ~~could cause our actual operating results to differ materially from those indicated or suggested by forward~~Vital-~~looking~~Q ~~statements~~Brand ~~made in~~and ~~this Form 10-K or presented elsewhere by management from time to time.~~Lifestyle

IfWe will wemarket doour ~~not~~proposed ~~obtain~~products ~~additional~~using ~~financing~~the Vital-Q branding and Lifestyle marketing phrase, ~~our~~Health-Conscious ~~business~~Solutions. ~~may~~BioQuest’s beproduct atand ~~risk~~lifestyle orline ~~execution~~ of CBD branding will lead the ~~Business~~industry ~~Plan~~in ~~may~~bringing unique Men’s, Women’s, Lifestyle and Pet products that are CBD based to the consumer marketplace. The majority of our marketing will be ~~delayed~~targeted at retail, small chains, and direct to consumer distribution. We will utilized Internet advertising and employed marketing companies will publicize and deliver a form of brand recognition.

To date, the Company has raised approximately $1,500,000 through contacts, high net-worth individuals and strategic investors situated mainly in Europe and Canada. This was part of a $1,000,000 initiative that was oversubscribed. The purpose of the raise was to fund the first phase of our deployment in North-American and engage top tier management team. In order to commence our business operations we have very limited assets upon which to rely on and we anticipate that we will have to raise additional funding. Additional funding will be needed for implementing our business plan which includes various expenses such as, legal, operational set-up, general and administrative, marketing, employee salaries and other related start-up expenses.5

~~A second round of fund raising is in process~~Sales ~~where the Company anticipates raising $2,000,000 to be used for the set-up~~ and deployment of our technology to customers. The Company has not generated any revenue from operations since inception. The company is also considering raising $12 million to acquire the company who owns the IP which has a grown revenue along with positive cash-flow since 2006 with its main business in both the Middle East and Asia. Distribution

~~There is no assurance that we~~ We will besell ~~successful in~~our ~~raising~~proposed aproducts ~~sufficient~~through ~~amount~~our ofdirect ~~additional~~to ~~capital~~consumer, orlarge ifretail wechains, ~~are~~small ~~successful~~chains, ~~that~~and westore ~~will~~fronts, beand ~~able~~ to ~~raise~~retailers around ~~capital~~the ~~on reasonable terms~~U.S. IfCustomers wecan douse ~~raise~~credit ~~additional~~cards ~~capital,~~for ~~our~~direct ~~existing~~purchases ~~shareholders~~from ~~may~~us. ~~incur~~We ~~substantial~~are ~~and~~working ~~immediate~~to ~~dilution.~~begin Ifselling weour ~~are~~potential ~~not~~products, ~~able~~using todifferent ~~raise~~sales ~~the~~techniques, ~~capital~~and ~~necessary~~optimizing ~~to fund~~ our ~~business~~website. ~~objectives,~~Customers wewho ~~may~~purchase ~~have~~a tocertain ~~delay~~amount ~~the implementation~~ of our ~~business~~planned ~~plan.~~products receive Wefree ~~estimate~~shipping ~~that~~and wehandling ~~will~~on ~~need~~their ~~approximately~~purchases. ~~$20,000,000~~We incannot ~~additional funds~~predict tothe ~~complete~~likelihood ~~our~~of ~~business~~success ~~plan~~in using these techniques.

Obtaining additional funding will be subject to a number of factors, including general market conditions, investor acceptance of our business plan and initial results from our business operations. These factors may impact the timing, amount, terms or conditions of additional financing available to us. The most likely source of future funds available to us is through the sale of additional shares of common stock.Competition

~~Our~~The CBD ~~independent~~industry ~~auditor~~is ~~has~~relatively ~~issued~~new ~~a going~~but ~~concern~~showing ~~opinion~~large ~~after~~growth. ~~auditing~~Some of our ~~financial~~most ~~statements;~~likely ~~our~~competitors ~~ability~~are toCharlotte’s ~~continue~~Web, CBDistillary, and Veritas Farms, all of whom are in the CBD space. Many of these companies have greater resources and market recognition than we currently have available. There is ~~dependent~~also ona ~~our~~possibility ~~ability~~of a larger entity trying to ~~raise~~acquire ~~additional capital~~many ~~and~~of ~~our~~the ~~operations~~smaller ~~could~~companies bein ~~curtailed~~the industry, especially if regulatory uncertainties lessen. We plan on competing using specific products that we believe meet customer demands, selling them at prices that are ~~unable~~very affordable in relation to ~~obtain~~other ~~required~~products ~~additional~~in ~~funding~~the ~~when~~marketplace. ~~needed~~We cannot predict the likelihood of succeeding in these efforts.

We will be required to expend substantial amounts of working capital in order to acquire and market our proposed products and establish the necessary relationships to implement our business plan. We were incorporated on May 17, 2011. Our operations to date were funded entirely by capital raised from our private offering of securities. Notwithstanding the offering, we will continue to require additional financing to execute our business strategy. We are totally dependent on external sources of financing for the foreseeable future. Failure to raise additional funds in the future will adversely affect our business operations, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. We are entirely dependent on our ability to attract and receive additional funding from either the sale of securities or the issuance of debt securities. There is no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future could restrict our ability to grow and reduce our ability to continue to conduct business operations. After reviewing our financial statements, our independent auditor issued a going concern opinion and our ability to continue is dependent on our ability to raise additional capital. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans which could cause us to become dormant. Any additional equity financing may involve substantial dilution to our then existing stockholders.Suppliers

WeOur future ~~lack~~products anwill ~~operating~~be ~~history~~made ~~and~~by ~~have~~independent ~~not~~vendors, ~~generated~~with ~~any~~third ~~revenues~~ party lab tests for each individual product batch uploaded to ~~date~~our website. We ~~There~~will ispurchase noour ~~assurance~~potential ~~our~~products ~~future~~from ~~operations~~select vendors. All ingredients that we will ~~result~~purchase inare ~~revenues~~purchased by the vendors. IfAll products wewill ~~cannot~~be ~~generate~~tested ~~sufficient~~by ~~revenues~~these vendors to ~~operate~~ensure no presence of THC. The vendors primarily package and label the items being delivered ~~profitably,~~to weus. ~~may~~We have tonot ~~cease~~experienced ~~operations~~nor are we aware of any shortages of supplies available.

~~We were incorporated in May 17, 2011 and have~~The ~~more~~Cannabinoid recently changed business direction. We do not have any operating history upon which an evaluation of our future success or failure can be made. Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to earn profit by attracting enough clients who will buy our product or services.Industry

WeThe Brightfield ~~cannot~~Group ~~guarantee~~“is ~~that~~calling wefor ~~will~~year-over-year beCBD ~~successful~~ product sales from $5B in ~~generating~~2020 ~~revenues~~to ~~and~~around ~~profit~~$17B inby 2025. With the ~~future.~~20 ~~Failure~~largest companies tocommanding ~~generate~~less ~~revenues~~than ~~and~~17% ~~profit~~of ~~will~~the ~~cause~~total usMarket, towe ~~suspend~~are oraggressively ~~cease~~evaluating ~~operations~~other “Non-Public” companies for possible acquisitions.

5During the Covid-19 Period, the market has dramatically increased with 50-60% of purchases made online.

~~Because we are considered to be a “shell~~By ~~company”~~all ~~under applicable securities rules~~measures, ~~investors may not be able to rely on~~ the ~~resale~~market ~~exemption~~for ~~provided~~hemp, ~~by Rule 144 of the Securities Act unless~~ and ~~until~~for weproducts ~~cease~~based toon beextracts ~~a shell company and have satisfied the requirements~~ of ~~Rule 144(i)(1)(2). As a result~~hemp, ~~investors~~is ~~may~~expected ~~not be able~~ to ~~re-sell~~grow ~~our~~substantially ~~shares~~over ~~and~~the ~~could~~coming ~~lose their entire investment~~years.

~~We are a “shell company” as defined~~While ~~by Rule 12b-2 promulgated under~~ the ~~Exchange~~industry ~~Act.~~is ~~Accordingly~~growing rapidly, the ~~securities~~cannabis inindustry ~~this~~faces ~~offering~~some ~~can~~major ~~only~~obstacles bethat ~~resold~~challenge ~~through~~its ~~registration under~~growth ~~the~~and ~~Securities~~profitability. ~~Act~~First, ~~meeting~~ the ~~safe~~cultivation ~~harbor provisions~~ of ~~paragraph~~Hemp ~~(i)~~is ofa ~~Rule~~very ~~144, or in reliance upon Section 4(1) of the Securities Act of 1933 for non~~capital-~~affiliates~~intensive enterprise. ~~The~~ ~~SEC~~Many ~~has~~hemp ~~adopted~~entrepreneurs ~~final~~do ~~rules~~not ~~amending~~have ~~Rule~~access ~~144~~to ~~which~~the ~~became~~capital ~~effective~~required onto ~~February~~build ~~15,~~the ~~2008.~~infrastructure ~~Pursuant~~required to ~~Rule~~meet ~~144,~~growing ~~one~~demand ~~year~~and ~~must~~sales ~~elapse~~projections. ~~from~~Traditional ~~the~~sources ~~time~~of ~~a "shell company"~~financing, such as ~~defined~~banks, inare not ~~Rule~~available ~~405 of~~currently ~~the~~to ~~Securities~~hemp ~~Act~~producers and ~~Rule~~retailers. ~~12b-2 of the Exchange Act~~Secondly, ~~ceases~~there tois be a ~~"shell~~significant ~~company"~~shortage ~~and~~of ~~files~~knowledge ~~Form~~related 10to ~~information~~virtually ~~with~~all ~~the~~areas ~~SEC,~~of ~~during which time~~ the ~~issuer~~cannabinoid ~~must remain current in its filing obligations, before a restricted shareholder can resell their holdings in reliance on Rule 144~~business.

~~The term "Form 10 information" means~~We ~~the~~face ~~information~~extensive ~~that~~government isregulation ~~required~~both bywithin ~~SEC~~and ~~Form~~outside ~~10, to register under~~ the ~~Exchange Act each class of securities being sold under Rule 144~~U.S. ~~The~~relating ~~Form~~to ~~10 information is deemed filed when~~ the ~~initial~~development, ~~filing~~manufacture, ismarketing, ~~made with the SEC. Under Rule 144~~sale, ~~restricted or unrestricted~~and ~~securities,~~distribution ~~that~~of ~~were~~our ~~initially~~future ~~issued~~products. byThe afollowing ~~reporting~~sections ordescribe ~~non-reporting~~certain ~~shell~~significant ~~company~~regulations ~~or a company~~ that ~~was~~we atare ~~anytime~~subject ~~previously a~~to. ~~reporting~~These ~~or non-reporting shell company, can only be resold in reliance on Rule 144 if the following conditions~~ are ~~met: (1)~~ ~~the~~not ~~issuer of~~ the ~~securities~~only regulations that ~~was~~our ~~formerly~~businesses amust ~~reporting~~comply orwith. ~~non-reporting~~For ~~shell company has ceased to be~~ a ~~shell~~description ~~company; (2) the issuer~~ of ~~the~~risks ~~securities~~related ~~is subject~~ to the ~~reporting~~regulations ~~requirements~~that ofour ~~Section 13 or 15(d) of the Exchange Act; (3) the issuer~~businesses ofare ~~the~~subject ~~securities has filed all reports and material required~~ to ~~be filed under Section 13 or 15(d) of the Exchange Act~~, asplease ~~applicable, during~~refer ~~the preceding twelve months (or shorter period that the issuer was required~~ to ~~file such reports and materials), other than Form 8-K reports; and (4) at least one year has elapsed from~~ the ~~time~~section ~~the~~entitled ~~issuer~~“Risk ~~filed~~Factors—Risks ~~the~~Related ~~current~~to ~~Form~~Our ~~10 type information with the SEC reflecting its status as an entity that is not a shell company~~Businesses.”

WeThe principal ~~may~~uncertainties beare ~~exposed~~whether toregulators ~~potential~~will, ~~risks~~at ~~and~~any ~~significant~~time, ~~expenses resulting~~attempt ~~from~~to ~~the~~treat ~~requirements~~CBD ~~under~~products ~~section 404~~similarly ofto ~~the~~THC ~~Sarbanes-Oxley Act of 2002~~products.

~~If we become registered with the SEC, we will~~Some bestates ~~required,~~are ~~pursuant~~considering tovarious ~~Section~~taxation ~~404~~ of ~~the Sarbanes~~cannabis-~~Oxley~~related ~~Act of 2002, to include in our annual report our assessment of the effectiveness of our internal control over financial reporting~~products. WeThese ~~expect~~considerations toseem ~~incur significant continuing costs, including accounting fees and staffing costs, in order~~ to ~~maintain~~range ~~compliance~~from ~~with~~routine ~~the~~sales ~~internal~~taxes ~~control requirements of the Sarbanes-Oxley Act of 2002. Development of our business will necessitate ongoing changes~~ to ~~our internal control systems, processes and information systems. Currently,~~ wetaxes ~~have~~similar ~~no employees. We do not intend~~ to ~~develop~~those orimposed ~~manufacture~~on ~~any~~tobacco products,. ~~and~~It ~~consequently~~is ~~have~~unclear nowhether products incontaining ~~development, manufacturing~~Hemp ~~facilities~~Derived orCBD ~~intellectual~~would ~~property~~fall ~~rights.~~under Asthese tax weplans ~~develop~~if ~~our business, hire employees~~ and ~~consultants~~when ~~and~~they ~~seek to protect our intellectual property rights, our current design for internal control over financial reporting will not be sufficient to enable management to determine that our internal controls~~ are ~~effective for any period, or on an ongoing basis~~imposed. Accordingly, as we develop our business, such development and growth will necessitate changes to our internal control systems, processes and information systems, all of which will require additional costs and expenses.

In the future, if we fail to complete the annual Section 404 evaluation in a timely manner, we could be subject to regulatory scrutiny and a loss of public confidence in our internal controls. In addition, any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to meet our reporting obligations.6

~~However,~~IRS section as280E anprevents ~~“emerging~~cannabis ~~growth~~companies ~~company,” as~~from ~~defined~~deducting inexpenses ~~the~~from ~~JOBS~~their ~~Act~~income, ~~our~~except ~~independent~~for ~~registered~~those ~~public~~considered ~~accounting~~cost ~~firm~~of ~~will~~goods ~~not~~sold. beNo deduction ~~required~~or tocredit ~~formally~~is ~~attest~~allowed tofor any amount paid or incurred during the ~~effectiveness of~~taxable ~~our~~year ~~internal~~in ~~control~~carrying ~~over~~on ~~financial~~any ~~reporting~~trade ~~pursuant~~or tobusiness ~~Section~~if ~~404~~such oftrade or business (or the ~~Sarbanes-Oxley~~activities ~~Act~~which ofcomprise ~~2002~~such ~~until~~trade ~~the~~or ~~later~~business) consists of trafficking in controlled substances (within the meaning ~~year~~of ~~following~~schedule ~~our~~I ~~first~~and ~~annual~~II ~~report~~of ~~required~~the toControlled beSubstances ~~filed~~Act) ~~with~~which ~~the~~is ~~SEC,~~prohibited by Federal law or the ~~date~~law weof ~~are~~any noState ~~longer~~in anwhich ~~emerging~~such ~~growth company.~~trade Ator ~~such~~business ~~time,~~is ~~our~~conducted. ~~independent~~If ~~registered~~this ~~public~~section ~~accounting~~is ~~firm~~enforced ~~may~~against ~~issue~~the aCompany ~~report~~even ~~that~~though isits ~~adverse~~future inproducts ~~the~~contain ~~event~~no itTHC isor ~~not~~other ~~satisfied~~illegal ~~with~~substance, ~~the~~it ~~level~~could atcreate ~~which~~serious ~~our~~operating ~~controls~~and ~~are~~cash ~~documented,~~flow ~~designed~~problems orin ~~operating~~the future.

~~Because one shareholder owns 73.9 % of our issued and outstanding common stock, he can make and control corporate decisions that may be disadvantageous to minority shareholders.~~Regulation

~~One~~We face ~~shareholder,~~extensive ~~Conseil~~government ~~Plumage~~regulation ~~Blanc~~both ~~Ltd. (“CPB”),~~within ~~owns~~and ~~approximately~~outside ~~73.9% of~~ the ~~outstanding~~U.S. ~~shares~~relating ofto ~~our~~the ~~common~~development, ~~stock.~~manufacture, ~~Accordingly~~marketing, ~~CPB~~sale ~~will~~and ~~have~~distribution of aour ~~significant influence~~future inproducts, ~~determining~~software, ~~the~~and ~~outcome~~services. ofThe ~~all~~following ~~corporate~~sections ~~transactions~~describe orcertain ~~other~~significant ~~matters,~~regulations ~~including~~that ~~mergers,~~we ~~consolidations,~~are ~~and~~subject ~~the~~to. ~~sale~~These ofare ~~all~~not orthe ~~substantially~~only ~~all~~regulations ofthat our ~~assets.~~businesses ~~CPB~~must ~~will~~comply ~~also~~with. ~~have~~For ~~the~~a ~~power~~description toof ~~prevent~~risks orrelated ~~cause~~to athe ~~change~~regulations inthat ~~control. The interests~~our ofbusinesses ~~CPB~~are ~~may~~subject ~~differ~~to, ~~from~~please ~~the~~refer ~~interests~~to of the ~~other~~section ~~stockholders~~entitled ~~and~~“Risk ~~thus~~Factors—Risks ~~result~~Related ~~in corporate decisions that are disadvantageous~~ to ~~other~~Our ~~shareholders~~Businesses.”

~~Any~~Our operations ~~inability~~are potentially subject to ~~adequately~~a ~~find~~complex web of Federal and state regulations that are evolving at a rapid rate. The USDA and ~~retain~~FDA ~~employees~~may ~~needed~~change torules ~~build~~or enforcement proceedings at any time. We do not believe that current rules and enforcement have a ~~deployment~~significant potential ~~team,~~impact because we only use Hemp Derived CBD which is Federally legal. As the legal landscape and ~~customer~~understanding ~~service~~about ~~team~~the differences in hemp derived cannabinoids unfolds, ~~sales~~it ~~team~~will ~~along~~be ~~development~~increasingly important to distinguish “cannabis” & “THC” (with noted varying degrees of psychotropic effects and ~~testing~~deficits ~~staff,~~in executive function) from CBD. Our future products and messaging will ~~could~~be ~~harm~~very ~~our~~clear ~~ability~~and toprecise ~~compete~~in announcing those differences and we make no claims of any “cures” or “specific ailment” remedies.

~~Our future success and ability to compete depends~~The inprincipal ~~part~~uncertainties ~~upon~~are ~~finding~~whether ~~and~~regulators ~~retaining~~will, ~~highly~~at ~~skilled~~any ~~business~~time, ~~product~~attempt ~~development,~~to ~~technical~~treat ~~and~~CBD ~~other~~products ~~personnel~~similarly ~~and there can be no assurance that we will be successful in recruiting such personnel. A failure on our part~~ to ~~retain~~THC ~~the services of key personnel could have a material adverse effect on our operating results and financial condition~~products.

6Federal Government Regulations

~~Our~~In 2014, ~~business~~the ~~can~~distinction between the use of Cannabis Sativa L. for medical, recreational, and industrial purposes was made via Section 7606 of the Agricultural Act of 2014, which cleared a legal path for industrial hemp to be ~~affected~~grown byin ~~currency~~three ~~rate~~limited ~~fluctuations~~circumstances, 1) by researchers asat wean ~~may~~institute ~~receive~~of ~~payments~~higher ~~and~~education, ~~incur~~2) ~~expenses~~by state departments of agriculture, or 3) by farmers participating in ~~foreign~~a ~~currency~~research program permitted and overseen by a state department of agriculture.

WeIn 2016 ~~will~~the ~~receive~~DEA, ~~earnings~~U.S. inDepartment USof ~~currency~~Agriculture, and the Food and Drug Administration (FDA) issued a joint statement detailing the guidelines for growth of industrial hemp as part of state-sanctioned research programs. ~~However~~Those guidelines state that hemp can only be sold in states with pilot programs, plants and seeds can only cross state lines as part of permitted state research programs, and seeds can only be ~~some~~imported by individuals registered with the DEA. We believe the recent passage of ~~our~~the ~~clients~~2018 ~~might~~Farm ~~pay~~Bill uswill inallow ~~foreign~~the ~~currency~~Company to expand its marketplace opportunities. ~~Also~~On December 20, 2018, President Donald J. Trump signed into law the Agriculture Improvement Act of 2018, otherwise known as ~~our~~the ~~operations~~“Farm ~~are~~Bill”. ~~based~~Prior into ~~Montreal~~its passage, ~~Quebec~~hemp, ~~some~~a member of ~~our~~the ~~expenses~~cannabis family, and hemp-derived CBD were ~~will~~classified beas ~~incurred~~a inSchedule ~~Canadian~~I ~~Dollars~~controlled substances, ~~Great~~and ~~Britain~~so ~~Pounds,~~illegal orunder ~~Euros~~the CSA. If weWith ~~are~~the ~~not~~passage ~~able~~of tothe ~~successfully~~Farm ~~protect~~Bill, ~~ourselves~~hemp cultivation is ~~against~~broadly ~~currency~~permitted. ~~fluctuations,~~The ~~then~~Farm ~~our~~Bill ~~profits~~explicitly ~~will~~allows ~~also~~the ~~fluctuate~~transfer ~~and~~of ~~could~~hemp-derived ~~cause~~products usacross tostate belines ~~less~~for ~~profitable~~commercial or ~~incur~~other ~~losses~~purposes. It also puts no restrictions on the sale, ~~even if~~transport, ~~our~~or ~~business~~possession isof ~~doing~~hemp-derived ~~well~~products, so long as those items are produced in a manner consistent with the law.

~~Our~~Under Section ~~shares~~10113 of ~~common~~the ~~stock~~Farm ~~are~~Bill, ~~subject~~ hemp cannot contain more than 0.3 percent THC. THC refers to the ~~“penny~~chemical ~~stock’~~compound ~~rules~~found ofin cannabis that produces the ~~securities~~psychoactive “high” associated with cannabis. Any cannabis plant that contains more than 0.3 percent THC would be considered non-hemp cannabis—or marijuana—under federal law and ~~exchange~~would ~~commission~~thus face no legal protection under this new legislation and would be an illegal Schedule 1 drug under the ~~trading~~CSA. ~~market~~Under Section in10113 ~~our~~of ~~securities~~the ~~will~~Farm Bill, state departments of agriculture must consult with the state’s governor and chief law enforcement officer to devise a plan that must be ~~limited~~submitted to the Secretary of the United States Department of Agriculture (hereafter referred to as the “USDA”). A state’s plan to license and regulate hemp can only commence once the Secretary of USDA approves that state’s plan. In states opting not to devise a hemp regulatory program, ~~which~~USDA will ~~make~~construct ~~transactions~~a regulatory program under which hemp cultivators in ~~our~~those ~~stock~~states ~~cumbersome~~must apply for licenses and ~~may~~comply ~~reduce~~with ~~the~~a ~~value~~federally run program. This system of anshared ~~investment~~regulatory programming is similar to options states had in ~~our~~other ~~stock~~policy areas such as health insurance marketplaces under the Affordable Care Act, or workplace safety plans under Occupational Health and Safety Act—both of which had federally-run systems for states opting not to set up their own systems.

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in "penny stocks.” Penny stocks generally are equity securities with a price of less than $5 (other than securities registered on certain national securities exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system). Penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document prepared by the SEC, which specifies information about penny stocks and the nature and significance of risks of the penny stock market. A broker-dealer must also provide the customer with bid and offer quotations for the penny stock, the compensation of the broker-dealer, and sales person in the transaction, and monthly account statements indicating the market value of each penny stock held in the customer's account. In addition, the penny stock rules require that, prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for stock that becomes subject to those penny stock rules. If a trading market for our common stock develops, our common stock will probably become subject to the penny stock rules, and shareholders may have difficulty in selling their shares.7

~~Our shares of common stock trading on the OTC~~The ~~Bulletin~~Farm ~~Board~~Bill ~~will~~outlines ~~fluctuate~~actions ~~significantly.~~that Asare ofconsidered ~~the~~violations ~~date~~ of ~~this~~federal ~~Annual~~hemp ~~Report,~~law ~~our~~(including ~~common~~such ~~stock~~activities ~~does~~as ~~not~~cultivating ~~yet~~without ~~trade~~a ~~on the Over-the-Counter~~license ~~Bulletin~~or ~~Board.~~producing Ifcannabis ~~our shares of common stock commence trading on the Bulletin Board, there is a volatility associated~~ with ~~Bulletin Board~~more ~~securities~~than in0.3% ~~general and the value of your investment could decline due to the impact of any of the following factors upon the market price of our common stock: (i~~THC). ~~disappointing~~The ~~results~~Farm ~~from~~Bill ~~our~~details ~~discovery~~possible orpunishments ~~development~~for ~~efforts;~~such ~~(ii)~~violations, ~~failure~~pathways ~~to meet our revenue or profit goals or operating budget; (iii) decline in demand~~ for ~~our common stock; (iv) downward revisions in securities~~violators ~~analysts'~~to ~~estimates~~become orcompliant, ~~changes~~and ineven ~~general~~which ~~market~~activities ~~conditions;~~qualify ~~(v)~~as ~~technological~~felonies ~~innovations~~under bythe ~~competitors~~law, orsuch inas ~~competing~~repeated ~~technologies; (vi) lack of funding generated for operations; (vii) investor perception of our industry or our prospects; and (viii) general economic trends~~offenses.

~~Any~~One of ~~additional~~the ~~funding~~goals weof ~~arrange~~the ~~through~~previous 2014 Farm Bill was to generate and protect research into hemp. The 2018 Farm Bill continues this effort. Section 7605 re-extends the ~~sale~~protections for hemp research and the conditions under which such research can and should be conducted. Further, section 7501 of ~~our~~the Farm Bill extends hemp research by including hemp under the Critical Agricultural Materials Act. This provision recognizes ~~common~~the ~~stock~~importance, ~~will~~diversity, ~~result~~and inopportunity ~~dilution~~of the plant and the products that can be derived from it, but also recognizes that there is still a lot to ~~existing~~learn ~~shareholders~~about hemp and its products from commercial and market perspectives.

~~We must raise additional capital in order for~~FDA ~~our~~Regulation ~~business plan to succeed. Our most likely source~~ of ~~additional~~Hemp capital will be through the sale of additional shares of common stock. Such stock issuances will cause stockholders' interests in our company to be diluted. Such dilution will negatively affect the value of investors’ shares.Extracts

WeThe United doStates ~~not~~Food ~~expect~~& toDrug ~~pay~~Administration ~~dividends~~(“FDA”) inis generally responsible for protecting the ~~foreseeable~~public ~~future~~health by ensuring the safety, efficacy, and security of (1) prescription and over the counter drugs; (2) biologics including vaccines, blood & blood products, and cellular and gene therapies; (3) foodstuffs including dietary supplements, bottled water, and baby formula; and (4) medical devices including heart pacemakers, surgical implants, prosthetics, and dental devices.

~~We have never paid any dividends on our common~~Regarding ~~stock. We~~its doregulation ~~not~~of ~~expect~~drugs, tothe ~~pay~~FDA ~~cash~~process ~~dividends~~requires ona ~~our~~review ~~common~~that ~~stock~~begins atwith ~~any time in~~ the ~~foreseeable~~filing ~~future. The future payment~~ of ~~dividends~~an ~~directly~~investigational ~~depends~~new ~~upon~~drug ~~our~~(IND) ~~future earnings~~application, with ~~capital~~follow ~~requirements,~~on ~~financial~~clinical ~~requirements~~studies and ~~other~~clinical ~~factors~~ trials that ~~our~~the ~~board~~FDA ofuses ~~directors~~to ~~will~~determine ~~consider. Since~~whether wea dodrug ~~not~~is ~~anticipate~~safe ~~paying~~and ~~cash dividends on our common stock~~effective, aand ~~return~~therefore onsubject ~~your~~to ~~investment,~~approval iffor ~~any,~~human ~~will~~use ~~depend~~by ~~solely on an increase, if any, in~~ the ~~market value of our common stock~~FDA.

WeAside from ~~will~~the ~~incur~~FDA’s ~~on-going~~mandate ~~costs~~to regulate drugs, the FDA also regulates dietary supplement products and ~~expenses~~dietary ingredients under the ~~for~~Dietary ~~SEC~~Supplement ~~reporting~~Health and ~~compliance~~Education Act of 1994. ~~Without~~This ~~revenue~~law weprohibits ~~may~~manufacturers ~~not~~and bedistributors ~~able~~of todietary ~~remain~~supplements inand ~~compliance,~~dietary ingredients ~~making~~from itmarketing ~~difficult~~products that are adulterated or misbranded. This means that these firms are responsible for ~~investors~~evaluating the tosafety ~~sell~~and labeling of their ~~shares,~~products ifbefore atmarketing to ensure that they meet all the requirements of the law and FDA regulations, including, but not limited to the following labeling requirements: (1) identifying the supplement; (2) nutrition labeling; (3) ingredient labeling; (4) claims; and (5) daily use information.

~~Projects~~The FDA ~~for~~has ~~the~~not ~~acquisition~~approved cannabis, marijuana, hemp, or derivatives as a safe and ~~development~~ effective drug for any indication. As of the ~~Company’s~~date ~~products~~of ~~are~~this filing, ~~subject~~we have not, and do not intend to ~~many~~file ~~factors~~an IND with the FDA, ~~which~~concerning ~~are~~any ~~outside~~of our ~~control. These~~proposed ~~factors~~products ~~include~~that ~~general~~contain CBD derived ~~economic~~from ~~conditions~~industrial inhemp ~~North~~or ~~America~~cannabis ~~and~~delivered ~~worldwide~~in ~~(such~~the asState ~~recession,~~of ~~inflation,~~California. ~~unemployment~~Further, ~~and~~our ~~interest~~proposed ~~rates),~~products ~~shortages~~containing CBD derived from industrial ofhemp ~~labor~~are ~~and~~not ~~materials~~marketed ~~and~~or ~~price~~sold ofusing ~~materials~~claims ~~and~~that ~~competitive~~their ~~products~~use is safe and ~~the~~effective ~~regulation~~treatment byfor ~~federal~~any ~~and~~medical ~~state~~condition ~~governmental~~subject ~~authorities~~to the FDA’s jurisdiction.

~~Lack~~The FDA has concluded that products containing cannabis or industrial hemp derived CBD are excluded from the dietary supplement definition under sections 201(ff)(3)(B)(i) and (ii) of ~~diversification~~the U.S. Food, Drug & Cosmetic Act, respectively. The FDA’s position is that products containing cannabis, CBD or derivatives are Schedule 1 drugs under the Controlled Substances Act, and so are illegal. Our planned products containing CBD derived from industrial hemp or cannabis delivered in other States are not marketed or sold as dietary supplements. However, at some indeterminate future time, the FDA may choose to change its position concerning generally cannabis and products containing hemp derived CBD and may choose to enact regulations that are applicable to such products. In this event, our proposed. industrial hemp-based products containing CBD and cannabis may be subject to regulation (See Risk Factors).

~~Because of the limited financial resources~~Environmental ~~that~~Laws ~~the Company has, we do not currently intend to diversify our operations. Our inability to diversify our activities into more than one area will subject the Company to economic fluctuations~~ and ~~therefore increase the risks associated with the Company’s operations.~~Regulations

~~Item~~Our operations 1Band properties are subject to laws and regulations relating to environmental protection, including those governing air emissions, water discharges and waste management, and workplace health and safety. ~~Unresolved~~In ~~Staff~~addition, ~~Comments~~certain of our proposed products are regulated by the U.S. Environmental Protection Agency and comparable state regulatory agencies. For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, please refer to the section entitled “Risk Factors—Risks Related to Our Businesses.”

~~None.~~8

7Seasonality

~~Item~~We do 2.not ~~Properties~~expect any seasonality in our business.

~~The Company maintains a corporate office~~Our ~~located~~fiscal atyear ~~1395~~end ~~Brickell~~is ~~Avenue,~~April ~~Suite 800, Miami, FL, 33131~~30. ~~The Company maintained a correspondence office located at 2135 De La Montagne, Montreal, Quebec, H3G 1Z8 CANADA.~~

~~Item~~Our company 3.is ~~Legal~~in ~~Proceedings~~the development stage and has generated no revenues

~~None.~~Employees

~~Item~~We have 47 full-time or part-time employees of our business or operations who are employed at will by BioQuest Corp. ~~Mine~~We ~~Safety~~anticipate ~~Disclosures~~adding additional employees in the next 12 months, as needed. We do not feel that we would have any unmanageable difficulty in locating needed staff. None of the employees is represented by a labor union for purposes of collective bargaining. The Company considers its relations with the employees to be good.

~~Not~~Bankruptcy or ~~applicable~~Similar Proceedings

8There has been no bankruptcy, receivership, or similar proceeding.

~~PART~~WHERE YOU IICAN GET ADDITIONAL INFORMATION

~~Item~~We file 5annual, quarterly, and current reports, proxy statements and other information with the SEC. ~~Market~~You ~~for~~may ~~Registrant~~read and copy our reports or other filings made with the SEC at the SEC’s ~~Common~~Public ~~Equity~~Reference Room, ~~Related~~located ~~Stockholder~~at ~~Matters~~100 ~~and~~F ~~Issuer~~Street, ~~Purchases~~N.E., Washington, DC 20549. You can obtain information on the operations of ~~Equity~~the ~~Securities~~Public Reference Room by calling the SEC at 1-800-SEC-0330. You can also access these reports and other filings electronically on the SEC’s web site, www.sec.gov.

~~Market~~Item 1A. ~~Information~~Risk Factors

AsWe are ~~the Company is~~ a “smaller reporting company,” itas isdefined ~~not~~by ~~required~~Rule to12b-2 ~~provide~~of the ~~performance~~Securities ~~graph~~Exchange Act of 1934 and are not required into ~~paragraph~~provide ~~(e)~~the ofinformation under ~~Item~~this ~~201~~item.

WeAn investment ~~have~~in ~~one~~the ~~class~~Company’s common stock involves a high degree of ~~securities,~~risk. ~~Common~~One ~~Voting~~should carefully consider the following risk factors ~~Equity~~in ~~Shares~~evaluating ~~("Common~~an ~~Stock").~~investment ~~Our~~in the Company’s common stock. isIf ~~quoted~~any onof the ~~NASDAQ~~following ~~OTC~~risks ~~Bulletin~~actually ~~Board~~occurs, ~~(“OTCQB”)~~the ~~under~~Company’s business, ~~the~~financial ~~symbol~~condition, ~~"SELT.QB". As~~results of ~~April~~operations ~~30,~~or ~~2014~~cash flow could be materially and adversely affected. In such case, the price of the Company’s common stock ~~was~~could ~~held~~decline, byand 26one ~~shareholders~~could lose all or part of ~~record,~~ ~~which~~one’s ~~does~~investment. ~~not~~One ~~include~~should ~~shares~~also ~~that~~refer ~~are~~to ~~held~~the other information set forth in ~~street~~this orreport, ~~nominee~~including ~~name~~the Company’s consolidated financial statements and the related notes.

~~The closing share prices presented below represent~~Our ~~prices~~business ~~between broker-dealers~~ and dofuture ~~not~~operations ~~include~~may ~~retail~~be ~~mark-ups~~adversely ~~and~~affected ~~mark-downs~~by orepidemics ~~any commission to the dealer~~ and ~~have~~pandemics, ~~been~~such ~~adjusted for~~as the ~~one~~recent ~~hundred~~COVID-~~for-one~~19 ~~forward stock split which occurred on May 1, 2014~~outbreak. ~~The following chart is indicative of the fluctuations in the stock prices:~~

	For the Year Ended April 30, 2014				For the Year Ended April 30, 2013
	High		Low		High		Low
First Quarter	$	NA	$	NA	$	NA	$	NA
Second Quarter	$	NA	$	NA	$	NA	$	NA
Third Quarter	$	NA	$	NA	$	NA	$	NA
Fourth Quarter	$	0.25	$	0.20	$	NA	$	NA

We may face risks related to health epidemics and pandemics or other outbreaks of communicable diseases, which could result in a widespread health crisis that could adversely affect general commercial activity and the economies and financial markets of the country as a whole. For example, the recent outbreak of COVID-19, has been declared by the World Health Organization to be a “pandemic,” has spread across the globe, including the United States of America. A health epidemic or pandemic or other outbreak of communicable diseases, such as the current COVID-19 pandemic, poses the risk that we, or potential business partners may be disrupted or prevented from conducting business activities for certain periods of time, the durations of which are uncertain, and may otherwise experience significant impairments of business activities, including due to, among other things, operational shutdowns or suspensions that may be requested or mandated by national or local governmental authorities or self-imposed by us, our customers or other business partners. While it is not possible at this time to estimate the impact that COVID-19 could have on our business, our customers, our potential customers, suppliers or other current or potential business partners, the continued spread of COVID-19, the measures taken by the local and federal government, actions taken to protect employees, and the impact of the pandemic on various business activities could adversely affect our results of operations and financial condition.

~~Our authorized capital stock consists of 500,000,000 shares of common stock, par value $0.001 per share. The holders of our common stock:~~9

*The Accompanying ~~have~~Financial ~~equal~~Statements ~~ratable~~Have ~~rights~~Been toPrepared ~~dividends~~Assuming ~~from~~the ~~funds~~Company ~~legally~~Will ~~available~~Continue ifAs ~~and~~A ~~when~~Going declared by our board of directors; * are entitled to share ratably in all of our assets available for distribution to holders of common stock upon liquidation, dissolution or winding up of our affairs; * do not have preemptive, subscription or conversion rights and there are no redemption or sinking fund provisions or rights; and * are entitled to one non-cumulative vote per share on all matters on which stockholders may voteConcern.

WeThe accompanying ~~refer~~financial ~~you~~statements tohave ~~our~~been ~~Articles~~prepared ofassuming ~~Incorporation~~that the Company will continue as a going concern, which contemplates the ~~Bylaws~~realization of its assets and the ~~applicable~~liquidation ~~statutes~~ of its liabilities in the ~~State~~normal course of ~~Nevada~~business. ~~for~~However, the Company has generated no revenues, has accumulated a ~~more~~loss ~~complete~~since ~~description~~formation ofand currently lacks the ~~rights~~capital ~~and~~to ~~liabilities~~effectively ofpursue ~~holders~~its business plan. This raises ofsubstantial ~~our~~doubt ~~securities~~about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.

~~The~~We May ~~Company’s~~Continue ~~transfer~~to ~~agent~~Lose ~~is Global Transfer~~Money, ~~LLC~~And ofIf ~~Deltona~~We Do Not Achieve Profitability, ~~Florida~~We May Not Be Able to Continue Our Business.

~~Dividend~~Since our ~~Distributions~~formation, we have generated no revenues from operations, and have incurred expenses and losses. In addition, we expect to continue to incur operating losses for the foreseeable future. As a result, we will need to generate sufficient revenues to achieve profitability, which may not occur. Even if we do achieve profitability, we may be unable to sustain or increase profitability on a quarterly or annual basis in the future. We expect to have quarter-to-quarter fluctuations in revenues, expenses, losses, and cash flow, some of which could be significant. Results of operations will depend upon numerous factors. Some of these factors, such as market acceptance of our product and competition, are beyond our control.

WeThe Company ~~have~~Is ~~not~~Subject ~~historically~~to ~~and~~The doRisks ~~not~~Inherent ~~intend~~in toThe ~~distribute~~Creation ~~dividends to~~of ~~stockholders~~a inNew ~~the foreseeable future~~Business.

~~Securities~~The Company ~~authorized~~is ~~for~~subject ~~issuance~~to ~~under~~substantially all the risks inherent in the creation of a new business. The implementation of our business strategy ~~equity~~is ~~compensation~~still ~~plans~~in the development stage. Our business and operations should be considered to be in the development stage and subject to all of the risks inherent in the establishment of a new business venture. Accordingly, our intended business and operations may not prove to be successful in the near future, if at all. Any future success that we might enjoy will depend upon many factors, several of which may be beyond our control, or which cannot be predicted at this time, and which could have a material adverse effect upon our financial condition, business prospects, and operations and the value of an investment in the Company.

~~The~~We May ~~Company~~Be ~~does~~Subject ~~not~~to ~~have~~Government ~~any~~Laws ~~equity~~and ~~compensation plans~~Regulations Particular to Our Operations with Which We May Be Unable to Comply.

~~Penny~~We may ~~Stock~~not be able to comply with all current and future government regulations which are applicable to our business. Our business operations are subject to all government regulations normally incident to conducting business (e.g., occupational safety and health acts, workmen’s compensation statutes, unemployment insurance legislation, income tax, and social security laws and regulations, environmental laws and regulations, consumer safety laws and regulations, etc.) as well as to governmental laws and regulations applicable to small public companies and their capital formation efforts. Although we will make every effort to comply with applicable laws and regulations, we can provide no assurance of our ability to do so, nor can we predict the effect of those regulations on our proposed business activities. Our failure to comply with material regulatory requirements would likely have an adverse effect on our ability to conduct our business and could result in our cessation of active business operations.

Our ~~common stock is considered "penny~~ ~~stock"~~independent ~~under~~registered ~~the~~public ~~rules~~accounting offirm ~~the Securities and Exchange Commission (the "SEC") under the Securities Exchange Act of 1934. The SEC~~ has ~~adopted~~expressed ~~rules~~substantial ~~that~~doubt ~~regulate~~about ~~broker-dealer~~our ~~practices~~ability into ~~connection~~continue ~~with~~as ~~transactions in penny stocks. Penny stocks are generally equity securities with~~ a ~~price~~going ~~of less than $5~~concern, ~~other than securities registered on certain national securities~~which ~~exchanges~~may orhinder ~~quoted~~our onability ~~the NASDAQ Stock Market System, provided that current price and volume information with respect~~ to ~~transactions in~~obtain ~~such~~future ~~securities is provided by the exchange or quotation system~~financing. ~~The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the Commission, that:~~

·Our independent ~~contains~~registered apublic ~~description~~accounting firm has issued its report, which includes an explanatory paragraph for going concern uncertainty on our consolidated financial statements as of and for the ~~nature~~year ~~and~~ended ~~level~~April 30, 2021. Because we have not yet generated revenues from our operations our ability to continue as a going concern is currently heavily dependent upon our ability to obtain additional financing to sustain our operations. Such financing may take the form of ~~risks~~the issuance of common or preferred stock or debt securities or may involve bank financing. The fact that our auditors have issued a “going concern” opinion may hinder our ability to obtain additional financing in the ~~market~~future. ~~for~~Currently, ~~penny~~we ~~stocks~~have inno ~~both~~commitments ~~public~~to ~~offerings~~obtain any additional financing, and ~~secondary~~there ~~trading;~~can be no assurance that financing will be available in amounts or on terms acceptable to us, if at all.

· contains a description of the broker's or dealer's duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of Securities' laws; contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;10

·If we ~~contains~~encounter aunforeseen ~~toll-free~~difficulties ~~telephone~~with ~~number~~our ~~for~~business ~~inquiries~~or operations in the future that require us to obtain additional working capital, and we cannot obtain additional working capital on ~~disciplinary~~favorable ~~actions;~~terms, or at all, our business may suffer.

·Our cash, ~~defines~~on ~~significant~~hand ~~terms~~totaled inapproximately ~~the~~$260 ~~disclosure~~at ~~document~~April or30, in2021. To date, we have relied primarily upon cash from the ~~conduct~~private sale of ~~trading~~equity securities into ~~penny~~generate ~~stocks;~~the ~~and~~working capital needed to finance our operations.

·We may ~~contains~~encounter ~~such~~unforeseen difficulties with our business or operations in the future that may deplete our capital resources more rapidly than anticipated. As a result, we may be required to obtain additional working capital in the future through bank credit facilities, public or private debt or equity financings, or otherwise. We have not identified other ~~information~~sources for additional funding and iscannot be certain that additional funding will be available on acceptable terms, or at all. If we are required to raise additional working capital in the future, such ~~form~~financing may be unavailable to us on favorable terms, ~~including~~if ~~language~~at all, ~~type~~or may be dilutive to our existing stockholders. If we fail to obtain additional working capital as and when needed, ~~size~~such failure could have a material adverse impact on our business, results of operations and ~~format~~financial condition. Furthermore, assuch ~~the~~lack ~~Commission~~of ~~shall~~funds ~~require~~may byinhibit ~~rule~~our ability to respond to competitive pressures or ~~regulation~~unanticipated capital needs, or may force us to reduce operating expenses, which could significantly harm the business and development of operations. Because our independent auditors have expressed doubt as to our ability to continue as a “going concern,” as reported in their report on our financial statements, our ability to raise capital may be severely hampered. Similarly, our ability to borrow any such capital may be more expensive and difficult to obtain until this “going concern” uncertainty is resolved.

9We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected.

~~The~~We operate ~~broker-dealer~~in ~~also~~a ~~must~~highly ~~provide,~~competitive ~~prior to~~environment. ~~effecting~~Our ~~any~~competition ~~transaction~~includes all other companies that are in athe ~~penny~~business ~~stock~~of selling cannabis-based products or other related items. A highly competitive environment could materially adversely affect our business, ~~the~~financial ~~customer~~condition, results ~~with:~~of operations, cash flows and prospects.

·We may ~~bid~~not ~~and~~be ~~offer~~able ~~quotations~~to ~~for~~compete successfully with other established companies offering the ~~penny~~same ~~stock;~~or similar products and, as a result, we may not achieve our projected revenue and user targets.

·If we ~~the~~are ~~compensation~~unable ofto ~~the~~compete ~~broker~~successfully with other businesses in our planned markets, we may not achieve our projected revenue and/or customer targets. We compete with both start-~~dealer~~up and ~~its~~established ~~salesperson~~companies. Compared to our business, some of our competitors may have greater financial and other resources, have been in ~~the~~business ~~transaction;~~longer, have greater name recognition and be better established in our markets of choice.

·As a ~~the~~growing ~~number~~company, ofwe ~~shares~~have yet to ~~which~~achieve ~~such~~a ~~bid~~profit and ~~ask~~may ~~prices~~not ~~apply,~~achieve ora ~~other~~profit ~~comparable~~in ~~information relating to~~ the ~~depth~~near ~~and~~future, ~~liquidity~~if ofat ~~the marker for such stock; and~~all.

·We have ~~monthly~~not ~~account~~yet ~~statements~~produced ~~showing~~a net profit and may not in the ~~market~~near ~~value~~future, if at all. While we expect our revenue to grow, we have not achieved profitability and cannot be certain that we will be able to sustain our current growth rate or realize sufficient revenue to achieve profitability. Further, many of ~~each~~our ~~penny~~competitors ~~stock~~have ~~held~~a insignificantly larger user base and revenue stream but have yet to achieve profitability. Our ability to continue as a going concern may be dependent upon raising capital from financing transactions, increasing revenue throughout the ~~customer's~~year, ~~account~~and keeping operating expenses below our revenue levels in order to achieve positive cash flows, none of which can be assured.

In addition, the penny stock rules that require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written acknowledgement of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitably statement.11

~~These~~Our lack ~~disclosure~~of ~~requirements~~adequate D&O insurance may ~~have~~also ~~the~~make ~~effect~~it ofdifficult ~~reducing~~for ~~the trading~~us ~~activity~~to inretain ~~the~~and ~~secondary~~attract ~~market~~talented ~~for~~and ~~our~~skilled ~~stock~~directors and officers.

~~Related~~In the ~~Stockholder~~future ~~Matters~~we may be subject to additional litigation, including potential class action and stockholder derivative actions. Risks associated with legal liability are difficult to assess and quantify, and their existence and magnitude can remain unknown for significant periods of time. To date, we have not obtained directors and officers liability (“D&O”) insurance. Without adequate D&O insurance, the amounts we would pay to indemnify our officers and directors should they be subject to legal action based on their service to the Company could have a material adverse effect on our financial condition, results of operations and liquidity. Furthermore, our lack of adequate D&O insurance may make it difficult for us to retain and attract talented and skilled directors and officers, which could adversely affect our business

~~None~~We expect to incur substantial expenses to meet our reporting obligations as a public company. In addition, failure to maintain adequate financial and management processes and controls could lead to errors in our financial reporting and could harm our ability to manage our expenses.

~~Purchase~~We estimate ofthat ~~Equity~~it ~~Securities~~will cost approximately $250,000 annually to maintain the proper management and financial controls for our filings required as a public company. In addition, if we do not maintain adequate financial and management personnel, processes and controls, we may not be able to accurately report our financial performance on a timely basis, which could cause a decline in our stock price and adversely affect our ability to raise capital.

~~None~~Different states and different advertising networks may have their own regulations and restrictions regarding advertising CBD products.

~~Item~~Relevant state 6and local laws may make it difficult to advertise in various markets. ~~Selected~~The ~~Financial~~two ~~Data~~largest ad buying platforms — Facebook and Google — still do not allow CBD advertising (it is designated as a “dangerous product”) on their platforms, which limits the digital marketing efforts of CBD companies to organic marketing. For new businesses, the inability to promote their brand without paid social and search ads makes it extremely challenging to get the qualified traffic needed to grow our online retail and wholesale businesses.

AsAdditional regulatory considerations that must be considered include the ~~Company~~Federal isTrade aCommission’s ~~“smaller~~regulation ~~reporting~~of ~~company~~unfair and deceptive product labeling and marketing,” ~~this~~as well as state law regulation of food safety. States have the authority to regulate matters related to the ~~item~~health isand ~~inapplicable~~safety of its own citizens, such that the 2018 Farm Bill and regulation by the USDA will not necessarily preempt state or local laws regulating the manufacture and distribution of cannabis-related products that are not directly in conflict with federal law. States may still choose to enact their own laws that can promote or restrict the sale of cannabis-based products.

~~Item~~Any and 7.all ~~Management’s~~claims ~~Discussion~~of ~~and~~medicinal ~~Analysis~~value ofmust ~~Financial~~be ~~Condition~~substantiated with reputable scientific support and ~~Results~~may ofbe ~~Operation~~subject to evaluation by the FDA.

~~You should read the following discussion~~There ofare ~~our~~limitations ~~results~~to ofhow ~~operations~~CBD ~~and~~may ~~financial~~be ~~condition~~marketed ~~with the audited financial statements~~ and ~~related~~what ~~notes~~potential ~~included~~benefits elsewhere in this report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs, and that involve numerous risks and uncertainties, including, but not limited to, those described in the “Risk Factors” section of this report. Actual results may ~~differ~~be ~~materially from those contained in any forward-looking statements~~advertised. ~~See “Cautionary Statement Concerning Forward-Looking Statements.”~~

~~Company~~Any and ~~Overview~~all claims of medicinal value must be substantiated with reputable scientific support and may be subject to evaluation by the FDA and we may be unable to effectively market our potential products without proper scientific documentation.

~~Select-TV~~In April ~~Solutions~~2019, ~~Inc.~~outgoing (FDA Commissioner Scott Gottlieb acknowledged that the ~~"Company",~~FDA is considering whether to use its authority to issue regulations ~~“SELT”,~~that ~~“we”,~~would ~~“us”~~permit orthe ~~“our”)~~marketing ~~was~~of ~~incorporated~~CBD in ~~Nevada~~foods onor ~~May~~as 17dietary supplements. However, ~~2011~~until ~~under~~the law changes, it is the FDA’s position ~~name~~that selling unapproved products with unsubstantiated therapeutic claims both violates the law and potentially puts patients at risk. Commissioner Gottlieb also asserted that it continues to be unlawful to market foods containing added CBD or THC or dietary supplements containing CBD or THC, regardless of ~~Renaissance~~whether ~~Films~~the ~~Inc~~substances are hemp-derived and regardless of the claims being made. (FDA takes this position based on the operation of statutory “~~RFI~~exclusionary clauses”) in the Food, Drug and ~~intended~~Cosmetic Act related to ~~produce~~food ~~documentary~~additives and ~~films~~dietary supplements. OnSpecifically, ~~September~~FDA 26has determined that both CBD and THC, ~~2011~~which are now active ingredients in FDA-approved drugs, were the ~~Company~~subject of substantial clinical investigations before they were marketed as foods or dietary supplements, and due to the operation ~~changed~~of ~~its~~the ~~name~~exclusionary clauses, FDA concludes that it is currently illegal to ~~Sedition~~introduce ~~Films~~CBD ~~Inc~~or THC into the food supply or to market these ingredients as dietary supplements.

On April 7, 2014, the Company experienced a change in control. Conseil Plumage Blanc Ltd. (“CPB”) acquired a majority of the issued and outstanding common stock of the Company in accordance with a stock purchase agreement by and between CPB and Jesse Lawrence, the Company’s former director and majority shareholder. On the closing date, April 7, 2014, pursuant to the terms of the Stock Purchase Agreement, CPB purchased from Jesse Lawrence 4,000,000 (40,000,000 post-split) shares of the Company’s outstanding common stock for $375,000. As a result of the change in control, CPB owned a total of 4,000,000 (40,000,000 post-split) shares of the Company’s common stock representing 74%.12

~~In conjunction with the change in control,~~Additional ~~Mr.~~regulatory ~~Jesse~~considerations ~~Lawrence~~that ~~resigned~~must asbe ~~the~~taken ~~Company's~~into ~~director,~~account ~~and~~include ~~any other positions held by him on April 9, 2014. The resignation was not~~ the ~~result~~Federal ofTrade ~~any disagreement with the Company or any matter relating to the Company'~~Commission’s ~~operations,~~regulation ~~policies~~of orunfair ~~practices.~~and deceptive Onproduct ~~the~~labeling ~~same~~and ~~date~~marketing, ~~Mr.~~as ~~Philippe~~well ~~Germain~~as ~~and~~state ~~Mr.~~law ~~Antonio~~regulation ~~Treminio~~of ~~were~~food ~~appointed as directors~~safety.

OnWe have ~~May~~limited 1,or ~~2014,~~no ~~the~~control ~~Company~~over ~~filed~~the anmanufacturing ~~amendment to~~and ~~its~~quality ~~Articles~~ of ~~Incorporation in~~ the ~~State~~products ofwe ~~Nevada~~plan to ~~change its name to Select-TV Solutions, Inc~~sell. ~~The Company intends to pursue significant opportunities available within the entertainment sector and online interactive niche.~~

OnWe will ~~May~~not 1,directly ~~2014,~~manufacture any of the ~~Company's~~proposed ~~Board~~products ofthat ~~Directors~~we currently plan to sell. Consequently, we have limited or no control ~~declared~~over amanufacturing ~~ten-~~practices at the suppliers from whom we procure the products we plan to~~-one~~ ~~forward~~sell. ~~stock~~We ~~split~~put offorth ~~all~~considerable ~~outstanding~~efforts ~~shares~~to ensure ofthat ~~common~~the ~~stock~~products we plan to sell are safe and comply with all applicable regulations. ~~The~~In ~~effect~~spite of ~~the~~these ~~stock~~efforts, ~~split~~there ~~increased~~is ~~the~~a risk ~~number~~that ofwe ~~shares~~could ofinadvertently ~~common~~resell ~~stock~~products ~~outstanding~~which ~~from~~fail 5to comply with applicable regulations or have other quality defects. If this were to occur,~~413,400~~ we could be forced to 54conduct a product recall,~~134,000.~~ ~~The~~defend ~~total~~regulatory ~~number~~or ofcivil ~~authorized~~claims, ~~common~~or ~~shares~~take ~~and~~other ~~the par~~actions, ~~value~~any ~~thereof~~of ~~was~~which ~~not~~could have ~~changed~~a bymaterial ~~the~~adverse ~~split~~effect upon our business.

OnIncreases in ~~July 7, 2014,~~ the ~~company’s~~cost ~~shareholders appointed~~of ~~Mr.~~shipping, ~~Geoffrey~~postage P.or ~~Mott~~credit ascard ~~the~~processing ~~Company’s~~could ~~Chief~~harm ~~Executive~~our ~~Officer~~business.

10We ship our potential products to customers by United States mail and other overnight delivery and surface services. We generally invoice the costs of delivery and parcel shipments directly to customers as separate shipping and handling charges. Any increases in shipping, postal or credit card processing rates could harm our operating results as we may not be able to effectively pass such increases on to our customers. Similarly, strikes or other service interruptions by these shippers could limit our ability to market or deliver our proposed products on a timely basis.

~~Plan~~We face an inherent risk of ~~Operation~~exposure to product liability claims in the event that the products we manufacture or sell allegedly cause personal injury.

~~The~~We face ~~Company,~~an ~~through~~inherent ~~its~~risk ~~sublicense,~~of ~~has~~exposure ~~the right~~ to ~~carry~~product onliability claims in the ~~Select-TV~~event ~~Business,~~that ~~Intellectual~~the ~~Property,~~products ~~Trademarks,~~we ~~trade~~plan ~~Names,~~to ~~Copyrights~~sell ~~and~~allegedly ~~Trade~~cause ~~Secrets~~personal injury. ~~The~~Although ~~Company believes~~we ithave ~~has~~not aexperienced ~~strong~~any ~~technology~~significant ~~platform,~~losses ~~proven~~due ~~market~~to ~~validation~~product inliability ~~some~~claims, ofwe ~~the~~may ~~best~~experience ~~hotels~~such losses in the future. ~~world~~While ~~and~~our asuppliers ~~great~~maintain ~~opportunity~~insurance against product liability claims but cannot be certain that such coverage will be adequate to ~~become~~cover aany ~~leader~~liabilities inthat ~~the~~we ~~North~~may ~~American~~incur, ~~hospitality~~or ~~market~~that ~~over~~such ~~the~~insurance ~~next~~will ~~few~~continue ~~years.~~to Atbe aavailable ~~time~~on ~~when~~acceptable ~~consumer~~terms. ~~expectations~~A ~~for~~successful claim ~~entertainment~~brought ~~quality~~against ~~and~~us ~~service~~in ~~value-added~~excess ~~are~~of onavailable ~~the~~insurance ~~rise~~coverage, ~~hotel~~ ~~owners~~or ~~and~~any ~~brands~~claim ~~know~~that ~~they~~results ~~need~~in tosignificant ~~redefine~~adverse ~~what~~publicity, ~~they~~could have ~~should~~a ~~expect~~material ~~from~~adverse ~~in-room~~effect ~~entertainment~~upon ~~systems~~our ~~and their vendors~~business.

~~Management~~We conduct ~~continues~~our toretail ~~explore~~operations ~~new~~through ~~investment opportunities with~~ a ~~focus~~single ondistribution ~~technology and the hospitality market~~facility.

~~Critical~~Substantially all ~~Accounting~~of ~~Policies~~our U.S. Retail inventory will be stored and ~~Estimates~~shipped from one distribution center. We will depend in large part on the orderly operation of this receiving and distribution process, which depends, in turn, on adherence to shipping schedules and effective management of the distribution center. We may not be able to accurately anticipate all of the changing demands that our expanding operations will impose on our receiving and distribution system. In addition, events beyond our control, such as disruptions in operations due to labor disagreements, shipping problems, fires, or natural disasters, could have a material adverse effect upon our business and operations.

~~Our significant accounting policies are described~~We in Note 2 of the audited financial statements included elsewhere in this report. The preparation of the financial statements in accordance with U.S. GAAP requires management to make significant judgments and estimates. Some accounting policies have a significant impact on amounts reported in these financial statements. Our financial position and results of operations may be ~~materially~~unable ~~different when reported under different conditions or when using different assumptions in the application of such policies. In the event estimates or assumptions prove~~ to bekeep ~~different~~pace ~~from~~with ~~actual~~changes ~~amounts, adjustments are made~~ in ~~subsequent periods to reflect more current information. The preparation of interim financial statements involves~~ the ~~use~~industries ~~of certain estimates~~ that ~~are~~we ~~consistent~~serve ~~with~~and ~~those~~advancements ~~used~~ in ~~the~~technology ~~preparation~~as of our ~~annual~~business ~~financial~~and ~~statements~~market strategy evolves.

~~Results~~As changes in the industries we serve occur or macroeconomic conditions fluctuate we may need to adjust our business strategies or find it necessary to restructure our operations or businesses, which could lead to changes in our cost structure, the need to write down the value of ~~Operations~~assets, or impact our profitability. We will also make investments in existing or new businesses, including investments in technology and expansion of our business plans. These investments may have short-term returns that are negative or less than expected and the ultimate business prospects of the business may be uncertain.

~~For~~As our ~~the~~business ~~Years~~and ~~Ended~~market ~~April~~strategy 30evolves, ~~2014~~we also will need to respond to technological advances and ~~2013~~emerging industry standards in a cost-effective and timely manner in order to remain competitive, such as adaptive learning technologies, better and more interactive products and web accessibility standards. The need to respond to technological changes may require us to make substantial, unanticipated expenditures. There can be no assurance that we will be able to respond successfully to technological change.

~~Revenues~~13

~~The~~If we ~~Company~~are ~~had~~unable noto ~~revenue~~protect ~~for~~ the ~~years~~confidentiality ~~ended~~of ~~April~~our 30trade secrets, ~~2014~~our business and ~~2013~~ competitive position would be harmed.

~~Operating~~The Company ~~Expenses~~plans on relying on trade secrets, including unpatented know-how, technology, and other proprietary information, to maintain our competitive position. We will seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. We will seek to protect our confidential proprietary information, in part, by entering into confidentiality and invention or patent assignment agreements with our employees and consultants; currently no such agreements have been entered into with relevant parties. Moreover, to the extent we enter into such agreements, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.

~~For the year ended April 30, 2014, total operating~~We ~~expenses~~rely ~~were~~in ~~$251,903~~part ~~compared~~on totrade ~~$8,277~~secrets ~~for the previous year. The increase is due~~ to ~~expenses~~protect ~~incurred~~our totechnology, ~~create~~ and ~~begin~~our ~~implementation of~~failure ~~the~~to ~~Company’s~~obtain ~~revised~~or ~~business~~maintain ~~plan~~trade ~~since~~secret ~~the~~protection ~~change~~could inlimit ~~control. Expenses were mainly comprised of professional fees,~~our ~~marketing,~~ability ~~travel~~to ~~and consulting fees~~compete.

~~Loss~~We rely ~~from~~on ~~Operations~~trade secrets to protect some of our technology and proprietary information, especially where we believe patent protection is not appropriate or obtainable. However, trade secrets are difficult to protect. Litigating a claim that a third party had illegally obtained and was using our trade secrets would be expensive and time consuming, and the outcome would be unpredictable. Moreover, if our competitors independently develop similar knowledge, methods, and know-how, it will be difficult for us to enforce our rights and our business could be harmed.

~~For~~Our products ~~the~~may ~~year~~not ~~ended~~gain ~~April~~commercial ~~30,~~or ~~2014~~market acceptance, ~~the~~which ~~loss from~~would ~~operations~~prevent ~~was~~us ~~$251,903~~from ~~compared~~achieving toincreased ~~$8,277~~revenues ~~for~~and ~~the~~market ~~previous year~~share.

~~Other~~The development ~~Income~~of ~~(Expense)~~a successful market for our products may be adversely affected by a number of factors, many of which are beyond our control, including:

~~Other~~● ~~expenses~~our ~~for~~failure to produce products that compete favorably against other products on the ~~year~~basis ~~ended~~of ~~April~~cost, 30quality, ~~2014~~ ~~were~~and ~~($364,283)~~performance. ~~compared~~● toany ~~$nil~~limitations ~~the~~or ~~previous~~warnings ~~year~~on our products approved labeling. ~~Other~~● ~~expenses~~the ~~included~~willingness ~~$364,250~~of ~~paid~~the target population to ~~Conseil~~try ~~Plumage~~our ~~Blanc~~new ~~Ltd~~technology and whether or not customers will accept our new technology. ● our failure to ~~effectuate~~ ~~the~~develop ~~change~~and inmaintain ~~control~~successful ofrelationships ~~the~~with ~~Company~~distributors, ~~currency~~project ~~exchange~~developers ~~loss~~and ofother ~~$985~~resellers, ~~and~~as ~~loss~~well onas ~~disposal~~strategic ofpartners; ~~equipment~~and ● the strength of ~~$498,~~marketing ~~offset by~~and adistribution ~~refund~~support ~~received~~and timing of ~~$1,450~~market introduction.

~~Loss~~If our ~~Before~~products ~~Income~~fail ~~Taxes~~to gain market acceptance, we would be unable to realize revenues, gain or increase market share and achieve and sustain profitability.

~~Loss~~Our Common ~~before~~Stock ~~incomes~~May ~~taxes~~Be ~~for~~Considered ~~the~~a ~~year~~“Penny ~~ended April~~Stock” ~~30,~~And ~~2014~~Be ~~was~~Subject ~~$616,186 compared~~ to ~~$8,277~~the ~~for~~“Penny ~~the~~Stock” ~~previous~~Rules ~~year.~~of The ~~loss~~Securities ~~for the current year was due to general and administrative~~Exchange ~~expenses along with expenses incurred to complete the change in control~~Commission.

11Our common stock may be subject to the “penny stock” rules adopted under Section 15(g) of the Exchange Act. The penny stock rules generally apply to companies whose common stock is not listed on The NASDAQ Stock Market or other national securities exchange and trades at less than $5.00 per share, other than companies that have had average revenue of at least $6,000,000 for the last three years or that have tangible net worth of at least $5,000,000 ($2,000,000 if the company has been operating for three or more years). These rules require, among other things, that brokers who trade penny stock to persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document and quote information under certain circumstances. Many brokers have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited. If we remain subject to the penny stock rules for any significant period, it could have an adverse effect on the market for our securities. If our securities are subject to the penny stock rules, investors will find it more difficult to dispose of our securities.

~~Liquidity and Capital Resources~~14

~~Cash~~Future sales ~~used~~of inour ~~operating~~common ~~activities~~stock ~~was~~could ~~$600,340 and~~put ~~$7,629~~downward ~~for~~selling ~~the~~pressure ~~years~~on ~~ended~~our ~~April~~common 30stock, ~~2014,~~ and ~~2013,~~adversely ~~respectively. The~~affect ~~principal elements of cash flow used in operations for~~ the ~~year~~per ~~ended~~share ~~April~~price. ~~30,~~There ~~2014 included~~ is a ~~net~~risk ~~loss~~that ofthis ~~$616,186,~~downward ~~offset~~pressure bymay ~~depreciation~~make ~~expense~~it ofimpossible ~~$648,~~for ~~expenses paid by a shareholder of $750, loss on disposal of equipment of $498 and~~ an ~~increase~~investor into ~~accounts~~sell ~~payable~~shares of ~~$14,700.~~common ~~The~~stock ~~principal~~at ~~elements~~any ofreasonable ~~cash flow used in operations for the year ended April 30~~price, ~~2013~~if ~~included~~at ~~a net loss of $8,277, offset by depreciation expense of $648~~all.

NoFuture sales ~~cash~~of ~~was~~substantial ~~used~~amounts of our common stock in ~~investing~~the ~~activities~~public ~~during~~ market or the ~~years~~perception ~~ended~~that ~~April~~such 30sales could occur, ~~2014~~could put downward selling pressure on our common stock and ~~2013~~adversely affect its market price.

~~Cash provided by financing activities was~~We ~~$1,136,215~~do ~~for~~not ~~the~~anticipate ~~year~~paying ~~ended~~dividends ~~April~~in ~~30, 2014 compared to cash generated of $14,661 for~~ the ~~year~~foreseeable ~~ended April 30, 2013~~future. ~~Financing~~ activities for the year ended April 30, 2014 included $1,482,366 received for stock subscriptions offset by the repayment of a loan from a shareholder and advances to related parties of $346,050 while the cash generated for the year ended April 30, 2013 included a loan from a shareholder for $101 and proceeds from the sale of common stock of $14,560.

~~Management~~We do ~~currently~~not ~~believes~~anticipate ~~that~~paying ~~the~~dividends ~~Company does~~on ~~have~~our ~~sufficient~~common ~~working~~stock ~~capital~~in ~~needed~~the foreseeable future, but plan rather to ~~meet~~retain ~~its~~earnings, ~~current~~if ~~fiscal~~any, ~~obligations~~for the operation, growth, and expansion of our business. InBecause ~~order~~the toCompany ~~continue~~does tonot ~~meet~~anticipate ~~its~~paying ~~fiscal~~cash ~~obligations beyond~~dividends in the ~~next~~foreseeable ~~twelve~~future which ~~months,~~may ~~management~~lower ~~has~~expected ~~plans~~returns tofor ~~pursue~~investors, ~~various~~and ~~financing~~as ~~alternatives~~such ~~including,~~our ~~but~~stockholders will not ~~limited~~be able to, ~~merger and~~receive ~~acquisition~~a ~~activity,~~return ~~raising~~on ~~capital~~their ~~through~~investment unless ~~the~~they ~~equity~~sell ~~markets~~their ~~and~~shares ~~debt~~of ~~financing~~common stock.

~~The primary source for capital for the Company~~Risks isRelating ~~the equity markets. Management plans~~ to ~~continue its canvassing efforts of investors and financial institutions to invest capital in~~ the Company through private placement offerings of common shares or units consisting of common shares and warrants. The terms and pricing of any such financing would be determined in the context of the markets. The Company has not entered into an agency agreement or arrangement with any financial institution to raise capital at this time.Internet

~~Should the Company not be successful at raising~~We ~~capital through the issuance of capital stock, the Company may consider raising capital by the issuance of debt. However, unless the appropriate features, such as convertible options,~~ are ~~attached~~dependent toon ~~the~~our ~~debt instruments~~telephone, ~~this~~Internet ~~form~~and ofmanagement ~~financing~~information issystems ~~less~~for ~~desirable until such time as~~ the ~~Company~~sales ~~may~~and bedistribution ~~in a position to reasonably foresee the generation~~ of ~~cash~~our ~~flow~~potential ~~to service and repay debt~~products. ~~The Company does not currently have plans to issue debt.~~

~~Going~~Our success ~~Concern~~depends, in part, on our ability to provide prompt, accurate and complete service to our customers on a competitive basis and our ability to purchase and promote products, manage inventory, ship products, manage sales and marketing activities and maintain efficient operations through our telephone and proprietary management information system. A significant disruption in our telephone, Internet or management information systems could harm our relations with our customers and the ability to manage our operations. We can offer no assurance that our back-up systems will be sufficient to prevent an interruption in our operations in the event of disruption in our management information systems, and an extended disruption in the management information systems could adversely affect our business, financial condition and results of operations.

~~Our independent auditors included an explanatory~~Online ~~paragraph~~security inbreaches ~~their~~could ~~report~~harm ~~on the accompanying financial statements regarding concerns about~~ our ~~ability to continue as a going concern~~business. ~~Our financial statements contain additional note disclosures describing the circumstances that lead to this disclosure by our independent auditors.~~

The secure ~~accompanying~~transmission ~~financial~~of ~~statements~~confidential ~~have been~~information ~~prepared~~over onthe aInternet ~~going~~is ~~concern~~essential ~~basis,~~to ~~which~~maintain ~~contemplates~~consumer ~~the~~confidence ~~realization~~in ofour ~~assets~~website. ~~and~~Substantial or ~~the~~ongoing ~~satisfaction~~security breaches of ~~liabilities~~our insystem ~~the normal~~or ~~course~~other ofInternet-based systems could significantly harm our business. ~~The~~ ~~Company~~Any ~~has~~penetration ~~incurred~~of our anetwork ~~net~~security ~~loss~~or other misappropriation of ~~$616,186~~our ~~for~~users’ ~~the~~personal ~~year~~information ~~ended~~could ~~April~~subject ~~30,~~us ~~2014,~~to ~~has~~liability. ~~incurred~~We may be liable ~~cumulative~~for ~~losses~~claims ~~since~~based ~~inception~~on ofunauthorized ~~$626,683. These~~purchases ~~factors~~with ~~raise~~credit ~~substantial~~card ~~doubt~~information, ~~about~~fraud, ~~the~~or ~~ability~~misuse of ~~the~~personal ~~Company~~information, ~~to continue~~such as afor ~~going~~unauthorized marketing ~~concern~~purposes. ~~for~~These aclaims ~~reasonable~~could ~~period~~result ofin ~~time.~~litigation ~~The~~and ~~Company~~financial isliability. ~~highly~~We ~~dependent~~rely on ~~its~~licensed ~~ability~~encryption toand ~~continue~~authentication technology to ~~obtain investment~~effect ~~capital~~secure ~~and~~transmission ~~loans~~of ~~from~~confidential aninformation, ~~affiliate~~including ~~and~~credit ~~shareholder~~card innumbers. ~~order~~It tois ~~fund~~possible ~~the~~that ~~current~~advances ~~and planned operating levels. The~~in ~~financial~~computer ~~statements~~capabilities, donew ~~not~~discoveries ~~include~~or ~~any~~other ~~adjustments~~developments ~~relating~~could toresult ~~the~~in ~~recoverability~~a ~~and~~compromise ~~classification~~or breach of ~~recorded~~the ~~asset~~technology ~~amounts or~~we ~~the~~use ~~amounts~~to ~~and~~protect customer ~~classification~~transaction ofdata. ~~liabilities~~We ~~that~~may ~~might~~incur besubstantial ~~necessary~~expense ~~should~~to ~~the~~protect ~~Company~~against beand ~~unable~~remedy tosecurity ~~continue~~breaches asand atheir ~~going concern~~consequences. A ~~The~~party ~~Company’s~~that ~~continuation~~is asable ato ~~going~~circumvent ~~concern~~our issecurity ~~dependent~~systems ~~upon~~could ~~its~~steal ~~ability~~proprietary toinformation ~~bring~~or cause interruptions in ~~income~~our ~~generating~~operations. ~~activities~~We ~~and~~cannot ~~its~~guarantee ~~ability~~that toour ~~continue~~security ~~receiving~~measures ~~investment~~will ~~capital~~prevent ~~and~~security ~~loans~~breaches. ~~from~~Any anbreach ~~affiliate~~resulting ~~and~~in ~~shareholder~~misappropriation toof ~~sustain its current level~~confidential ofinformation ~~operations. No~~would ~~assurance~~have ~~can~~a bematerial ~~given~~adverse ~~that~~effect ~~the~~on ~~Company~~our ~~will~~business, befinancial ~~successful~~condition, inand ~~these~~results ~~efforts~~of operations.

~~Off-Balance~~Government regulation ~~Sheet~~and ~~Arrangements~~legal uncertainties relating to the Internet and online commerce could negatively impact our business operations.

WeOnline commerce ~~currently~~is ~~have~~rapidly nochanging, ~~off-balance~~and ~~sheet~~federal ~~arrangements~~and state regulation relating to the Internet and online commerce is evolving. The U.S. Congress ~~that~~has ~~have~~enacted orInternet ~~are~~laws ~~reasonably~~regarding ~~likely~~online privacy, copyrights, and taxation. Due to ~~have~~the aincreasing ~~current~~popularity orof ~~future~~the ~~material~~Internet, ~~effect~~it onis possible ~~our~~that ~~financial~~additional ~~condition~~laws and regulations may be enacted with respect to the Internet, ~~changes~~covering inissues ~~financial~~such as user privacy, pricing, ~~condition~~taxation, ~~revenues~~content, orcopyrights, ~~expenses~~distribution, ~~results~~antitrust and quality of ~~operations,~~products ~~liquidity,~~and ~~capital~~services. ~~expenditures~~The adoption or ~~capital~~modification ~~resources~~of laws or regulations applicable to the Internet could harm our business operations.

~~Item 7A. Quantitative and Qualitative Disclosures About Market Risk.~~15

AsChanging technology ~~the~~could ~~Company~~adversely isaffect athe ~~“smaller~~operation ~~reporting~~of ~~company,”~~our ~~this item is inapplicable~~website.

12The Internet, online commerce and online advertising markets are characterized by rapidly changing technologies, evolving industry standards, frequent new product, and service introductions, and changing customer preferences. Our future success will depend on our ability to adapt to rapidly changing technologies and address its customers’ changing preferences. However, we may experience difficulties that delay or prevent us from being able to do so.

~~Item~~Going concern ~~8. Financial Statements and Supplementary Data.~~risk

Index		Page
Report of Independent Registered Public Accounting Firm – DKM Certified Public Accountants		F-1
Report of Independent Registered Public Accounting Firm – ZBS Group LLP		F-2
Financial Statements		F-3
	Balance Sheets	F-3
	Statements of Operations	F-4
	Statements of Cash Flows	F-5
	Statements of Stockholders’ Deficit	F-6
Notes to Financial Statements		F-7

The Company is an early-stage enterprise and has commenced principal operations. The Company had no revenues and has an accumulated deficit of $9.843,870 as of April 30, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

13There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources, such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations, or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company’s existing stockholders.

~~2451~~The Company Nintends to overcome the circumstances that impact its ability to remain a going concern through a combination of the growth of revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. ~~McMullen~~The ~~Booth~~Company ~~Road~~anticipates ~~Suite~~raising additional funds through public or private financing, strategic relationships, or other arrangements in the near future to support its business operations; however, the Company may not have commitments from third parties for a sufficient amount of additional capital.~~308~~ The ~~Clearwater~~Company cannot be certain that any such financing will be available on acceptable terms, FLor ~~33759~~at ~~Toll~~all, ~~fee:~~and ~~855~~its failure to raise capital when needed could limit its ability to continue its operations.~~334~~ The Company’s ability to obtain additional funding will determine its ability to continue as a going concern.~~0934~~ ~~Fax:~~Failure ~~800~~to secure additional financing in a timely manner and on favorable terms would have a material adverse effect on the Company’s financial performance, results of operations and stock price and require it to curtail or cease operations, sell off its assets, seek protection from its creditors through bankruptcy proceedings, or otherwise.~~581~~ Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary, to raise additional funds, and may require that the Company relinquish valuable rights.~~1908~~ Please see Financial Statements – Note 3. Going Concern for further information.

~~REPORT~~Item 1B. OFUnresolved ~~INDEPENDENT~~Staff ~~REGISTERED PUBLIC ACCOUNTING FIRM~~Comments

~~The Board of Directors and Stockholders~~None.

~~SELECT-TV SOLUTIONS INC~~Item 2. Properties

~~We have audited the accompanying balance sheet~~Our ofprincipal ~~SELECT-TV~~executive ~~SOLUTIONS~~office ~~INC.~~is aslocated ofat ~~April~~4570 ~~30,~~Campus ~~2014~~Drive, ~~and~~Suite ~~the related statement of operations~~23, ~~stockholders’~~Newport ~~deficiency~~Beach, ~~and cash~~CA ~~flows~~92660. ~~for~~The ~~the~~telephone ~~year~~number ~~ended~~at ~~April~~our ~~30,~~principal executive ~~2014.~~office ~~These~~is ~~financial~~(714) ~~statements~~978-4425. ~~are~~Our ~~the~~website ~~responsibility~~is ofwww.bioquestcorp.com, ~~the~~and ~~Company’s~~our ~~management. Our~~email ~~responsibility~~address is tobusiness@bioquestcorp.com. ~~express~~We anbelieve that ~~opinion on~~ these ~~financial~~offices ~~statements~~are ~~based~~adequate onfor our ~~audit~~purposes. ~~The~~We ~~financial~~do ~~statements for~~not ~~the~~own ~~year~~any ~~ended~~real ~~April~~property ~~30,~~or ~~2013~~significant ~~were~~assets. ~~audited~~Management bybelieves ~~another~~that ~~accountant~~this office ~~who~~space ~~issued~~will anmeet ~~unqualified~~our ~~opinion~~needs onfor ~~June~~the 5,next ~~2013~~12 months.

We ~~conducted our audit in accordance with the~~ ~~standards~~do ofnot ~~the~~have ~~Public~~any ~~Company~~investments ~~Accounting~~or ~~Oversight~~interests ~~Board~~in ~~(United~~any ~~States).~~real ~~Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement~~estate. ~~The~~We ~~Company~~do is not ~~required~~invest toin ~~have~~real estate mortgages, nor ~~were~~do we ~~engaged~~invest to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in ~~the~~securities ~~circumstances, but not for the purpose~~ of ~~expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly~~, weor ~~express~~interests ~~no such opinion. An audit includes examining~~in, onpersons aprimarily ~~test~~engaged ~~basis, evidence supporting the amounts and disclosures~~ in ~~the~~real ~~financial~~estate ~~statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation~~activities. ~~We believe that our audit provide a reasonable basis for our opinion.~~

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of SELECT-TV SOLUTIONS INC. as of April 30, 2014, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.16

~~The accompanying financial statements have~~Item ~~been prepared assuming that the Company will continue as a going concern~~3. AsLegal shown in the accompanying financial statements, the Company has significant net losses and cash flow deficiencies. Those conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding those matters are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Proceedings

~~/s/~~We know ~~DKM~~of ~~Certified~~no ~~Public~~material, ~~Accountants~~existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which our director, officer, or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

~~DKM~~Item 4. ~~Certified~~Mine ~~Public~~Safety ~~Accountants~~Disclosures

~~Clearwater, Florida~~Not Applicable.

~~August 12, 2014~~Part II

~~PCAOB~~Item 5. ~~Registered~~Market for Common Equity and Related Stockholder Matters

~~AICPA~~ The ~~Member~~shares of our common stock are not currently listed for sale on any exchange, although we do plan to attempt to have our shares quoted for sale or the OTC Bulletin Board. However, there can be no assurance that we will be successful in having our shares quoted or traded on any public market.

F-The following table sets forth the high and low bid prices for our Common Stock per quarter for the past two years as reported by the OTC Markets, based on our fiscal year end April 30, and taking into effect the 1-2000 reverse split that occurred on November 14, 2019. These prices represent quotations between dealers without adjustment for retail markup, markdown or commission and may not represent actual transactions.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

	Price Ranges
Fiscal Year Ended April 30, 2021	High		Low
First Quarter	$	27.00	$	22.00
Second Quarter		22.00		4.20
Third Quarter		5.50		.75
Fourth Quarter		1.95		.59

To the Board of Directors and

Fiscal Year Ended April 30, 2020
First Quarter	$	2,900.00	$	30.00
Second Quarter		3,000.00		2,100.00
Third Quarter		2,100.00		27.00
Fourth Quarter		27.00		27.00

~~Stockholders~~There were approximately 214 holders of ~~Sedition~~record ~~Films,~~of ~~Inc~~our common stock. This number does not include stockholders for whom shares were held in “nominee” or “street name”.

WeOur transfer ~~have~~agent ~~audited~~is ~~the~~Globex ~~accompanying~~Transfer, ~~balance sheets of Sedition Films~~LLC, ~~Inc.~~whose ~~(the~~address ~~Company)~~is as780 ofDeltona ~~April 30~~Blvd., ~~2013~~Suite ~~and the related statements of operations~~202, ~~stockholders’ equity~~Deltona, ~~and~~FL ~~cash flows for the year ended April 30~~32725, ~~2013.~~telephone ~~Sedition~~number ~~Films,~~(813) ~~Inc.’s management is responsible for these financial~~344-4490, ~~statements.~~and ~~Our~~email ~~responsibility is to express an opinion on these financial statements based on our audit~~mt@globextransfer.com.

~~We conducted our audits in accordance with~~Record the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.Holders

InAs of ~~our~~April ~~opinion~~30, ~~the financial statements referred to above present fairly~~2021, inthere ~~all~~were ~~material respects~~8,730,733 ~~the~~shares ~~financial position~~ of ~~Sedition~~the ~~Films,~~registrant’s ~~Inc~~$0.001 aspar ofvalue ~~April~~common ~~30,~~stock ~~2013,~~ issued and ~~the~~outstanding ~~results of its operations~~ and ~~its~~were owned ~~cash~~by ~~flows~~approximately ~~for~~214 ~~the~~holders ~~year~~of ~~ended~~record ~~April~~and 3073,304 ~~2013~~shares in ~~conformity with accounting principles generally accepted in~~ the ~~United~~public ~~States of America~~float.

~~The accompanying financial statements have~~Penny ~~been~~Stock prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company is in development stage with limited operations and resources, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Regulation

~~/s/~~Shares of ~~ZBS~~our ~~Group~~common ~~LLP~~stock will probably be subject to rules adopted by the SEC that regulate broker-dealer practices in connection with transactions in “penny stocks”. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in those securities is provided by the exchange or system). The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from those rules, deliver a standardized risk disclosure document prepared by the SEC, which contains the following:

~~Melville,~~● ~~New~~a ~~York~~description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading;

~~August 12, 2014~~17

~~115~~● ~~Broad~~a ~~Hollow~~description ~~Road~~of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to violation to such duties or other requirements of securities’ laws; ● a brief, ~~Suite~~clear, ~~350 Melville~~narrative description of a dealer market, ~~New~~including ~~York~~“bid” ~~11747~~and “ask” prices for penny stocks and the significance of the spread between the “bid” and “ask” price; ● a toll-free telephone number for inquiries on disciplinary actions; ● definitions of significant terms in the disclosure document or in the conduct of trading in penny stocks; and ● such other information and is in such form (including language, type, size, and format), as the SEC shall require by rule or regulation.

~~Tel:~~Prior to ~~(516)~~effecting ~~394-3344~~any ~~Fax:~~transaction ~~(516) 908~~in penny stock, the broker-~~7867~~dealer also must provide the customer the following:

~~www~~● the bid and offer quotations for the penny stock; ● the compensation of the broker-dealer and its salesperson in the transaction; ● the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and ● monthly account statements showing the market value of each penny stock held in the customer’s account.~~zmscpas.com~~

FIn addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-2dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgment of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for a stock that becomes subject to the penny stock rules. Holders of shares of our common stock may have difficulty selling those shares because our common stock will probably be subject to the penny stock rules.

~~Select-TV~~Description of ~~Solutions,~~Registrant’s ~~Inc.~~Securities

~~f/k/a/~~We have ~~Sedition~~authorized ~~Films~~capital ~~Inc~~stock consisting of 500,000,000 shares of common stock, $0.001 par value per share (“Common Stock”), and no shares of preferred stock.

~~Balance~~Equity ~~Sheets~~Compensation Plans

	April 30,
	2014			2013
ASSETS
Current assets:
Cash and cash equivalents	$	543,853		$	7,978
Due from related parties		346,050			–
Total current assets		889,903			7,978
Equipment, net		–			1,146
Total assets	$	889,903		$	9,124
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	14,700		$	–
Due to shareholder		–			101
Total current liabilities		14,700			101
Other liabilities		–			–
Total liabilities		14,700			101
Stockholders' deficit:
Common stock, $0.001 par value, 75,000,000 shares authorized, 54,134,000 shares issued and outstanding at April 30, 2014 and 2013, respectively		54,134			54,134
Paid-in capital (deficiency)		(34,614	)		(34,614	)
Common stock issuable		1,482,366			–
Deficit accumulated during the development stage		(626,683	)		(10,497	)
Total stockholders' deficit		875,203			9,023
Total liabilities and stockholders' deficit	$	889,903		$	9,124

The Company has registered its 2021 Equity Compensation Plan, with the SEC on June 29, 2021. The Plan authorizes up to 2,000,000 shares of company common stock to be issued to its officers, directors, consultants, and any other persons whom the Board of Directors wishes to incite to contribute to the Company.

~~See~~Warrants, ~~accompanying~~Options ~~notes~~and toConvertible ~~financial statements.~~Securities

~~F-3~~The Company issued multiple notes payable in the amount of $40,000 due in January and February 2022, with interest at 6% and convertible in common shares at $1.00 per share.

~~Select-TV~~The Company ~~Solutions~~issued a note payable in September 2020 due in one year in the amount of $27,500 ~~Inc~~including interest at 10%. The note is convertible at a 40% discount to market price after 90 days. The company recorded a note discount of $2,500. In November 2020 the Company issued an addition note payable due in one year in the amount of $30,800 including interest at 10%. The note convertible at a 60% discount to market price. The Company recorded a note discount of $2,800.

~~f/k/a/ Sedition Films Inc.~~18

~~Statements~~Other ofthan ~~Operations~~the aforementioned we do not have any outstanding warrants, options, or convertible securities.

	For the Year Ended April 30,
	2014			2013
Revenues	$	–		$	–
Operating expenses:
General and administrative expenses		251,903			8,277
Loss from operations		(251,903	)		(8,277	)
Other income (expense):
Refund		1,450			–
Exchange loss		(985	)		–
Other expense		(364,250	)		–
Loss on disposal of equipment		(498	)		–
Total other income (expense)		(364,283	)		–
Loss before income taxes		(616,186	)		(8,277	)
Provision for income taxes		–			–
Net loss	$	(616,186	)	$	(8,277	)
Net loss per share - basic and diluted	$	(0.01	)	$	(0.00	)
Weighted average number of shares outstanding - Basic and Diluted		54,134,000			52,306,120

Recent Sales of Unregistered Securities

~~See~~During ~~accompanying~~the ~~notes~~year toended ~~financial~~April ~~statements~~30, 2021, the Company issued 67,500 shares for $135,000 cash.

~~F-4~~Repurchase of Equity Securities

~~Select-TV Solutions, Inc~~None.

~~f/k/a/ Sedition Films Inc.~~Dividends

~~Statements~~We have never declared or paid any cash dividends on our common stock. For the foreseeable future, we intend to retain any earnings to finance the development and expansion of ~~Cash~~our ~~Flows~~business, and we do not anticipate paying any cash dividends on our common stock. Any future determination to pay dividends will be at the discretion of the Board of Directors and will be dependent upon then existing conditions, including our financial condition and results of operations, capital requirements, contractual restrictions, business prospects, and other factors that the board of directors considers relevant.

	For the Year Ended April 30,
	2014			2013
Cash flows from operating activities:
Net loss	$	(616,186	)	$	(8,277	)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation expense		648			648
Loss on disposal of equipment		498			–
Changes in operating assets and liabilities:
Prepaid expenses		–			–
Accounts payable		14,700			–
Net cash used in operating activities		(600,340	)		(7,629	)
Cash flows from investing activities:		–			–
Cash flows from financing activities:
Loans from shareholders		–			101
Payments on loans from shareholders		(101	)		–
Advances to related parties		(346,050	)		–
Proceeds from sale of stock subscriptions		1,482,366			–
Proceeds from sale of common stock		–			14,560
Net cash provided by financing activities		1,136,215			14,661
Net increase in cash		535,875			7,032
Cash and cash equivalents at beginning of year		7,978			946
Cash and cash equivalents at end of year	$	543,853		$	7,978
Supplemental disclosure of cash flow information:
Cash paid for interest	$	–		$	–
Cash paid for taxes	$	–		$	–

Section Rule 15(g) of the Securities Exchange Act of 1934

~~See~~The ~~accompanying~~Company’s ~~notes~~shares are covered by Section 15(g) of the Securities Exchange Act of 1934, as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to ~~financial~~persons ~~statements~~other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses). For transactions covered by the Rule, the broker/dealer must make a special suitability determination for the purchase and have received the purchaser’s written agreement to the transaction prior to the sale. Consequently, the Rule may affect the ability of broker/dealers to sell our securities and also may affect your ability to sell your shares in the secondary market.

~~F-5~~Section 15(g) also imposes additional sales practice requirements on broker/dealers who sell penny securities. These rules require a one page summary of certain essential items. The items include the risk of investing in penny stocks in both public offerings and secondary marketing; terms important to in understanding of the function of the penny stock market, such as “bid” and “offer” quotes, a dealers “spread” and broker/dealer compensation; the broker/dealer compensation, the broker/dealers duties to its customers, including the disclosures required by any other penny stock disclosure rules; the customers rights and remedies in causes of fraud in penny stock transactions; and, FINRA’s toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker/dealers and their associated persons.

~~Select-TV~~Item 6. ~~Solutions,~~Selected ~~Inc.~~Financial Data

~~f/k/~~We are a/ ~~Sedition~~smaller ~~Films~~reporting ~~Inc~~company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

~~Statement of Stockholders' Deficit~~19

~~For~~Item ~~the~~7. ~~years~~Management’s ~~ended~~Discussion ~~April~~and ~~30,~~Analysis ~~2014~~of Financial Condition and ~~2013~~Results of Operations

					Paid-in			Common					Total
	Common stock				capital			stock		Accumulated			stockholders'
	Shares		Amount		(deficiency)			issuable		deficit			deficit
Balance, April 30, 2012		44,800,000	$	44,800	$	(39,840	)	$	–	$	(2,220	)	$	2,740
Shares issued for cash at $0.002		4,800,000		4,800		(3,840	)		–		–			960
Shares issued for cash at $0.03		4,534,000		4,534		9,066			–		–			13,600
Net loss for the year		–		–		–			–		(8,277	)		(8,277	)
Balance, April 30, 2013		54,134,000		54,134		(34,614	)		–		(10,497	)		9,023
Stock subscriptions received for 29,647,316 shares of common stock		–		–		–			1,482,366		–			1,482,366
Net loss for the year		–		–		–			–		(616,186	)		(616,186	)
Balance, April 30, 2014		54,134,000	$	54,134	$	(34,614	)	$	1,482,366	$	(626,683	)	$	875,203

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. You should read this report completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

~~See~~Working ~~accompanying notes to financial statements.~~Capital

F-6

	April 30, 2021 $			April 30, 2020 $
Cash		260			166
Current Assets		17,097			166
Current Liabilities		1,786,638			98,745
Working Capital (Deficit)		(1,769,541	)		(98,579	)

~~Select-TV Solutions, Inc.~~Cash Flows

f/k/a Sedition Films Inc.

	April 30, 2021 $			April 30, 2020 $
Cash Flows from (used in) Operating Activities		(193,206	)		(124,834	)
Cash Flows from (used in) Investing Activities		193,300			125,000
Cash Flows from (used in) Financing Activities		-			-
Net Increase (decrease) in Cash During Period		94			166

~~Notes~~Results for the Year Ended April 30, 2021, compared to ~~Financial~~the ~~Statements~~Year Ended April 30, 2020

~~April 30, 2014~~Operating Revenues

~~Note~~The Company’s 1revenues –were ~~Nature~~$-0- offor ~~Business~~the Year ended April 30, ~~Presentation~~2021, ~~and~~compared ~~Going~~to ~~Concern~~$-0- in 2020.

~~Organization~~Cost of Revenues

~~Select-TV Solutions, Inc. (the "Company",~~The ~~“SELT”,~~Company’s ~~“we”,~~cost ~~“us”~~of orrevenues ~~“our”)~~ was ~~incorporated~~$-0- infor ~~Nevada on May 17, 2011 under~~ the ~~name~~ ofYear ~~Renaissance~~ended ~~Films~~April ~~Inc. (“RFI”) and intended to produce documentary films. On September 26~~30, ~~2011~~2021, ~~the~~compared ~~Company changed its name~~ to ~~Sedition~~$-0- ~~Films~~in ~~Inc~~2020. ~~As of the date hereof, the Company has no operations.~~

~~On April 7, 2014, the Company experienced a~~Gross change in control. Conseil Plumage Blanc Ltd. (“CPB”) acquired a majority of the issued and outstanding common stock of the Company in accordance with a stock purchase agreement by and between CPB and Jesse Lawrence, the Company’s former director and majority shareholder. On the closing date, April 7, 2014, pursuant to the terms of the Stock Purchase Agreement, CPB purchased from Jesse Lawrence 4,000,000 (40,000,000 post-split) shares of the Company’s outstanding common stock for $375,000. As a result of the change in control, CPB owned a total of 4,000,000 (40,000,000 post-split) shares of the Company’s common stock representing 74%.Profit

OnFor the ~~May~~Year 1ended April 30, ~~2014~~2021, the Company’s ~~filed~~gross anprofit ~~amendment to~~was ~~its~~$nil ~~Articles~~compared ~~of Incorporation in the State of Nevada~~ to ~~change its name to Select~~$-TV0- ~~Solutions,~~in ~~Inc~~2020. ~~The Company intends to pursue significant opportunities available within the entertainment sector and online interactive niche.~~

~~On July 18, 2014,~~General the Company entered into a Merger Agreement with Select-TV Solutions (USA), Inc. (“STVU”), a Florida corporation. Pursuant to the terms of the Agreement, the Company shall issue 1.25 shares for each share STVU, or 49,678,443, and anAdministrative additional 6,000,000 shares pursuant to a Convertible Promissory Note, maturing December 31, 2014, for a principal amount of CAD$150,000.00 issued by STVU, for a total of 55,678,443 shares. As a result of the merger, the Company, as the surviving entity, shall acquire the license rights to Select-TV HITV (Hospitality Interactive TV, software and hardware, and EMAGINE (home IPTV software and hardware), thus enabling the Company to provide end-to-end IPTV (Internet Protocol Television) solutions to the Hospitality, Residential and Hospital subscribers in North America. The Closing of the transaction was effective on the close of business July 31, 2014.Expenses

~~Stock~~Operating expenses ~~Split~~and general and administrative expenses consisted of compensation of $1,408,000, stock compensation expense of $530,000, professional fees of $152,162 and general and administrative expenses of $110,387 for total operating expenses of $2,200,549 for the year ended April 30, 2021. For the year ended April 30, 2020, operating expenses consisted of compensation of $164,000, stock compensation expense of $117,279, professional fees of $51,187 and general and administrative expenses were $24,097 for totaling operating expenses of $356,554.

On May 1, 2014, the Company's Board of Directors declared a ten-to-one forward stock split of all outstanding shares of common stock. The effect of the stock split increased the number of shares of common stock outstanding from 5,413,400 to 54,134,000. All common share and per common share data in these financial statements and related notes hereto have been retroactively adjusted to account for the effect of the stock split for all periods presented prior to May 1, 2014. The total number of authorized common shares and the par value thereof was not changed by the split.20

~~Basis~~Other Income ~~of Presentation~~(Expense)

~~The accompanying financial statements have~~Other ~~been~~income ~~prepared~~(expense) inconsisted ~~accordance with accounting principles generally accepted in The United States~~ of ~~America~~$nil and $nil for the ~~rules~~years ~~and~~ended ~~regulations of~~April ~~the~~30, ~~Securities~~2021, and ~~Exchange~~2020, ~~Commission (“SEC”)~~respectively.

~~Going Concern~~Net Loss

The ~~accompanying financial statements have~~ ~~been~~net ~~prepared~~loss onfor ~~a going concern basis, which contemplates~~ the ~~realization~~year ofended ~~assets~~April ~~and~~30, ~~the~~2021, ~~satisfaction~~was of$2,323,962 ~~liabilities~~compared into ~~the normal course of business. The Company has incurred net losses of~~ $~~616~~359,~~186~~029 ~~and~~compared ~~$8,277~~to for the ~~years~~year ended April 30, ~~2014~~ ~~and~~2020. ~~2013,~~The ~~respectively,~~net loss ~~and~~is ~~has~~influenced ~~incurred~~by ~~cumulative~~the ~~losses~~matters ~~since~~discussed ~~inception~~in ~~of $626,683. These conditions raise substantial doubt about~~ the ~~ability~~other sections of the ~~Company to continue as a going concern~~MD&A.

~~The ability of the Company to continue as a~~Liquidity ~~going concern is dependent upon its abilities to generate revenues, to continue to raise investment capital,~~ and ~~develop~~Capital ~~and implement its business plan. No assurance can be given that the Company will be successful in these efforts.~~Resources

The ~~financial statements do not include any~~ ~~adjustments~~ability ~~relating to the recoverability and classification~~ of ~~recorded asset amounts or~~ the ~~amounts and classification of liabilities that might be necessary should the~~ Company ~~be unable~~ to continue as a going concern~~. Management~~ ~~believes~~is ~~that~~dependent ~~actions presently~~on ~~being~~the ~~taken~~Company’s ability to ~~obtain~~raise additional ~~funding~~capital and implement its ~~strategic~~business ~~plans~~plan. ~~provide~~Since ~~the~~its ~~opportunity~~inception, ~~for~~ the Company ~~to continue~~has asbeen afunded ~~going~~by ~~concern. No~~related ~~assurance~~parties ~~can~~through becapital ~~given~~investment ~~that~~and ~~the~~borrowing ~~Company~~of ~~will be successful in these efforts~~funds.

~~F-7~~At April 30, 2021, the Company had total current assets of $17,097 compared to $166 at April 30, 2020. Current assets consisted of cash of $260 and prepaid expenses of $16,838. At April 30, 2021, the Company had total current liabilities of $1,786,638 compared to $98,745 at April 30, 2020. Current liabilities consisted primarily of accounts payable and accrued liabilities of $174,916, accrued compensation of $1,731,750, due to officers shareholders of $21,235, accrued interest of $5,981, notes payable of $74,302 and derivative liability of $138,555 for total current liabilities of $1,786,638. At April 30, 2020, current liabilities consisted of accounts payable and accrued liabilities of $18,330, accrued compensation of $70,000, due to officers shareholders of $9,590 and accrued interest of $825 for a total of $98,745 The increase in our current liabilities to staffing of the company and developing of our product line.

~~Select-TV~~We had ~~Solutions~~negative working capital of $1,769,140 ~~Inc~~as of April 30, 2021.

~~f/k/a~~Cash flow ~~Sedition~~from ~~Films~~Operating ~~Inc.~~Activities

~~Notes~~During the year ended April 30, 2021, cash used in operating activities was $193,206 compared to ~~Financial~~$124,834 ~~Statements~~for the year ended April 30, 2020. The increase in the amounts of cash used in operating activities was primarily due to the increase operating activities.

~~April~~Cashflow from ~~30,~~Investing ~~2014~~Activities

~~Note~~During the 2Year –Ended ~~Summary~~April of30, ~~Significant~~2021, ~~Accounting~~cash ~~Policies~~used in investing activities was $nil compared to $nil for the Year Ended April 30, 2020.

~~Use~~Cashflow from ofFinancing ~~Estimates~~Activities

~~The preparation of financial statements in~~During ~~conformity~~the ~~with~~year ~~accounting~~ended ~~principles~~April ~~generally~~30, ~~accepted~~2021, incash ~~the~~provided ~~United~~by ~~States~~financing ofactivity ~~America~~was ~~requires~~$193,300 ~~management~~compared to ~~make~~$125,000 ~~estimates and~~provided assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the ~~reporting~~year ~~period. Actual results~~ended ~~could differ from those estimates. Significant estimates in the accompanying financial statements include the~~April ~~depreciable~~30, ~~lives of property and equipment and the valuation allowance on deferred tax assets~~2020.

~~Earnings (Loss) Per Share~~Going Concern

~~The~~Management has ~~Company~~concluded ~~computes~~there ~~income~~is ~~(loss)~~substantial ~~per~~doubt ~~share in~~about ~~accordance~~our ~~with~~ability ~~the~~to ~~Financial~~continue ~~Accounting~~as ~~Standards~~a ~~Board~~going ~~(“FASB”)~~concern. ~~Accounting~~For ~~Standard~~the ~~Codification~~year ~~(“ASC”) ASC~~ended ~~Topic~~April ~~260~~30, ~~“Earnings Per Share"~~2021, ~~which~~the ~~requires presentation of both basic and diluted earnings per share (“EPS”)~~Company onhad ~~the~~a ~~face~~Stockholders ofDeficit ~~the statement~~ of ~~operations.~~$1,769,541, ~~Basic~~raising ~~EPS~~substantial isdoubt ~~computed~~about bythe ~~dividing~~Company’s ~~income~~ability ~~(loss)~~to ~~available~~continue toas ~~common~~a ~~shareholders~~going byconcern. ~~the~~The ~~weighted~~continuation ~~average number~~ of ~~shares outstanding during~~ the ~~period.~~Company ~~Diluted~~as ~~EPS~~a ~~gives~~going ~~effect~~concern tois ~~all~~dependent ~~dilutive~~upon ~~potential shares of common stock outstanding during~~ the ~~period~~continued ~~using~~financial ~~the~~support ~~treasury~~from ~~stock~~its ~~method~~shareholders, ~~and convertible preferred stock using~~ the ~~if-converted~~ability ~~method.~~of ~~In computing diluted EPS,~~ the ~~average~~Company ~~stock~~to ~~price~~obtain ~~for~~necessary ~~the~~equity ~~period~~financing ~~is used in determining the number of shares assumed~~ to be ~~purchased~~continue ~~from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of April 30~~operations, ~~2014~~ and ~~2013,~~the ~~respectively,~~attainment ~~there~~of ~~were~~profitable ~~no common share equivalents outstanding which would be deemed as dilutive~~operations.

~~Fair~~Bioquest, Corp., ~~Value~~markets, ofpackages, ~~Financial~~and ~~Instruments~~distributes Hemp-CBD based products. . Our mission is to create high end unique content and aggregate all relevant CBD content in the Nutraceutical and Pharmaceutical markets including Medical Grade Products and Immune Health Products CBD. Bioquest Corp. is positioned to generate revenue by acquiring established company and bringing new products to the market, generating immediate revenues. The Company is implementing and marketing to the business-to-business and to direct to consumers’ markets. The Company is implementing this plan to achieve profitable and sustainable operations.

ASC 825 "Financial Instruments" codified Statement of Financial Accounting Standard No. 107, Disclosures about fair value of financial instruments, requires that the Company disclose estimated fair values of financial instruments. Unless otherwise indicated, the fair values of all reported assets and liabilities, which represent financial instruments, none of which are held for trading purposes, approximate the carrying values of such amounts.21

~~Dividends~~The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

The Company has not yet ~~adopted~~established ~~any~~an ~~policy~~ongoing source of revenues sufficient to cover its operating costs for the next fiscal year and allow ~~regarding~~it ~~payment~~to continue as a going concern. The ability of ~~dividends~~the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. NoFor ~~dividends~~the ~~have~~year ~~been~~ended ~~paid~~April ~~during~~30, 2021, the ~~periods~~Company ~~shown~~has a net loss of $2,323,962, and if the Company is unable to obtain adequate capital, it could be forced to cease operations.

~~Cash~~During the year ended April 30, 2021, Company has net cash used in operating activities of $193,206 as well as stock compensation non-cash expenses of $530,000 and ~~Cash~~a ~~Equivalents~~net loss of $2,323,623 The Company raised $193,300 from financing activities in the year ended April 30, 2021, which resulted in a negative working capital of $1,769,540 as of April 30, 2020. If the Company is unable to raise additional adequate capital, it could be forced to cease operations.

~~The Company considers all highly~~Future liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At April 30, 2014 and 2013, the Company had cash or cash equivalents of $543,853 and 7,978, respectively.Financings

~~Income~~We will ~~Taxes~~continue to rely on equity sales of our common shares in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund planned acquisitions and development activities.

~~The~~Since inception, ~~Company~~we ~~accounts~~have ~~for~~financed ~~income~~our ~~taxes under~~cash ~~ASC~~flow ~~Topic~~requirements ~~740-10-25~~through ~~(“ASC~~issuance ~~740-10-25”). Under~~of ~~ASC~~common ~~740-10-25,~~stock ~~deferred~~and ~~tax~~loans ~~assets~~to ~~and~~third ~~liabilities are~~parties. ~~recognized~~As ~~for~~we ~~the~~expand ~~future~~our activities, ~~tax~~we ~~consequences~~may, ~~attributable~~and tomost ~~differences~~likely ~~between~~will, ~~the~~continue ~~financial~~to ~~statement~~experience ~~carrying~~net ~~amounts of~~negative ~~existing~~cash ~~assets~~flows ~~and~~from ~~liabilities~~operations, ~~and~~pending ~~their~~receipt ~~respective~~of ~~tax bases~~revenues. ~~Deferred~~ Additionally, ~~tax~~we ~~assets~~anticipate ~~and~~obtaining ~~liabilities~~additional ~~are~~financing ~~measured using~~to ~~enacted~~fund ~~tax~~operations ~~rates~~through ~~expected~~common tostock ~~apply~~offerings, to ~~taxable~~the ~~income~~extent inavailable, or ~~the~~to ~~years~~obtain inadditional ~~which~~financing ~~those~~to ~~temporary~~the ~~differences~~extent ~~are~~necessary ~~expected~~ to be ~~recovered~~augment orour ~~settled~~working capital. ~~Under~~ ~~ASC~~In ~~740-10-25,~~ the ~~effect~~future onwe ~~deferred~~will ~~tax~~need ~~assets~~to ~~and~~generate ~~liabilities~~sufficient revenues offrom asales ~~change~~ in ~~tax~~order ~~rates is~~to ~~recognized~~eliminate inor ~~income~~reduce in the ~~period~~need ~~that~~to ~~includes~~sell ~~the~~additional ~~enactment~~stock ~~date. A~~or ~~valuation~~obtain ~~allowance~~additional isloans. ~~provided~~There ~~for~~can ~~certain deferred~~be ~~tax~~no ~~assets~~assurance we ifwill itbe issuccessful ~~more~~in ~~likely~~raising ~~than not that~~ the ~~Company~~necessary ~~will~~funds ~~not~~to ~~realize~~execute ~~tax~~our ~~assets~~business ~~through future operations~~plan.

~~Stock~~We anticipate ~~Based~~that ~~Compensation~~we will incur operating losses in the next twelve months. Our lack of operating history makes predictions of future operating results difficult to ascertain. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets. Such risks for us include, but are not limited to, an evolving and unpredictable business model and the management of growth.

~~The Company accounts for Stock-Based Compensation~~To ~~under~~address ~~ASC~~these ~~Topic~~risks, ~~718-10~~we ~~(“ASC 718-10”)~~must, ~~which~~among ~~addresses~~other ~~the accounting for transactions in which an entity exchanges its equity instruments for goods or services~~things, ~~with~~obtain a ~~primary~~customer ~~focus~~base, onimplement ~~transactions~~and insuccessfully ~~which~~execute anour ~~entity~~business ~~obtains~~and ~~employee services~~marketing instrategy, ~~share-based~~continually ~~payment~~develop ~~transactions.~~and ~~ASC~~upgrade ~~718-10~~our isbusiness amodel ~~revision~~and ~~to SFAS No. 123~~website, ~~"Accounting~~respond ~~for~~to ~~Stock-Based~~competitive ~~Compensation~~developments," and ~~supersedes Accounting Principles Board (“APB”) Opinion No. 25~~attract, ~~“Accounting~~retain ~~for Stock Issued to Employees,”~~ and motivate ~~its~~qualified ~~related implementation guidance~~personnel. ~~ASC~~There ~~718-10~~can ~~requires~~be ~~measurement~~no ofassurance ~~the~~that ~~cost~~we ofwill ~~employee~~be ~~services~~successful ~~received~~ in ~~exchange for~~addressing ansuch ~~award~~risks, ofand ~~equity instruments based on~~ the ~~grant-date~~failure ~~fair~~to ~~value~~do ~~of the award (with limited exceptions). Incremental compensation~~so ~~costs~~can ~~arising~~have ~~from~~a ~~subsequent~~material ~~modifications~~adverse ofeffect ~~awards~~on ~~after~~our ~~the~~business ~~grant~~prospects, ~~date~~financial ~~must~~condition, ~~be recognized. The Company has not adopted a stock option plan~~ and ~~has~~results ~~not~~of ~~granted any stock options~~operations.

FOff-8Balance Sheet Arrangements

~~Select~~We have no significant off-TVbalance ~~Solutions~~sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, ~~Inc~~changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

~~f/k/a~~Critical Accounting ~~Sedition Films Inc.~~Policies

~~Notes~~Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to ~~Financial~~make ~~Statements~~estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

~~April~~We regularly 30evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements. In general, ~~2014~~management’s estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

~~Note~~Recently Issued ~~2 – Summary of Significant~~ Accounting ~~Policies (Continued)~~Pronouncements

~~Issuance~~The Company ofhas ~~Shares~~implemented ~~for~~all ~~Services~~new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

~~The Company accounts for the issuance of equity~~Contractual ~~instruments to acquire goods and services based on the fair value of the goods and services or the fair value of the equity instrument at the time of issuance, whichever is more reliably measurable.~~Obligations

~~Fixed~~We are ~~Assets~~a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

~~Fixed assets are stated at cost less accumulated~~Item ~~depreciation~~7A. ~~Depreciation~~Quantitative ~~was~~and ~~calculated~~Qualitative ~~using~~Disclosures ~~the~~about ~~straight-line~~Market ~~method over the estimated useful lives of the respective assets.~~Risk

~~Impairment~~We are ora ~~Disposal~~smaller ofreporting ~~Long~~company as defined by Rule 12b-~~Lived~~2 of the Securities Exchange Act of 1934 and are not required to provide the information ~~Assets~~under this item.

The Company accounts for the impairment or disposal of long-lived assets according to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 360 “Property, Plant and Equipment”. ASC 360 clarifies the accounting for the impairment of long-lived assets and for long-lived assets to be disposed of, including the disposal of business segments and major lines of business. Long-lived assets are reviewed when facts and circumstances indicate that the carrying value of the asset may not be recoverable. When necessary, impaired assets are written down to estimated fair value based on the best information available. Estimated fair value is generally based on either appraised value or measured by discounting estimated future cash flows. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. The Company did not recognize any impairment losses for the years ended April 30, 2014 and 2013.22

~~Comprehensive~~Item 8. ~~Income~~Financial Statements and Supplemental Data

~~During the year ended April 30, 2014, the~~BioQuest ~~Company paid $364,250 to CPB to enable CPB to acquire the 4,000,000 shares to effectuate the change in control~~Corp. ~~This expense has been classified as other expense.~~

~~The Company adopted ASC 220, Comprehensive Income which establishes~~Index standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to ~~owners.~~Financial ~~The Company has no elements of “other comprehensive income” for the periods ended April 30, 2014 and 2013.~~Statements

Development Stage Enterprise

Table of Contents		Page

Report of Independent Registered Public Accounting Firm		24
Balance Sheets as of April 30, 2021, and 2020		26
Statements of Operations for the Years Ended April 30, 2021, and 2020		27
Statement of Changes in Stockholders’ Deficit for the Years Ended April 30, 2021, and 2020		28
Statements of Cash Flows for the Years Ended April 30, 2021, and 2020		29
Notes to Financial Statements		30

On June 10, 2014 the FASB issued authoritative guidance which eliminates the concept of a development stage entity. The incremental reporting requirements for presenting the development stage operations and cash flows since inception will no longer apply to development stage entities. The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 are to be applied retrospectively and are effective for fiscal years beginning after December 15, 2014. The Company previously had been considered a development state entity as its operations had not begun and has elected early adoption of this guidance effective with the filing of this annual report.23

~~Note~~REPORT OF 3INDEPENDENT –REGISTERED ~~Recent~~PUBLIC ~~Accounting~~ACCOUNTING ~~Pronouncements~~FIRM

~~In June 2014 the FASB issued Accounting Standards~~To ~~Update (“ASU”) 2014-10, “Development Stage Entities (Topic 915)”, which provides guidance on~~ the ~~elimination~~ ofBoard ~~the concept~~ of aDirectors ~~development stage entity. The incremental reporting requirements for presenting the development stage operations~~ and cash flows since inception will no longer apply to development stage entities. The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 are to be applied retrospectively and are effective for fiscal years beginning after December 15, 2014. The Company has elected early adoption of this guidance effective with the filing of this annual report.

~~In February 2013, the FASB issued ASU 2013-04,”Liabilities~~Stockholders ~~(Topic 405)”, which provides guidance for the recognition, measurement, and disclosure~~ of ~~obligations~~BioQuest resulting from joint and several liability arrangements. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. ASU 2013-04 is effective for fiscal years beginning after December 15, 2013. We do not believe the adoption of ASU 2013-04 will have a material effect on the Company’s financial statements.Corp

~~F-9~~Opinion on the Financial Statements

~~Select~~We have audited the accompanying balance sheets of BioQuest Corp. (the Company) as of April 30, 2021 and 2020, and the related statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-TVyear ~~Solutions~~period ended April 30, ~~Inc~~2021, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two-year period ended April 30, 2021, in conformity with accounting principles generally accepted in the United States of America.

~~f/k/a~~Consideration of ~~Sedition~~the ~~Films~~Company’s ~~Inc.~~Ability to Continue as a Going Concern

~~Notes~~The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to ~~Financial~~the ~~Statements~~financial statements, the Company has incurred losses since inception, has negative cash flows from operations, and has negative working capital. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~April~~Basis for ~~30, 2014~~Opinion

~~Note~~These financial 3statements –are ~~Recent~~the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting ~~Pronouncements~~Oversight Board (~~Continued~~United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

InWe conducted ~~February~~our ~~2013,~~audits ~~the~~in ~~FASB~~accordance ~~issued~~with ~~ASU 2013-02,~~the ~~“Reporting~~standards of ~~Amounts~~the ~~Reclassified~~PCAOB. ~~Out~~Those ofstandards ~~Accumulated~~require ~~Other~~that ~~Comprehensive~~we ~~Income.”~~plan ~~ASU~~and ~~2013-02~~perform ~~requires~~the audit to obtain ~~disclosure~~reasonable ofassurance ~~the~~about ~~amounts~~whether ~~reclassified~~the ~~out~~financial ofstatements ~~each~~are ~~component~~free of ~~accumulated~~material ~~other~~misstatement, ~~comprehensive~~whether ~~income~~due ~~and~~to ~~into~~error ~~net~~or ~~earnings~~fraud. The Company ~~during~~is ~~the~~not ~~reporting~~required ~~period~~to ~~and~~have, isnor ~~effective~~were ~~for~~we ~~reporting~~engaged ~~periods~~to ~~beginning~~perform, ~~after~~an ~~December~~audit ~~15,~~of ~~2013~~its internal control over financial reporting. WeAs dopart ~~not~~of ~~believe~~our ~~the~~audits, ~~adoption~~we are required to obtain an understanding of ~~ASU~~internal ~~2013−02~~control ~~will~~over ~~have~~financial areporting, ~~material~~but ~~impact~~not for the purpose of expressing an opinion on the ~~measurement~~effectiveness of ~~net~~the ~~earnings~~Company’s orinternal ~~other~~control ~~comprehensive income~~over financial reporting. Accordingly, we express no such opinion.

InOur audits ~~December~~included ~~2011,~~performing ~~the~~procedures ~~FASB~~to ~~issued~~assess ~~ASU~~the ~~2011-11, “Disclosures~~risks ~~about~~of ~~Offsetting~~material ~~Assets~~misstatement ~~and~~of ~~Liabilities”~~the ~~and~~financial ~~in January 2013~~statements, ~~the~~whether ~~FASB~~due ~~issued~~to ~~ASU~~error or ~~2013-01~~fraud, ~~“Clarifying the~~and ~~Scope~~performing ofprocedures ~~Disclosures~~that ~~about~~respond ~~Offsetting~~to ~~Assets~~those ~~and Liabilities”~~risks. ~~ASU~~Such ~~2011-11,~~procedures asincluded ~~clarified~~examining, ~~enhances~~on ~~disclosures surrounding~~a ~~offsetting~~test ~~(netting) assets and liabilities. The clarified standard applies to derivatives~~basis, ~~repurchase~~evidence ~~agreements and~~regarding ~~securities~~the ~~lending~~amounts ~~transactions~~ and ~~requires~~disclosures ~~companies~~in tothe ~~disclose~~financial ~~gross~~statements. ~~and~~Our ~~net~~audits ~~information~~also ~~about~~included ~~financial~~evaluating ~~instruments~~the ~~and~~accounting ~~derivatives eligible~~principles ~~for~~used ~~offset~~ and tosignificant estimates ~~disclose~~made ~~financial~~by ~~instruments~~management, ~~and~~as ~~derivatives~~well ~~subject~~as toevaluating ~~master~~the ~~netting~~overall ~~arrangements~~presentation inof the financial statements. ~~The~~ ~~clarified~~We ~~standard~~believe ~~did~~that ~~not~~our ~~have~~audits provide a ~~material~~reasonable ~~effect~~basis onfor our ~~financial position or results of operations~~opinion.

In October 2013, the FASB issued ASU 2013-04, “Technical Corrections and Improvements” in Accounting Standards Update No. 2013-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2013. The adoption of ASU 2013-04 did not have a material impact on our financial position or results of operations.24

~~Management does not believe any recently issued~~Critical ~~but~~Audit ~~not yet effective accounting pronouncements, if adopted, would have a material effect on the Company’s present or future financial statements.~~Matters

~~Note~~The critical 4audit –matters ~~Equipment~~communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, ~~net~~subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

~~Equipment,~~Critical Audit ~~net,~~Matter ~~consisted of the following at April 30, 2014 and 2013:~~Description

	April 30,
	2014		2013
Film Equipment	$	–	$	1,956
Accumulated depreciation		–		(810	)
Equipment, net	$	–	$	1,146

As described further in Notes 5 of the financial statements, during the year ended April 30, 2021 and in prior periods, the Company issued convertible debt that required management to assess whether the conversion features of the convertible debt required bifurcation and separate valuation as a derivative liability. The Company determined that the conversion features of certain of its convertible debt issued in financing arrangements required to be accounted for as derivative liabilities due to: (1) variable conversion prices (2) the Company’s inability to assert it had sufficient authorized but unissued shares available to settle instruments considering all other stock-based commitments. The derivative liabilities were recorded at fair value when issued and subsequently re-measured to fair value upon settlement or at the end of each reporting period. The Company utilized a Black-Scholes option pricing model to determine the fair value of the derivative liabilities, which uses certain assumptions related to exercise price, term, expected volatility, and risk-free interest rate.

~~Depreciation~~ We ~~expense~~identified ~~was~~auditing ~~$648~~the determination and ~~$648~~valuation ~~for~~of the ~~years~~derivative ~~ended~~liabilities ~~April 30~~as ~~2014~~a ~~and~~critical ~~2013,~~audit ~~respectively.~~matter Indue ~~April~~to ~~2014,~~the insignificant judgements ~~conjunction~~used ~~with~~by the Company’s ~~change~~ in ~~control,~~determining whether the ~~film~~embedded ~~equipment~~conversion ~~was~~features required derivative accounting treatment and the ~~disposed~~significant judgements used in determining the fair value of atthe derivative liabilities. Auditing the determination and valuation of the derivative liabilities involved a ~~loss~~high degree of ~~$498~~auditor judgement, and specialized skills and knowledge were needed.

~~Note~~How the 5Critical –Audit ~~Related~~Matter ~~Parties~~Was Addressed in the Audit

~~During the year ended April 30, 2013, a shareholder~~Our ~~and~~audit ~~officer~~procedures ~~loaned~~included ~~$160 to~~ the ~~Company to open a bank account and to help fund operations. The loan was unsecured~~following, ~~non-interest bearing~~among and due on demand. $59 and $101 was been repaid to the shareholder and officer during the years ended April 30, 2014 and 2013, respectively. The balances due to the shareholder and officer was $-0- and $101 as of April 30, 2014 and 2013, respectively.others:

~~During~~● ~~the~~We ~~year~~inspected ~~ended~~and ~~April~~reviewed ~~30,~~debt ~~2014,~~agreements to evaluate the Company ~~advanced~~’s adetermination ~~total~~ of ~~$346~~whether derivative accounting was required,~~050~~ toincluding ~~STVU~~assessing ~~for~~and ~~working~~evaluating ~~capital~~management’s ~~purposes~~application of ~~STVU~~relevant accounting standards to such transactions. ~~The~~● ~~loan~~We istested ~~unsecured~~the reasonableness, ~~non~~accuracy, and completeness of the data and assumptions used by the Company in the Black-~~interest~~Scholes ~~bearing~~option pricing model, including exercise price, expected term, expected volatility, and ~~due on~~risk-free ~~demand~~interest rate. No● ~~payments~~We ~~have~~developed ~~been~~independent ~~received~~expectations ~~from~~for ~~STVU~~comparison ~~and~~to the ~~balance~~Company’s ~~due~~estimates. ~~from~~● ~~STVU~~We isevaluated ~~$346,050~~the asaccuracy and completeness of ~~April~~the ~~30,~~Company’s ~~2014~~presentation of these instruments in the financial statements and related disclosures in Notes 5 including evaluating whether such disclosures were in accordance with relevant accounting standards.

~~Note~~Haynie 6& –Company ~~Stockholders~~Salt Lake City, Utah August 13, 2021 We have served as the Company’s ~~Deficit~~auditor since 2020.

~~The Company has authorized 75,000,000 shares of Common Stock, $0.001 par value. As of April 30, 2014 and 2013, the Company had 54,134,000 shares of Common Stock issued and outstanding.~~25

~~On July 5, 2012, the Company issued 4,800,000~~Bioquest ~~shares of common stock for cash proceeds of $960 at $0~~Corp.~~0002 per share.~~

~~On July 27, 2012, the Company issued 4,534,000~~Balance ~~shares of common stock for cash proceeds of $13,600 at $0.003 per share.~~Sheets

F-10

	April 30, 2021			April 30, 2020

Assets
Current Assets
Cash	$	260		$	166
Prepaid Expenses		16,837
Total Current Assets		17,097			166

Total Assets	$	17,097		$	166

Liabilities and Stockholders’ Deficit
Current Liabilities
Accounts Payable and Accrued Liabilities	$	174,915		$	18,330
Accrued Compensation		1,371,750			70,000
Due to Officers Shareholders		21,235			9,590
Accrued Interest		5,981			825
Convertible Notes Payable		40,000
Notes Payable, Net of Discount of $24,098		34,202
Derivative Liability		138,555
Total Current Liabilities		1,786,638			98,745

Long-Term Liabilities
Notes Payable		-			40,000
Total Liabilities		1,786,638			138,745

Commitments and Contingencies					-

Stockholders’ Deficit
Common Stock, $.001 Par Value 500,000,000 Authorized; 8,730,733 and 8,044,233 Issued and Outstanding at April 30, 2020 and 2019 respectively		8,731			8,044
Stock Payable		-			50,000
Additional-Paid-in-Capital		8,065,598			7,323,285
Accumulated Deficit		(9,843,870	)		(7,519,908	)
Total Stockholders’ Deficit		(1,769,541	)		(138,579	)
Total Liabilities and Stockholders’ Deficit	$	17,097		$	166

~~Select-TV~~The accompanying ~~Solutions,~~notes ~~Inc~~are an integral part of these financial statements.

~~f/k/a Sedition Films Inc.~~26

~~Notes to Financial Statements~~Bioquest Corp.

~~April~~Statement of ~~30, 2014~~Operations

Note 6 – Stockholders’ Deficit (Continued)

	For the Year Ended			For the Year Ended
	April 30, 2021			April 30, 2020

Revenues	$	-		$	-

Operating Expenses
Compensation		1,408,000			164,000
Stock Compensation Expense		530,000			117,270
Professional Fees		152,162			51,187
General and Administrative Expenses		110,387			24,097
Total Operating Expenses		2,200,549			356,554
Operating Loss		(2,200,549	)		(356,554	)
Derivative Expense		85,775
Interest Expense		37,638			2,475
Net Loss	$	(2,323,962	)	$	(359,029	)

Basic and Fully Dilutive Loss per Share	$	(0.09	)	$	(0.09	)

Weighted Average Common Shares - Basic and Fully Diluted		8,283,502			4,104,900

~~On May 1, 2014, the Company's Board of Directors declared a ten-to-one forward stock split of all outstanding shares of common stock.~~ The ~~effect of the stock split increased the~~ ~~number~~accompanying ~~of shares of common stock outstanding from 5,413,400 to 54,134,000. All common share and per common share data in these financial statements and related~~ notes ~~hereto~~are ~~have~~an ~~been~~integral ~~retroactively~~part ~~adjusted to account for the effect~~ of ~~the~~these ~~stock~~financial ~~split for all periods presented prior to May 1, 2014~~statements. ~~The total number of authorized common shares and the par value thereof was not changed by the split.~~

~~On May 6, 2014, the Company filed an amendment to its Articles of Incorporation increasing the authorized shares of Common Stock to 500,000,000. The par value of $0.001 remained unchanged.~~27

~~Note 7 – Income Taxes~~Bioquest Corp.

~~No provision was made for income taxes for~~Statement the period from May 17, 2011 (Inception) to April 30, 2014 as the Company had cumulative operating losses. For the years ended April 30, 2014 and 2013, the Company realized net losses for tax purposes of ~~$10,473~~Changes ~~and~~in ~~$8,277,~~Stockholders’ ~~respectively.~~Deficit

~~The income tax expense (benefit) differs from~~For the ~~amount~~Years ~~computed~~Ended byApril ~~applying~~30, ~~the~~2021 ~~United~~and ~~States Statutory corporate income tax rate as follows:~~2020

	For the Year Ended April 30,
	Common Shares		Par Value $.001		Stock Payable			Additional Paid-In Capital		Accumulated Deficit			Stockholders’ Deficit
	2014		2013
Balance April 30, 2019		102,233	$	102		-		$	7,151,957	$	(7,160,879	)	$	(8,820	)
United States statutory corporate income tax rate		34.0%		34.0%
Shares Issued for Settlement of debt		135,000		135		-			26,865		-			27,000
Change in valuation allowance on deferred tax assets		-34.0%		-34.0%
Shares Issued for Employment and Consulting Services		7,747,000		7,747		-			89,523		-			97,270
Provision for income tax		–%		–%
Shares Issued for Cash		60,000		60		-			54,940		-			55,000
Shares Issuable for Cash		-		-		30,000			-		-			30,000
Shares Issuable in connection with Notes Payable		-		-		20,000			-		-			20,000
Net Loss		-		-		-			-		(359,029	)		(359,029	)
Balance April 30, 2020		8,044,233		8,044		50,000			7,323,285		(7,519,908	)		(138,579	)
Stock Issued for Cash		67,500		68		-			134,932		-			135,000
Shares Issued for Stock Payable		70,000		70		(50,000	)		49,930		-			-
Shares Issued for Employment and Consulting Services		540,000		540		-			539,460		-			540,000
Shares Issued for Prepaid Marketing Services		9,000		9		-			17,991		-			18,000
Net Loss for the Year Ended April 30, 2021		-		-		-			-		(2,323,962	)		(2,323,962	)
Balance April 30, 2021		8,730,733	$	8,731	$	-		$	8,065,598	$	(9,843,870	)	$	(1,769,541	)

~~Deferred income taxes reflect the tax effect~~The ofaccompanying ~~temporary~~notes ~~differences~~are ~~between~~an ~~the~~integral ~~carrying~~part ~~amounts~~ of ~~assets~~these ~~and liabilities for~~ financial ~~reporting purposes and the amounts used for tax purposes~~statements. ~~The components of the net deferred income tax assets are approximately as follows:~~

	April 30,
	2014			2013
Deferred income tax assets:
Net operating loss carry forwards	$	213,070		$	3,570
Valuation allowance		(213,070	)		(3,570	)
Net deferred income tax assets	$	–		$	–

~~The Company has established a full valuation~~Bioquest ~~allowance on our deferred tax asset because of a lack of sufficient positive evidence to support its realization~~Corp. ~~The valuation allowance increased by $209,500 and $2,815 for the years ended April 30, 2014 and 2013, respectively.~~

~~No provision for income taxes has been provided~~Statements ~~in these financial statements due to the net loss for the years ended April 30, 2014 and 2013. At April 30, 2014, the Company has net operating loss carry forwards~~ of ~~approximately~~Cash $626,680, which expire commencing 2032. The potential tax benefit of these losses may be limited due to certain change in ownership provisions under Section 382 of the Internal Revenue Code (“IRS”) and similar state provisions.Flows

IRS Section 382 places limitations (the “Section 382 Limitation”) on the amount of taxable income which can be offset by net operating loss carry forwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. Generally, after a change in control, a loss corporation cannot deduct operating loss carry forwards in excess of the Section 382 Limitation. Due to these “change in ownership” provisions, utilization of the net operating loss and tax credit carry forwards may be subject to an annual limitation regarding their utilization against taxable income in future periods. The Company has not concluded its analysis of Section 382 through April 30, 2014, but believes the provisions will not limit the availability of losses to offset future income.

	For the Year Ended			For the Year Ended
	April 30, 2021			April 30, 2020

Cash Flows from Operating Activities
Net Loss	$	(2,323,962	)	$	(359,029	)
Adjustments to reconcile net loss to net cash used in operating activities.
Stock Based Compensation		530,000			117,270
Increase (Decrease) in Accounts Payable and Accrued Liabilities		156,585			36,510
Increase in Accrued Compensation		1,301,750			70,000
Increase in Due to Officers Shareholders		11,645			9,590
Accrued Interest		5,156			825
Non Cash Marketing		12,600			-
Derivative Expense net of Debt Discount		113,020			-
Net Cash Used from Operating Activities		(193,206	)		(124,834	)

Cash Flows from Investing Activities		-			-

Cash from Financing Activities
Sale of Common Stock for Cash		135,000			55,000
Stock Subscriptions Payable for Cash		-			30,000
Issuance of Notes Payable		58,300			40,000
Net Cash Provided in Financing Activities		193,300			125,000
Net Increase in Cash		94			166
Beginning Cash		166			-
Ending Cash	$	260		$	166

Supplemental Information
Non-Cash Items:
Shares Issued for Extinguishment of Accounts Payable				$	27,000

The ~~Company is subject to income taxes in the~~ ~~U.S.~~accompanying ~~federal~~notes ~~jurisdiction and the state of Florida. The tax regulations within each jurisdiction~~ are ~~subject~~an tointegral ~~interpretation of~~part ~~related tax laws and regulations and require significant judgment to apply. As~~ of ~~April~~these ~~30,~~financial ~~2014, tax years 2012 through 2014 remain open for IRS audit~~statements. ~~The Company has received no notice of audit from the IRS for any of the open tax years.~~

~~F-11~~29

~~Select-TV Solutions, Inc~~BIOQUEST CORP.

~~f/k/a~~NOTES TO ~~Sedition~~THE ~~Films~~FINANCIAL ~~Inc.~~STATEMENTS

~~Notes~~For the toYears ~~Financial~~Ended ~~Statements~~April 30, 2021 and 2020

~~April~~NOTE 1 ~~30,~~- ~~2014~~ORGANIZATION AND OPERATIONS

~~Note~~Bioquest Corp.(the 8“Company”) –was ~~Subsequent~~originally ~~Events~~incorporated in the State of Nevada on May 17, 2011, as Renaissance Films Inc. On September 26, 2011, the Company changed its name to Sedition Films Inc. and on May 1, 2014, the Company changed its name to Select-TV Solutions, Inc. The Company was organized for the purpose of producing documentary films. On October 10, 2019, there was a change in control of the Company with the purchase of 270,000,000 of the Company’s Common stock and on that date the Company changed its name to Bioquest Corp. On October 12, 2019, the Company elected a new Board of Directors and approved a 2,000 to 1 Reverse Stock Split resulting in the reduction of the outstanding shares of the Company’s Common Stock from 454,254,585 shares to 237,233 shares of Common Stock. All common shares and per common share data in these financial statements and related notes hereto have been retroactively adjusted to account for the effect of the reverse stock split for all periods presented. The total number of authorized common shares and the par value thereof were not changed by the reverse stock split.

OnThe Company ~~July 3~~markets, ~~2014~~packages and distributes Hemp-CBD based products. . Our mission is to Create High End, Unique Content and aggregate all relevant CBD content in the ~~Company~~Nutraceutical ~~issued~~and ~~4,000,000~~Pharmaceutical markets. Bioquest Corp. is positioned to generate revenue by acquiring ~~shares~~established companies who have a current presence in the nutraceutical cannabis industry and bring new products to ~~each~~the ofmarket ~~its~~generating immediate ~~two~~revenues, ~~directors~~created, ~~for~~and ~~their~~marketed ~~services~~by Bioquest Corp.

~~On July 7, 2014, Mr. Geoffrey Mott was~~NOTE ~~hired~~2 as- ~~the~~SUMMARY ~~Company’s~~OF ~~Chief~~SIGNIFICANT ~~Executive~~ACCOUNTING ~~Officer and was appointed as a Director of the Company.~~ POLICIES

~~On July 18,~~Basis ~~2014, the Company entered into a Merger Agreement with Select-TV Solutions (USA), Inc. (“STVU”), a Florida corporation. Pursuant to the terms~~ of ~~the~~presentation Agreement, the Company shall issue 1.25 shares for each share STVU, or 49,678,443, and an additional 6,000,000 shares pursuant to a Convertible Promissory Note, maturing December 31, 2014, for a principal amount of CAN$150,000.00 issued by STVU, for a total of 55,678,443 shares. As a result of the merger, the Company, as the surviving entity, shall acquire the license rights to Select-TV HITV (Hospitality Interactive TV, software and hardware, and EMAGINE (home IPTV software and hardware), thus enabling the Company to provide end-to-end IPTV (Internet Protocol Television) solutions to the Hospitality, Residential and Hospital subscribers in the Americas. The Closing of the transaction was effective on the close of business July 31, 2014.

~~From~~The Company’s ~~May~~financial 1,statements ~~2014~~have ~~through~~been ~~July~~prepared ~~31,~~in ~~2014,~~accordance with accounting principles generally accepted in the United States ~~Company~~of ~~received~~America ~~$1,125,000~~(“U.S. ~~for~~GAAP”). ~~stock~~The ~~subscriptions~~preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to ~~purchase~~make ~~11,500,000~~estimates ~~shares~~and assumptions that affect the reported amounts of ~~its~~assets ~~common~~and liabilities ~~stock~~and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

~~The~~Management further ~~Company~~acknowledges ~~has~~that ~~evaluated~~it ~~subsequent~~is ~~events through~~solely ~~the~~responsible ~~date~~for ~~the~~adopting ~~financial~~sound ~~statements~~accounting ~~were~~practices, ~~issued~~establishing, and ~~filed~~maintaining ~~with~~a ~~Securities~~system of internal accounting control and ~~Exchange~~preventing ~~Commission~~and detecting fraud. The Company’s ~~has~~system ~~determined~~of internal accounting control is designed to assure, among other items, that ~~there~~1) recorded transactions are novalid; ~~other~~2) ~~such~~valid ~~events~~transactions ~~that~~are ~~warrant~~recorded; ~~disclosure~~and or3) ~~recognition~~transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.

~~F-12~~Income Taxes

~~Item~~The Company 9follows FASB ASC Subtopic 740, Income Taxes, for recording the provision for income taxes. ~~Changes~~Deferred intax assets and ~~Disagreements~~liabilities are ~~With~~computed ~~Accountants~~based onupon ~~Accounting~~the difference between the financial statement and ~~Financial~~income ~~Disclosure~~tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled.

OnDeferred income ~~July~~tax ~~18,~~expenses ~~2014,~~or benefits are based on the ~~Company~~changes ~~dismissed~~in ~~ZBS Group~~the ~~LLP~~asset ~~and~~or ~~engaged~~liability ~~DKM~~each ~~Certified~~period. ~~Public~~If ~~Accountants~~available asevidence ~~its~~suggests ~~independent~~that ~~registered~~it is ~~public~~more ~~accounting~~likely ~~firm~~than asnot ofthat ~~and~~some ~~for~~portion or all the ~~year ended~~deferred ~~April~~tax 30assets will not be realized, ~~2014.~~a ~~The~~valuation ~~change~~allowance inis ~~independent~~required ~~registered~~to ~~public~~reduce the ~~accounting~~deferred ~~firm~~tax isassets ~~not~~to the ~~result~~amount ofthat ~~any~~is ~~disagreement~~more ~~with~~likely ~~ZBS Group~~than ~~LLP~~not onto ~~any~~be ~~matter~~realized. ofFuture ~~accounting~~changes ~~principles~~in orsuch ~~practices,~~valuation ~~financial~~allowance ~~statement~~are ~~disclosure~~included in orthe ~~auditing~~provision ~~scope~~for ordeferred ~~procedure~~income taxes in the period of change.

Prior to its engagement as our independent auditors, DKM Certified Public Accountants, had not been consulted by us either with respect to the application of accounting principles to a specific transaction or the type of audit opinion that might be rendered our financial statements or on any other matter that was the subject of any prior disagreement between us and our previous certifying accountants.30

~~Item 9A. Controls and Procedures.~~Stock-based Compensation

~~Evaluation~~The Company follows FASB ASC Subtopic 718, Stock Compensation, for accounting for stock-based compensation. The guidance requires that new, modified, and unvested share-based payment transactions with employees, such as grants of ~~Disclosure~~stock ~~Controls~~options and ~~Procedures~~restricted stock, be recognized in the consolidated financial statements based on their fair value at the grant date and recognized as compensation expense over their vesting periods.

~~The Securities and Exchange Commission defines~~Basic ~~the~~Loss ~~term~~Per “disclosure controls and procedures” to mean a company's controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its chief executive and chief financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC's rules and forms and that information required to be disclosed is accumulated and communicated to chief executive and chief financial officers to allow timely decisions regarding disclosure.Share

AsFASB ASC ofSubtopic ~~the~~260, ~~end~~Earnings ofPer ~~the period covered by this report~~Share, weprovides ~~carried~~for ~~out~~the ancalculation ~~evaluation,~~of ~~under~~“Basic” ~~the~~and ~~supervision~~“Diluted” ~~and~~earnings ~~with~~per ~~the~~share. Basic ~~participation~~earnings ofper ~~our~~share ~~Chief~~is ~~Executive~~computed ~~Officer~~by ~~and~~dividing ~~our~~net ~~Chief Financial~~loss ~~Officer,~~available ofto ~~the~~common ~~effectiveness~~shareholders ofby the ~~design~~weighted ~~and~~average ~~operation~~number of ~~our~~common ~~disclosure~~shares outstanding ~~controls~~for ~~and~~the ~~procedures~~period. ~~Based~~All onpotentially ~~this~~dilutive ~~evaluation, the~~securities ~~Chief~~including ~~Executive~~stock ~~Officer~~options and ~~Acting~~stock ~~Chief~~payable ~~Financial Officer~~ have ~~concluded~~been ~~that~~excluded from the computations ~~Company’s~~since ~~disclosure~~they ~~controls~~would ~~and procedures~~be ~~are~~antidilutive. ~~not~~However, ~~effective~~these asdilutive ofsecurities ~~such~~could ~~date~~potentially dilute earnings per share in the future.

~~Management’s Annual Report on Internal Control over~~Cash ~~Financial~~and ~~Reporting~~Cash Equivalents

~~The~~Cash equivalents ~~management~~consist of ~~the~~highly ~~Company~~liquid isinvestments ~~responsible for~~with ~~the~~maturities ~~preparation~~ of ~~the~~three ~~financial~~months ~~statements~~or ~~and~~less ~~related~~when ~~financial information appearing in this Annual Report on Form 10-K~~purchased. ~~The~~ ~~financial~~Cash ~~statements~~ and ~~notes~~cash ~~have~~equivalents ~~been~~are on ~~prepared~~deposit ~~in conformity~~ with ~~accounting~~financial ~~principles~~institutions ~~generally~~without ~~accepted~~any ~~in the United States of America (“GAAP”)~~restrictions. ~~The~~At ~~management~~April of30, ~~the~~2021 ~~Company is also responsible for establishing~~ and ~~maintaining adequate internal control over financial reporting~~2020, ascash ~~defined~~equivalents inamounted ~~Rules 13a-15(f) and 15d-15(f) under the Exchange Act. A company's internal control over financial reporting is defined as a process designed~~ to ~~provide~~$260 ~~reasonable assurance regarding the reliability of financial reporting~~ and ~~the preparation of financial statements for external purposes in accordance with generally accepted accounting principles~~$166. ~~Our internal control over financial reporting includes those policies and procedures that:~~

· Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of our assets; · Provide reasonable assurance that our transactions are recorded as necessary to permit preparation of our financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and · Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.Revenue Recognition

~~Management,~~The Company ~~including~~will ~~the~~recognize ~~Chief~~revenue ~~Executive~~pursuant ~~Officer and~~to ~~Acting~~Accounting ~~Chief~~Standards ~~Financial~~Codification ~~Officer~~606, ~~does~~which ~~not~~requires ~~expect~~revenue to be recognized at an amount that reflects the ~~Company's~~consideration ~~disclosure~~expected ~~controls~~to ~~and~~be ~~internal~~received ~~controls~~in ~~will~~exchange ~~prevent~~for ~~all error~~transferring ~~and~~goods ~~all~~or ~~fraud~~services to customers. ~~Because~~Revenue ofis ~~its~~recognized when ~~inherent~~performance ~~limitations,~~obligations aare ~~system~~satisfied ofthrough ~~internal~~the transfer of control ~~over~~of ~~financial~~promised ~~reporting~~goods ~~can~~to ~~provide~~the ~~only~~Company’s customers. Control ~~reasonable,~~transfers ~~not~~once ~~absolute,~~a ~~assurance~~customer ~~that~~has the ~~objectives~~ability ofto direct the ~~control~~use ~~system~~of, ~~are met~~ and ~~may~~obtain ~~not~~substantially ~~prevent~~all orof ~~detect~~the ~~misstatements. Further,~~benefits ~~over time~~from, ~~control~~the ~~may~~product. ~~become~~This includes ~~inadequate~~the ~~because~~transfer of ~~changes~~legal intitle, ~~conditions~~physical orpossession, the ~~degree~~risks ofand ~~compliance~~rewards ~~with~~of ~~the~~ownership, ~~policies or~~and ~~procedures~~customer ~~may deteriorate~~acceptance.

14Revenue will be recognized for the Company’s wholesale customers sales when the Company ships the product from its inventory facility. Revenue will be recognized by the Company for e-commerce sales at the time the merchandise is shipped from our inventory facility. Customers typically receive goods within four days of shipment. Amounts related to shipping and handling that are billed to customers are reflected in revenues, and the related costs are reflected in cost of revenues. Taxes collected from customers and remitted to governmental authorities are presented in the consolidated statements of operations on a net basis. The nature of the Company’s business allows for customers to return previously purchased goods for a return or exchange which may result in a reduction of the Company’s revenues. These sales returns will not be significant to the Company’s revenues in the accompanying financial statements.

~~With~~Fair Value ~~the participation~~ of ~~the Chief Executive Officer and Acting Chief~~ Financial Officer, our management evaluated the effectiveness of the Company's internal control over financial reporting as of April 30, 2014 based upon the framework in Internal Control –Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management has concluded that, as of April 30, 2014, the Company had material weaknesses in its internal control over financial reporting. Specifically, management identified the following material weaknesses at April 30, 2014:Instruments

1.Financial Accounting ~~Lack~~Standards ofBoard ~~oversight~~(FASB) byAccounting ~~independent~~Standards ~~directors~~Codification in(ASC) ~~the~~820 ~~establishment~~“Fair Value Measurements and ~~monitoring~~Disclosures” of(ASC 820) ~~required~~defines ~~internal~~fair ~~controls~~value ~~and~~as ~~procedures;~~the 2.exchange ~~Lack~~price ofthat ~~functioning~~would ~~audit~~be ~~committee,~~received ~~resulting~~for inan ~~ineffective~~asset ~~oversight~~or paid to transfer a liability (an exit price) in the principal or most advantageous market for the ~~establishment~~asset ~~and~~or ~~monitoring~~liability ofin ~~required~~an ~~internal~~orderly ~~controls~~transaction ~~and~~between ~~procedures;~~market 3participants on the measurement date. ~~Insufficient~~ASC ~~personnel~~820 ~~resources~~also ~~within~~establishes ~~the~~a ~~accounting~~fair ~~function~~value tohierarchy ~~segregate~~that ~~the~~distinguishes ~~duties~~between ~~over~~(1) ~~financial~~market ~~transaction~~participant ~~processing~~assumptions developed based on market data obtained from independent sources (observable inputs) and (2) a reporting; 4entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). ~~Insufficient~~The ~~written~~fair ~~policies~~value ~~and~~hierarchy ~~procedures~~consists of ~~over~~three ~~accounting~~broad ~~transaction~~levels, ~~processing~~which ~~and~~gives ~~period~~the ~~end~~highest ~~financial~~priority ~~disclosure~~to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and ~~reporting~~the ~~processes~~lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

AsLevel 1 a- ~~result~~Unadjusted ofquoted ~~the~~prices ~~material~~in ~~weakness~~active ~~described above,~~markets ~~management has concluded~~ that, asare ofaccessible ~~April~~at ~~30,~~the ~~2014,~~measurement wedate ~~did~~for ~~not maintain effective internal control over financial reporting~~identical, ~~involving~~ ~~the~~unrestricted ~~preparation~~assets ~~and~~or ~~reporting of our financial statements presented in conformity with GAAP~~liabilities.

We understand that remediation of material weaknesses and deficiencies in internal controls is a continuing work in progress due to the issuance of new standards and promulgations. However, remediation of any known deficiency is among our highest priorities. Our management will periodically assess the progress and sufficiency of our ongoing initiatives and make adjustments as and when practical and necessary.31

~~This~~Level 2 ~~annual~~- ~~report~~Inputs ~~does~~other ~~not~~than ~~include~~quoted anprices ~~attestation~~included within Level 1 that are observable for the asset or liability, either directly or indirectly, ~~report~~including ofquoted ~~our~~prices ~~registered~~for ~~public~~similar ~~accounting~~assets ~~firm~~or ~~regarding~~liabilities ~~internal~~in ~~control~~active ~~over~~markets; ~~financial~~quoted ~~reporting.~~prices ~~Management’s~~for ~~report~~identical or similar assets or liabilities ~~was~~in ~~not~~markets ~~subject~~that toare ~~attestation~~not byactive; ~~our~~inputs ~~registered~~other ~~public~~than ~~accounting~~quoted ~~firm~~prices ~~pursuant~~that toare observable for the ~~rules~~asset ofor ~~the~~liability ~~SEC~~(e.g., interest rates); and inputs that ~~permit~~are usderived toprincipally ~~provide only~~from ~~management’s~~or ~~report~~corroborated inby ~~this~~observable ~~annual~~market ~~report~~data by correlation or other means.

~~Changes~~Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Our company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in ~~Internal~~estimating ~~Control~~fair ~~over~~value. Accordingly, ~~Financial~~the estimates of fair value may not be indicative of the amounts our company could realize in a current market exchange. ~~Reporting~~As of April 30, 2021, and 2020, the carrying value of accounts payable and loans that are required to be measured at fair value, approximated fair value due to the short-term nature and maturity of these instruments.

~~Other than the addition of Geoffrey Mott as~~NOTE ~~our~~3 ~~Chief~~– ~~executive~~GOING Officer and Acting Chief Financial Officer, there were no other changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.CONCERN

~~Item~~The accompanying ~~9B.~~financial ~~Other~~statements ~~Information~~have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

~~None~~As reflected in the accompanying financial statements, the Company had a Stockholders’ Deficit at April 30, 2021 of $1,769,941 as its liabilities exceeded its assets. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.

15Bioquest, Corp. markets, packages, and distributes Hemp-CBD based products and Pharmaceutical based and Government approved products. Our mission is to create high end unique content and aggregate all relevant CBD content in the Nutraceutical and Pharmaceutical markets including Medical Grade Products and Immune Health Products CBD. Bioquest Corp. is positioned to generate revenue by acquiring established company and bringing new products to the market, generating immediate revenues. The Company is implementing and marketing to the business-to-business and internet-based E-Commerce to the consumers’ market. The Company is implementing this plan to achieve profitable and sustainable operations.

~~PART~~The financial ~~III~~statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

~~Item~~NOTE 4 ~~10.~~– ~~Directors,~~RELATED ~~Executive~~PARTY ~~Officers and Corporate Governance.~~TRANSACTIONS

~~The~~During the ~~following~~year ~~table~~ended ~~sets~~April ~~forth~~30, ~~information with~~2020, ~~respect~~the Company issued to ~~persons~~its ~~who~~previous ~~are~~CEO ~~serving~~135,000 ascommon ~~directors~~shares ~~and~~(270,000,000 ~~officers~~pre reverse split) for repayment of related party debt incurred in payment of the Company’s expenses of $27,000. ~~Each~~ ~~director~~During ~~holds~~October ~~office~~2019, ~~until~~Tom Hemingway the Company’s ~~next~~new ~~annual~~CEO ~~meeting~~purchased ofthese ~~shareholders~~135,000 orshares ~~until~~creating ~~his~~a ~~successor~~change ~~has~~in ~~been~~control ~~elected~~of ~~and~~the ~~qualified~~Company.

			Held
			Position
Name	Age	Positions	Since
Geoffrey P. Mott	61	Chief Executive Officer	7/7/2014
Philippe Germain	30	Director	4/9/2014
Antonio Treminio	44	Director	4/9/2014
Jesse Lawrence (1)	38	Director, Chief Executive Officer and Chief Financial Officer	5/17/2011

During the year ended April 30, 2020, the Company issued 7,475,000 to its officers and directors under employment and consulting agreements. The agreements dated November 1, 2019, were for a five-year term with a five-year renewal options with compensation to begin April 1, 2020, with a one-time adjustment on August 1, 2020 and annual minimum increases. Under the employment agreements the Company issued 6,975,000 common shares valued at $.01 per share’ The consulting agreement with a director provided for the issuance of 500,000 common shares valued at $.01 per share. At April 30, 2020, there was $65,000 due to officers and shareholders under the employment and consulting agreements. At April 30, 2021 and 2020 there were $1,258,250 and $65,000 in accrued compensations due to officers and shareholders and $21,235 and $9,590 due to officers and shareholders for expense reimbursements.

~~(1)~~NOTE 5 ~~Resigned~~– onNOTES ~~April 9, 2014.~~PAYABLE

~~Biography~~The Company issued multiple notes payable in January and February 2020 in the amount of ~~Directors~~$40,000 due in two years from date of issuance, with interest at 6% and ~~Officers~~convertible in common shares at $1.00 per share.

Mr. Geoffrey P. Mott was appointed as Chief Executive Officer and Interim Chief Financial Officer of the Company on July 7, 2014. Mr. Mott has extensive experience as a Senior Executive, having served as Managing Director at VantagePoint Capital Partners and was involved in over $100M of direct investments across multiple IT sectors; CEO of Exymion Partners, an operational and financial consultancy based in Boston; Senior Vice President of Strategic Planning at Touchtunes Interactive Media; and Senior Advisor to Acuitux Technologies. Mr. Mott received his BA (1st Class Honors) and MA from Oxford University and a Master of Science in Management from the Sloan School of Economics at MIT, where he specialized in Finance, Economics and System Dynamics and was a Master’s thesis prizewinner.32

~~Mr.~~The Company ~~Philippe~~issued ~~Germain~~a ~~was~~note ~~appointed~~payable ~~as a~~in ~~Director~~September of2020 ~~the~~due ~~Company~~in onone ~~April~~year 9in the amount of $27,500 ~~2014.~~including Mrinterest at 10%. ~~Germain~~The note is ~~co-founder~~convertible at ofa ~~Oriana~~40% ~~Technologies/SelecTV~~discount ~~Solutions~~to (amarket ~~lead~~price ~~technological service~~after ~~provider~~90 ~~for~~days. ~~high-end~~In ~~boutique~~November ~~hotels);~~2020 ~~co-founder~~the ofCompany ~~Impera~~issued ~~Advisory~~an ~~Inc.,~~addition anote ~~strategic~~payable ~~business~~due ~~consulting~~in ~~firm~~one ~~headquartered~~ year in ~~Montreal~~the amount of $30,800 ~~Canada.~~including Heinterest ~~has~~at ~~held~~10%. ~~senior~~The ~~corporate~~note ~~positions~~convertible inat ~~both~~a ~~Europe~~60% ~~and~~discount ~~North~~to ~~America.~~market Mrprice. ~~Germain~~The ~~has~~Company aextended ~~combined~~the ~~degree~~due date into ~~economics~~February 2, 2022 and ~~political~~issued ~~sciences~~10,000 ~~with~~shares ~~specialization~~(postponement inshares) ~~finance~~for ~~and~~this ~~statistics~~extension. ~~from~~Because ~~Laval~~these ~~University~~convertible ~~and~~notes have floating conversion rates, the Company is ~~fluent~~unable into ~~French~~determine that there are sufficient shares authorized if the holders were to convert. Therefore, ~~German~~derivative accounting is triggered, which requires that we bifurcate and ~~English~~value the conversion features. We valued these features using the Black-Scholes pricing model. The related inputs are described below.

The expected ~~Mr.~~volatility ~~Antonio~~rate ~~Treminio~~ was ~~appointed~~estimated asbased on comparison to the volatility of a ~~Director on~~peer ~~April~~group 9,of ~~2014.~~companies ~~Mr.~~in ~~Treminio~~similar ~~has~~industries. ~~over~~The term 20for ~~years~~the conversion of ~~experience~~the innotes is based upon the ~~financial~~remaining ~~markets~~term ~~with special~~of ~~focus~~the onnotes. ~~corporate~~The ~~financing~~risk-free interest rate for ~~private~~periods ~~and~~within ~~public~~the contractual ~~companies~~life of the option is based on U.S. MrTreasury securities. ~~Treminio~~Circumstances ~~has~~may ~~broad~~change, ~~experience~~and inadditional ~~corporate~~data ~~debt~~may become available over time, which could result in changes to these assumptions and ~~equity~~methodologies, ~~structuring~~and thereby materially impact our fair value determination. The Company recorded an increase in note discount of $24,098, ~~market~~derivative ~~intelligence~~liability of $138,555 and ~~brand~~interest ~~recognition~~expense of $26,683. The Derivative liability is a Level 3 fair value instrument.

~~Mr. Jesse Lawrence was our President,~~The ~~Chief~~following ~~Executive~~table ~~Officer,~~for ~~Secretary, Treasurer and Chief Financial Officer Since~~ the ~~inception~~derivative ofliability ~~the~~summarizes ~~Company on May 17, 2011 and resigned from all positions on April 9, 2014. He has extensive experience within~~ the ~~film~~inputs ~~industry.~~used ~~His~~for previous practical work and background were closely connected with film making and film production works. Mr. Lawrence is a Chelsea School of Art and University of Miami graduate (2001) and has been working as a professional in the ~~film~~Black-Scholes ~~and~~pricing ~~television~~model ~~industry~~on ~~for~~ the ~~past~~nine ~~eight~~months ~~years on~~ended aApril ~~self-employed~~30, ~~basis~~2021.

Our directors are elected at the annual meeting of the shareholders, with vacancies filled by the Board of Directors, and serve until their successors are elected and qualified, or their earlier resignation or removal. Officers are appointed by the board of directors and serve at the discretion of the board of directors or until their earlier resignation or removal. Any action required can be taken at any annual or special meeting of stockholders of the corporation which may be taken without a meeting, without prior notice and without a vote, if consent of consents in writing setting forth the action so taken, shall be signed by the holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the corporation by delivery to its registered office, its principle place of business, or an officer or agent of the corporation having custody of the book in which the proceedings of meetings are recorded.

	Note 1			Note 2
Weighted average or exercise price	$	0.74		$	0.49
Risk free interest rate		0.66	%		0.75	%
Volatility		87.96	%		93.45	%
Expected terms years		0.66			0.75
Dividend yield		None			None

16NOTE 6 – STOCKHOLDERS’ DEFICIT

~~Indemnification~~Capital Stock ~~of Directors and Officers~~Issued

~~Nevada~~During the ~~Corporation~~year ~~Law~~ended ~~allows~~April ~~for the indemnification of officers~~30, ~~directors~~2020, ~~and~~the ~~any~~Company ~~corporate~~issued ~~agents~~7,747,000 inshares ~~terms~~of ~~sufficiently~~common ~~broad~~stock tounder ~~indemnify~~employment ~~such~~and ~~persons~~consulting ~~under~~agreements. ~~certain~~At ~~circumstances~~April ~~for liabilities~~30, ~~including reimbursement for expenses~~2020, ~~incurred arising under~~ the ~~1933~~company ~~Act.~~had ~~The~~subscription ~~Bylaws~~agreements offor ~~the~~30,000 ~~Company~~common ~~provide~~shares ~~that the Company will indemnify its directors and officers~~ to ~~the~~be ~~fullest~~issued ~~extent~~from ~~authorized~~cash orreceived ~~permitted~~of by$30,000 ~~law~~ and ~~such~~40,000 ~~right to indemnification~~shares ~~will~~for ~~continue~~cash asreceived tofrom aissuance ~~person~~of ~~who~~notes ~~has~~payable. ~~ceased~~During tothe beyear aended ~~director~~April or30,2021 ~~officer of~~ the Company ~~and~~issued ~~will~~67,500 ~~inure~~shares tofor ~~the benefit of his or~~$135,000 ~~her~~cash, ~~heirs~~70,000 ~~executors~~shares ~~and~~for ~~Consultants;~~stock ~~provided~~payable, ~~however~~540,000 ~~that,~~shares ~~except~~ for ~~proceedings to enforce rights to indemnification~~$540,000 the Company will not be obligated to indemnify any director or officer in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized by the Board of ~~Directors.~~employment ~~The~~and ~~right~~consulting toservices ~~indemnification conferred~~and ~~will~~9,000 ~~include~~shares ~~the~~for ~~right to be paid by the Company the expenses (including attorney’s fees) incurred in defending~~$18,000 ~~any~~on ~~such~~marketing ~~proceeding in advance of its final disposition~~services.

~~The Company may, to the extent authorized from~~Authorized ~~time~~Capital toStock ~~time~~Common by the Board of Directors, provide rights to indemnification and to the advancement of expenses to employees and agents of the Company similar to those conferred to directors and officers of the Company. The rights to indemnification and to the advancement of expenses are subject to the requirements of the 1940 Act to the extent applicable.Stock

~~Furthermore, the~~ The Company ~~may~~is ~~maintain~~authorized ~~insurance, at~~to ~~its~~issue ~~expense~~500,000,000 toshares ~~protect~~of ~~itself~~common ~~and~~stock ~~any~~with ~~director,~~a ~~officer,~~par ~~employee~~value orof ~~agent~~$0.001 ofper ~~the~~share. ~~Company~~As orof ~~another~~April ~~company~~30, ~~against~~2021, ~~any~~and ~~expense~~2020, ~~liability~~there orwere ~~loss~~8,730,733 ~~whether~~and ~~or not the Company would have the power to indemnify such person against such expense~~8,044,233 ~~liability~~shares ~~or loss~~issued ~~under~~and ~~the Nevada General Corporation Law~~outstanding.

~~Committees of the Board of Directors~~33

~~None.~~Note 7-INCOME TAXES

~~Auditors~~The components of the provision for income taxes are as follows:

Our independent registered public accounting firm is DKM Certified Public Accountants.

	Year Ended			Year Ended
	April 30, 2021			April 30, 2020
Current:
Federal	$	-		$	-
State
	$	-			-
Deferred:
Federal		(77,804	)		(75,396	)
State		-			-
		(77,804	)		(75,396	)
Valuation allowance		77,804			75,396
Total provision for income taxes	$	-		$	-

Deferred tax assets (liabilities) consist of the following:

Net Operating Loss for the Year		(2,323,962	)	$	(359,029	)
Deferred Stock Compensation		530,000
Deferred Compensation		1,308,500
Derivative Expense		85,775
Interest Expense Note Discount		28,682
Deferred Assets		1,952,957
Meals Adjustment		510
Taxable Loss		(370,495	)		(359,029	)
Net Operating Loss Carryforwards		729,524
Gross Deferred Tax Assets		2,682,481			354,554
Deferred Tax Asset		563,321			74,456
Valuation Allowance		(563,321	)		(74,456	)
Net Deferred Tax Assets	$	-		$	-

~~Code~~NOTE 8– ofSUBSEQUENT ~~Ethics~~EVENTS

~~We do not currently have a Code of Ethics because~~On weMay ~~have~~4, ~~limited~~2021, ~~business operations and only two officers/directors on~~ the ~~Board.~~Company Wefiled ~~believe~~Form a253(g)(2) ~~code~~to ofSupplement ~~ethics~~its ~~would~~Tier ~~have~~2 ~~limited utility~~Reg atA ~~this~~Filing ~~stage.~~in Weorder ~~intend~~ to ~~adopt~~reduce ~~such~~the ~~code~~share ofprice ~~ethics~~to ~~that would cover our business as soon as possible~~$1.00.

~~Item~~The Company ~~11.~~issued ~~Executive~~65,000 ~~Compensation~~shares of unrestricted common stock for cash of $65,000 through the use of its Regulation A Offering.

~~Our~~On June ~~directors~~29, do2021, ~~not~~the ~~receive~~Company ~~any~~authorized ~~stated~~its ~~salary for~~2021 ~~their~~Stock ~~services~~Compensation asPlan. ~~directors~~The orplan ~~members~~authorizes ofup ~~committees~~to ~~of the board of directors~~2,000,000 ~~but~~shares ~~by resolution~~ of ~~the~~company ~~board, a fixed fee~~common ~~may~~stock to be ~~allowed~~issued ~~for~~to ~~attendance~~its atofficers, ~~each meeting. Directors may also serve the company in other capacities as an officer~~directors, ~~agent or otherwise~~consultants, and ~~may~~any ~~receive compensation for their services in such~~ other ~~capacity.~~persons Nowhom ~~such~~the ~~fees~~Board ~~have~~of ~~been~~Directors ~~paid~~wishes to ~~any~~incite ~~director~~to contribute ~~since~~to ~~incorporation. Reasonable~~the ~~travel expenses are reimbursed~~Company.

1734

~~The following tables set forth information~~Item ~~concerning~~9. ~~all~~Changes ~~cash~~in ~~compensation~~and ~~awarded~~Disagreements ~~to,~~with ~~earned~~Accountants byon orAccounting ~~paid to all individuals serving as the Company’s principal executive officers during the last two completed fiscal years,~~ and ~~all~~Financial ~~non-cash compensation awarded to those same individuals as of April 30, 2014.~~Disclosure

						Stock		All Other
Name and Principal Position	Year	Salary		Bonus		Awards		Compensation		Total
Geoffrey P. Mott (1)	2014	$	–	$	–	$	–	$	–	$	–
Chief Executive Officer, Interim Chief Financial Officer	2013	$	–	$	–	$	–	$	–	$	–
Jesse Lawrence (2)	2014	$	–	$	–	$	–	$	–	$	–
Chief Executive Officer, Chief Financial Officer and Director	2013	$	–	$	–	$	–	$	–	$	–

None.

(1)		Mr. Geoffrey P. Mott was appointed as Chief Executive Officer and Interim Chief Financial Officer on July 7, 2014.
(2)		Mr. Jesse Lawrence was appointed as Chief Executive Officer, Chief Financial Officer and Director on May 17, 2011. Mr. Lawrence resigned from all positions on April 9, 2014.

Item 9A. Controls and Procedures

~~Item 12. Security Ownership of Certain Beneficial Owners~~ Controls and ~~Management and Related Stockholder Matters~~Procedures.

~~The following table shows the number and percentage~~Evaluation of ~~shares~~Disclosure ofControls ~~the Company’s common stock owned of record~~ and beneficially by each director and each officer of the Company, and by each person beneficially owning more than five (5%) percent of any class of the common stock, as of April 30, 2014. Except as otherwise noted, the address of the referenced individual is c/o Select-TV Solutions, Inc., 1395 Brickell Avenue, Suite 800, Miami, FL 33131.Procedures

AsIn connection ~~used~~with in the ~~table~~preparation ~~below~~of this annual report on Form 10-K, an evaluation was carried out by the ~~term~~Company’s “management, ~~beneficial~~who ~~ownership~~also ”serves ~~means~~as the ~~sole~~Chief orExecutive ~~shared~~Officer/Chief ~~power~~Financial toOfficer, ~~vote~~of orthe ~~direct~~effectiveness of the ~~voting,~~Company’s ordisclosure tocontrols and ~~dispose~~procedures or(as ~~direct~~defined in Rules 13a-15(e) and 15d-15(e) under the ~~disposition,~~Securities Exchange Act of 1934 (“Exchange Act”)) as of ~~any~~April ~~security~~30, 2021. ADisclosure ~~person~~controls isand ~~deemed~~procedures asare ofdesigned ~~any~~to ~~date~~ensure that information required to ~~have~~be ~~beneficial~~disclosed ~~ownership~~in ofreports ~~any~~filed or ~~security~~submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms and that such ~~person~~information ~~has~~is aaccumulated ~~right~~and communicated to ~~acquire~~ ~~within~~management, 60including ~~days~~the ~~after~~Chief ~~such~~Executive ~~date.~~Officer ~~Except~~and asthe ~~otherwise~~Chief Financial ~~indicated~~Officer, to allow timely decisions regarding required disclosures. Based on the ~~stockholders~~evaluation, ~~listed~~our ~~below~~Chief ~~have~~Executive ~~sole~~Officer/Chief ~~voting~~Financial Officer concluded disclosure controls and ~~investment powers~~procedures ~~with~~were ~~respect~~not toeffective as ~~the~~of ~~shares~~April ~~indicated~~30, 2021.

				Percent
	Title of Stock	Beneficial		of
Name and Postion	Class	Ownership		Class (4)
Conseil Plumage Blanc Ltd. (1)	Common Stock	40,000,000	(Direct)	73.89%
Geoffrey P. Mott (3)	Common Stock	–		–%
Philippe Germain (2)	Common Stock	–		–%
Antonio Treminio (2)	Common Stock	–		–%
All Directors and Officers as a Group	Common Stock	–		–%

Management’s Report on Internal Control over Financial Reporting

(1)		Conseil Plumage Blanc Ltd. is a company incorporated in Delaware having its offices at 3422 Old Capitol Trail, Suite 700, Wilmington, DE 19808
(2)		Indicates director.
(3)		Indicates officer.
(4)		The percentage of common stock is calculated based upon 54,134,000 shares issued and outstanding as of April 30, 2014.

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and Rule 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the Company’s Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that:

18● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; ● provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and ● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

~~Item~~The Company’s 13management assessed the effectiveness of the Company’s internal control over financial reporting as of April 30, 2021. ~~Certain~~In ~~Relationships~~making ~~and~~this ~~Related~~assessment, ~~Transactions~~it used the criteria set forth in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on its assessment, ~~and~~management ~~Director~~concluded ~~Independence~~that, as of April 30, 2021, the Company’s internal control over financial reporting is not effective based on those criteria due to the material weaknesses as described below.

The matters ~~Company~~involving ~~has~~internal nocontrols ~~cash. All~~and ~~operating~~procedures that our management considered to be material weaknesses under the standards of the ~~expenses~~Public ~~are~~Company ~~currently~~Accounting ~~being~~Oversight ~~paid~~Board bywere ~~our~~inadequate ~~majority~~segregation ~~Shareholder,~~of ~~Conseil~~duties ~~Plumage~~consistent ~~Blanc~~with ~~Ltd.~~control objectives, and ~~are~~lack ~~shown~~of asan ~~due~~audit committee toand ~~shareholder on~~limited expertise with complex debt and equity transactions. These material weaknesses were identified by our ~~balance~~Chief Financial ~~sheet~~Officer in connection with the above annual evaluation.

~~The Company has no formal written employment~~Management’s ~~agreement~~Remediation or other contracts with our current Chief Executive and Chief Financial Officers, and there is no assurance that the services to be provided by them will be available for any specific length of time in the future. The amounts of compensation and other terms of any full time employment arrangements would be determined, if and when, such arrangements become necessary.Initiatives

~~Item~~In an ~~14.~~effort ~~Principal~~to ~~Accounting~~remediate ~~Fees~~the identified material weaknesses and ~~Services.~~other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:

~~Audit~~We will ~~Fees~~create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us. And we plan to appoint one or more outside directors to our board of directors who shall be appointed to an audit committee resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures such as reviewing and approving estimates and assumptions made by management when funds are available to us.

OnManagement believes ~~July~~that ~~18, 2014,~~ the ~~Company~~appointment ~~replaced~~of ~~ZBS Group~~more ~~LLP~~outside ~~and~~directors, ~~engaged~~who ~~DKM~~shall ~~Certified~~be ~~Public~~appointed ~~Accountants~~to asa ~~its~~fully ~~independent~~functioning ~~registered~~audit ~~public~~committee, ~~accounting~~will ~~firm~~remedy ~~as of and for~~ the ~~year~~ ~~ended~~lack ~~April~~of ~~30,~~a ~~2014. The~~functioning ~~change~~audit incommittee ~~independent~~and ~~registered~~a ~~public~~lack ~~accounting~~of ~~firm~~a ~~was~~majority ~~not the result~~ of ~~any~~outside ~~disagreement with~~directors ~~ZBS~~on ~~Group~~our ~~LLP~~Board.

~~The aggregate fees billed by ZBS Group LLP~~We ~~for~~will ~~the~~work ~~audit~~as ofquickly ~~the~~as ~~Company’s~~possible ~~annual~~to ~~financial~~implement ~~statements~~these ~~were~~initiatives; ~~$-0- for the year ended April 30~~however, ~~2014. The aggregate fees billed by DKM Certified Public Accountants for~~ the ~~audit~~lack of ~~the~~adequate ~~Company’s~~working ~~annual~~capital ~~financial~~and ~~statements~~positive ~~were~~cash ~~$-0- for the year~~flow ~~ended~~from ~~April~~operations ~~30,~~will ~~2014.~~likely ~~The~~slow ~~aggregate~~this ~~fees billed by ZBS Group LLP for review of the Company's financial statements included in its quarterly reports on Form 10-Q were $2,250 during the year ended April 30, 2014~~implementation.

~~Audit-Related~~Changes in ~~Fees~~Internal Control

~~For~~As of the ~~years~~end of the period covered by this report, there have been no changes in internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the year ended April 30, ~~2014~~2021, ~~and~~that ~~2013~~materially affected, ~~our~~ ~~principal~~or ~~accountants~~are ~~did~~reasonably ~~not~~likely ~~render~~to ~~any~~materially affect, ~~audit-related~~the ~~services~~Company’s internal control over financial reporting.

~~Tax~~This annual ~~Fees~~report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management’s report in this annual report.

~~For the fiscal years ended April 30, 2014 and~~Item ~~2013,~~9B. ~~our~~Other ~~principal accountants did not render any services for tax compliance, tax advice, or tax planning work.~~Information

~~All Other Fees~~None.

~~The Company has no other related fees.~~35

~~Prior to engaging its accountants to perform~~Part a particular service, our board of directors obtains an estimate for the service to be performed. All of the services described above were approved by the board of directors in accordance with its procedures.III

19Item 10. Director and Executive Officer

~~PART~~Directors and IVExecutive Officers

~~Item~~The following ~~15.~~table ~~Exhibits~~sets forth information regarding our executive officers, ~~Financial~~directors, ~~Statement~~and ~~Schedules~~significant employees, including their ages as of April 30, 2021.

~~Financial~~As of ~~Statements~~April 30, 2021, BioQuest Corp. had seven-full-time employees, and no part-time employees. The directors and executive officers of the Company as of April 30, 2021, are as follows:

See Item 8. Financial Statements and Supplementary Data

Name	Position	Age	Date of Appointment	Approx. Hours Per Week
Thomas Hemingway	CEO and Director	64	October 10, 2019	40
Michael Krall	President, COO and Director	69	October 10, 2019	40
Robert Orbach	Director	66	October 10, 2019	10
David Noyes	CFO	78	October 10, 2019	40
Jeffery Donnell	EVP Operations EVP Operations and Director	69	October 10, 2019	40
Pam A. Daily	Marketing Officer	70	June 1, 2020	40

~~Exhibits~~Thomas Hemingway, Age 65: Chairman and CEO, Currently, Chairman and President of Redwood Investment Group (1996 to current), and Pillar Marketing Group, Inc. (April 2011 to current). Previously, the Founder, Chief Executive Officer and Chairman of Oxford Media (2004 to 2006) and Chief Executive Officer and Chairman MetroConnect (2007 to 2009). Mr. Hemingway has also served as CEO and Chairman of Esynch Corporation and Chairman and CEO of Intermark Corporation, a software developer and publisher in the entertainment markets. Prior, Mr. Hemingway was President and CEO of Omni Advanced Technologies and Intellinet Information Systems. In addition, Mr. Hemingway has been a consultant and or board member to several NASDAQ and privately held companies. Bachelor of Sciences, Political Science, SUNY Albany.

Exhibit 31.1	Rule 13a-14(a) Certification by the Chief Executive Officer *
Exhibit 31.2	Rule 13a-14(a) Certification by the Chief Financial Officer *
Exhibit 32.1	Certification by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
Exhibit 32.2	Certification by the Interim Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
101.INS	XBRL Instance Document **
101.SCH	XBRL Taxonomy Extension Schema Document **
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document **
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document **
101.LAB	XBRL Taxonomy Extension Label Linkbase Document **
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document **

Michael Krall, Age 69: President, COO and Board Member of BioQuest Corporation since October 2019 to current. Mr. Krall was the founder of PURE Bioscience, Inc. where he held the positions of President, CEO and Chairman of the Board from 1998 to 2014. From 2015 to present, Mr. Krall has advised companies on biotech products and processes. Additionally, he is an inventor and co-inventor of dozens of domestic and international patented biotech products. Mr. Krall brings a wealth of knowledge of the biotech, manufacturing, and securities industries, including his leadership ability, dedication and commitment to excellence make him well suited to this highly regulated industry.

*	Filed herewith.
**	XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

Jeffery Donnell, Age 69: CBDO (Chief Business Development Officer, Board Member) since October 2019 Mr. Donnell has served in senior level positions for private and public companies over the past 40 years including COO of Enviroguard Sciences, LLC, (2003 to 2007) a distribution company for bio-chemical products throughout the United States. Executive Vice President of Business Development for Pure Bioscience, (2007 to 2013) a public company responsible for the production and distribution of biochemical products nationally and internationally. From 2015 to current Mr. Donnell has been providing advisory services to companies on a part-time basis. He has established and expanded business relations with Fortune 500 companies including Cardinal Health, CareFusion and Brenntag.

2036

~~SIGNATURES~~David Noyes, Age 78: CFO - recently, Fort Worth based EnviroSolar Power, a green energy solutions provider to the home energy marketplace since March 2014. Previously, he was CFO for KOR Company, Inc. a commercial fire and security company from November 2012 until March 2014. He is Managing Director of Monarch Capital Resources, Inc., a business-consulting firm. He is co-founder and EVP for Tech Energy Services, Inc. a green energy technology firm. He has been CFO of five publicly traded companies, most recently NextPhase Wireless, Inc. from February 2007 through March 2008; Oxford Media, Inc. from August 2004 through February 2007; Local.com from January 2001 through January 2003 and Mergence Corporation from September 1999 through November 2000. He was Chief Executive Officer and Chief Financial Officer and Director of Ortho Mattress from 1996 through 1997; President, Chief Financial Officer and Director of California Software Products, Inc. in 1996 and Director and Chief Financial Officer of Griswold Industries in 1994 and 1995. Previously he was President, Director and Chief Executive Officer of Structural Coatings, Inc. and Executive Vice President, Chief Executive Officer, Chief Operating Officer and Chief Financial Officer of General Power Systems, Power Paragon and Scientific Drilling International. He was a senior Manager with Ernst and Young, is a Certified Public Accountant and has an MBA from the Anderson School of Management at UCLA. He has served on several Boards of Directors and has extensive SEC experience and has raised in excess of $500 million.

~~Pursuant~~Pamela A toDaily, Age 70: Chief Marketing Officer Pam is one of the ~~requirements~~founders of ~~Section~~the 13infomercial direct marketing industry. She has been instrumental orin ~~15(d)~~the rapid financial and physical growth of multiple Fortune 500 companies. Over the ~~Securities~~past ~~Exchange~~thirty ~~Act~~years, Pamela has held Executive positions with companies such as Media Arts International, National Media Corporation, Reliant Interactive, Achievement Dynamics (Verbal Advantage), Vision Direct Marketing, Aftermarket Company, Global Efficient Energy, Majic Beauty Inc., and many others. In all of ~~1934~~these entities, Pam’s ~~the~~executive ~~registrant~~duties ~~has~~resulted ~~duly~~in ~~caused~~record ~~this~~increases ~~report~~in revenues. Previous to beDaily’s ~~signed~~Executive onManagement ~~its~~and ~~behalf~~Marketing bycareer, she held Sales and Marketing positions in the ~~undersigned~~field of corporate advertising with AT&T, ~~thereunto~~ ~~duly~~Gannett ~~authorized~~Corporation and NBC.

/s/ Geoffrey P. Mott		August 13, 2014
Geoffrey P. Mott, Chief Executive Officer		Date

Robert Orbach, Age 66: Director, BioQuest Corporation, since October 2019, is a seasoned, accomplished entrepreneur with talent for recognizing emerging trends since 1992 and a proven track record for building strategic partnerships. Mr. Orbach has been providing advisory services on a part time basis to companies from 2015 to present. Bobby has over 30 years’ experience in retail, finance, IP and building emerging technology companies. Mr. Orbach was one of the founders of 47th Street Computers and electronics, a large retailer in the late 80’s and 90’s. He advised countless technology companies and managed successful business deals. Bobby has served as a director and board member of many public and private sector companies. Bobby has been a broker and advisor in the IP monetization business and has successfully sold and brokered over 60 technology patent portfolios. He was awarded Excellence and Quality service award from Intellectual Ventures in 2012. Throughout his career, Bobby has aligned his business interests with his personal values - nurturing human potential and promoting people relations as well as supporting philanthropic causes. Mr. Orbach is an advisor and on the board of several charities and nonprofit community organizations.

~~Pursuant to the requirements of the Securities~~Term ~~Exchange Act~~ of ~~1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.~~Office

/s/ Philippe Germain		August 13, 2014
Philippe Germain, Director		Date

Directors are appointed to hold office until the next annual meeting of our stockholders or until a successor is elected and qualified, or until they resign or are removed in accordance with the provisions of the Nevada Revised Statutes. Officers are appointed by our Board of Directors and hold office until removed by the Board. The Board of Directors has no nominating, auditing, or compensation committees.

/s/ Antonio Treminio		August 13, 2014
Antonio Treminio, Director		Date

Identification of Significant Employees

21Thomas Hemingway, David Noyes, and Michael Krall are officers and directors of the Company who serve on a full-time basis. Robert Orbach, Jeffery Donnell are Directors of the Company. Other than our officers and directors, we currently have two (2) employees. None of the employees are represented by a labor union for purposes of collective bargaining. The Company considers its relations with the employees to be good.

Family Relationship

We currently do not have any officers or directors of our Company who are related to each other.

Involvement in Certain Legal Proceedings

During the past ten years no director, executive officer, promoter, or control person of the Company has been involved in the following:

	(1)	A petition under the Federal bankruptcy laws or any state insolvency law which was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

	(2)	Such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

	(3)	Such person was the subject of any order, judgment, or decree, not subsequently reversed, suspended, or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities:

	i.	Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

	ii.	Engaging in any type of business practice; or

	iii.	Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

	(4)	Such person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (f)(3)(i) of this section, or to be associated with persons engaged in any such activity;

	(5)	Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

	(6)	Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

	(7)	Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended, or vacated, relating to an alleged violation of:

	i.	Any Federal or State securities or commodities law or regulation; or

	ii.	Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

	iii.	Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

(8)

Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Audit Committee and Audit Committee Financial Expert

The Company does not have an audit committee or an audit committee financial expert (as defined in Item 407 of Regulation S-K) serving on its Board of Directors. The current member of the Board of Directors lacks sufficient financial expertise for overseeing financial reporting responsibilities. The Company has not yet employed an audit committee financial expert on its Board due to the inability to attract such a person.

The Company intends to establish an audit committee of the Board of Directors, which will consist of independent directors. The audit committee’s duties will be to recommend to the Company’s Board of Directors the engagement of an independent registered public accounting firm to audit the Company’s financial statements and to review the Company’s accounting and auditing principles. The audit committee will review the scope, timing and fees for the annual audit and the results of audit examinations performed by the internal auditors and independent registered public accounting firm, including their recommendations to improve the system of accounting and internal controls. The audit committee will at all times be composed exclusively of directors who are, in the opinion of the Company’s Board of Directors, free from any relationship which would interfere with the exercise of independent judgment as a committee member and who possess an understanding of financial statements and generally accepted accounting principles.

Code of Ethics

Our board of directors has not adopted a code of ethics due to the fact that we presently only have four directors and we are in the development stage of our operations. We anticipate that we will adopt a code of ethics when we increase either the number of our directors and officers or the number of our employees.

Compliance with Section 16(a) of the Exchange Act

Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who beneficially own more than 10% of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership. These reporting persons are required by SEC regulations to furnish us with copies of all such reports they file. To our knowledge, based solely on our review of the copies of such reports furnished to us and written representations from certain insiders that no other reports were required, we believe there were no applicable reporting persons based on all applicable Section 16(a) filing requirements with respect to transactions during the fiscal years ended April 30, 2021 and 2020.

Item 11. Executive Compensation

The following summary compensation table sets forth all compensation awarded to, earned by, or paid to our named executive Officer paid by us during the years ended April 30, 2021 and 2020, in all capacities for the accounts of our executives, including the Chief Executive Officer (CEO) and Chief Financial Officer (CFO):

Narrative Disclosure to Summary Compensation Table

There are no employment contracts, compensatory plans or arrangements, including payments to be received from the Company with respect to any executive officer, that would result in payments to such person because of his or her resignation, retirement or other termination of employment with the Company, or its subsidiaries, any change in control, or a change in the person’s responsibilities following a change in control of the Company.

														Non-
														Qualified
												Non-Equity		Deferred
Name and						Stock		Stock		Options		Incentive Plan		Compensation		All Other				Accrued
Principal		Salary		Bonus		Awards		Awards		Awards		Compensation		Earnings		Compensation		Total		Compensation
Position	Year	$		$		Shares		$		$		$		$		$		$		$

Tom Hemingway	2021		36,000																36,000		308,500
CEO, Director	2020		38,500		-		2,875,000		28,750		-		-		-		-		60,250		20,000

Michael Krall	2021		32,500		-		-		-		-		-		-		-		32,500		317,500
President ,COO,Director	2020		31,500		-		2,550,000		25,500		-		-		-		-		57,000		20,000

Robert Orbach	2021		-		-		-		-		-		-		-		-		-		55,000
Director	2020		-		-		500,000		5,000		-		-		-		-		5,000		5,000

David Noyes	2021		12,000																12,000		228,000
CFO	2020		12,000		-		750,000		7,500		-		-		-		-		19,500		15,000

Jeffrey Donald	2021		-		-		-		-		-		-		-		-		-		175,000
EVP Operations	2020		15,000		-		800,000		8,000		-		-		-		-		23,000		15,000

Pam A. Daily	2021		10,000				200,000		200,000										210,000		145,000

Outstanding Equity Awards at Fiscal Year-End: Include the following language and chart:

The table below summarizes the outstanding equity awards to our executive officers as of April 30, 2021.

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END

OPTION AWARDS

STOCK AWARDS

Name

Number of

Securities

Underlying

Unexercised

Options

(#)

Exercisable

Number of

Securities

Underlying

Unexercised

Options

(#)

Unexercisable

Equity

Incentive

Plan

Awards:

Number of

Securities

Underlying

Unexercised

Unearned

Options

(#)

Option

Exercise

Price

($)

Option

Expiration

Date

Number
of
Shares
or Units
of
Stock That
Have
Not
Vested
(#)

Market

Value

Units

Stock

That

Have

Not

Vested

($)

Equity

Incentive

Plan

Awards:

Number

Unearned

Shares,

Units or

Other

Rights

That Have

Not

Vested

(#)

Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)

Long-Term Incentive Plans

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers.

Compensation Committee

We currently do not have a compensation committee of the Board of Directors. The Board of Directors as a whole determines executive compensation.

Compensation of Directors

Our directors receive no extra compensation for their service on our Board of Directors.

Item 12. Security Ownership of Certain Beneficial Owners and Management

The following table sets forth certain information concerning the number of shares of our common stock owned beneficially as of April 30, 2021 of: (i) each person (including any group) known to us to own more than five percent (5%) of any class of our voting securities, (ii) our director, and or (iii) our officer. Unless otherwise indicated, the stockholder listed possesses sole voting and investment power with respect to the shares shown.

We have determined beneficial ownership in accordance with Rule 13d-3 under the Exchange Act. Beneficial ownership generally means having sole or shared voting or investment power with respect to securities. Unless otherwise indicated in the footnotes to the table, each shareholder named in the table has sole voting and investment power with respect to the shares of common stock set forth opposite the shareholder’s name. We have based our calculation of the percentage of beneficial ownership on 8,730,733 shares of the Company’s common stock outstanding on April 30, 2021.

Name of Beneficial Owner	Amount and Nature of Beneficial Ownership(1)		Percentage of Beneficial Ownership(2)
Directors and Officers:
Tom Hemingway, CEO & Director		2,985,000		34	%
David Noyes, CFO		750,000		9	%
Michael Krall, President, & Director		2,550,000		29	%
Jeffery Donnell, Vice President, Director		800,000		9	%
Robert Orbach, Director		500,000		6	%
Pam Daily, Chief Marketing Officer		200,000		2	%
All executive officers and directors as a group		7,785,000		89	%
Total Outstanding		8,730,733		100	%

	1)	The number and percentage of shares beneficially owned is determined under rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares which the individual has the right to acquire within 60 days through the exercise of any stock option or other right. The persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and the information contained in the footnotes to this table
	2)	Based on 8,730,733 issued and outstanding shares of common stock as of April 30, 2021.

Changes in Control

There are no present arrangements or pledges of the Company’s securities, which may result in a change in control of the Company.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

Director Independence

The Board of Directors is currently composed of four members. Thomas Hemingway, and Michael Krall do not qualify as independent Directors in accordance with the published listing requirements of the NASDAQ Global Market. Robert Orbach qualifies as Independent Director in accordance with the published listing requirements of the NASDAQ Global Market. The NASDAQ independence definition includes a series of objective tests, such as that the Director is not, and has not been for at least three years, one of the Company’s employees and that neither the Director, nor any of his family members has engaged in various types of business dealings with us. In addition, the Board of Directors has not made a subjective determination as to each Director that no relationships exist which, in the opinion of the Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a Director, though such subjective determination is required by the NASDAQ rules. Had the Board of Directors made these determinations, the Board of Directors would have reviewed and discussed information provided by the Directors and the Company with regard to each Director’s business and personal activities and relationships as they may relate to the Company and its management.

Related Party Transactions

During the year ended April 30, 2020, the Company issued to its previous CEO 135,000 common shares (270,000,000 pre reverse split) for repayment of related party debt incurred in payment of the Company’s expenses of $27,000. During October 2019, Tom Hemingway the Company’s new CEO purchased these 135,000 shares creating a change in control of the Company.

Other than the foregoing, neither the director nor executive officer of the Company, nor any person who owned of record or was known to own beneficially more than 5% of the Company’s outstanding shares of its Common Stock, nor any associate or affiliate of such persons or companies, has any material interest, direct or indirect, in any transaction that has occurred during the past fiscal year, or in any proposed transaction, which has materially affected or will affect the Company.

With regard to any future related party transaction, we plan to fully disclose any and all related party transactions in the following manor:

	●	Disclosing such transactions in reports where required;
	●	Disclosing in any and all filings with the SEC, where required;
	●	Obtaining disinterested directors consent; and
	●	Obtaining shareholder consent where required.

Review, Approval or Ratification of Transactions with Related Persons

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 14. Principal Accounting Fees and Services

During the fiscal years ended April 30, 2021, we incurred approximately $54,117 in fees to our principal independent accountants for professional services rendered in connection with the audit and reviews of our financial statements for fiscal years ended April 30, 2021.

During the fiscal year ended April 30, 2020, we incurred approximately $-0- in fees to our principal independent accountants for professional services rendered in connection with the audit and reviews of our financial statements for fiscal year ended April 30, 2020.

Audit-Related Fees

All Other Fees

The aggregate fees billed during the fiscal years ended April 30, 2021, and 2020 for products and services provided by our principal independent accountants (other than the services reported in Items 9(e)(1) through 9(e)(3) of Schedule 14A was $0 and $0, respectively.

Part IV

Item 15. Exhibits

(a) Exhibits

Exhibit Number		Exhibit Description
31.1		Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Exchange Act pursuant to Section 302 of the Sarbanes- Oxley Act of 2002
32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
EX-101.INS		XBRL Instance Document
EX-101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
EX-101.SCH		XBRL Taxonomy Extension Schema Document
EX-101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
EX-101.LAB		XBRL Taxonomy Extension Labels Linkbase Document
EX-101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

Signatures

Pursuant to the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BIOQUEST CORP, INC.

BioQuest Corp.

/s/ Thomas Hemingway		August 13, 2021
Thomas Hemingway, CEO, Principal Executive Officer, Director		Date

/s/ Michael Krall		August 13, 2021
Michael Krall, President, Director		Date

/s/ David Noyes		August 13, 2021
David Noyes, CFO, Principal Accounting Officer		Date

/s/ Jeffery Donnell		August 13, 2021
Jeffery Donnell, Director		Date

/s/ Robert Orbach		August 13, 2021
Robert Orbach, Director		Date

Filing Compare · Bioquest Corp